10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                     to                      

Commission file number: 1-8923

WELLTOWER INC.

(Exact name of registrant as specified in its charter) 

Delaware			34-1096634
(State or other jurisdiction of Incorporation)			(IRS Employer Identification No.)
4500 Dorr Street	Toledo,	Ohio	43615
(Address of principal executive offices)			(Zip Code)
(419)			247-2800
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $1.00 par value per share	WELL	New York Stock Exchange
4.800% Notes due 2028	WELL28	New York Stock Exchange
4.500% Notes due 2034	WELL34	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨

Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	þ	Accelerated filer	¨	Non-accelerated filer	¨	Smaller reporting company	☐	Emerging growth company	☐
(Do not check if a smaller reporting company)

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No  þ

As of July 19, 2019, the registrant had 405,246,816 shares of common stock outstanding. 

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets - June 30, 2019 and December 31, 2018	3
Consolidated Statements of Comprehensive Income - Three and six months ended June 30, 2019 and 2018	4
Consolidated Statements of Equity - Three and six months ended June 30, 2019 and 2018	6
Consolidated Statements of Cash Flows - Six months ended June 30, 2019 and 2018	7
Notes to Unaudited Consolidated Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	28
Item 3. Quantitative and Qualitative Disclosures About Market Risk	50
Item 4. Controls and Procedures	51
PART II. OTHER INFORMATION
Item 1. Legal Proceedings	51
Item 1A. Risk Factors	52
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	52
Item 5. Other Information	52
Item 6. Exhibits	53
Signatures	53

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements 

CONSOLIDATED BALANCE SHEETS

WELLTOWER INC. AND SUBSIDIARIES

(In thousands) 

	June 30, 2019 (Unaudited)			December 31, 2018 (Note)
Assets:
Real estate investments:
Real property owned:
Land and land improvements	$	3,337,234		$	3,205,091
Buildings and improvements	28,691,274			28,019,502
Acquired lease intangibles	1,589,138			1,581,159
Real property held for sale, net of accumulated depreciation	1,704,206			590,271
Construction in progress	363,160			194,365
Less accumulated depreciation and amortization	(5,539,435		)	(5,499,958		)
Net real property owned	30,145,577			28,090,430
Right of use assets, net	550,342			—
Real estate loans receivable, net of allowance	368,994			330,339
Net real estate investments	31,064,913			28,420,769
Other assets:
Investments in unconsolidated entities	519,387			482,914
Goodwill	68,321			68,321
Cash and cash equivalents	268,666			215,376
Restricted cash	91,052			100,753
Straight-line rent receivable	419,501			367,093
Receivables and other assets	716,857			686,846
Total other assets	2,083,784			1,921,303
Total assets	$	33,148,697		$	30,342,072
Liabilities and equity
Liabilities:
Unsecured credit facility and commercial paper	$	1,869,188		$	1,147,000
Senior unsecured notes	10,606,106			9,603,299
Secured debt	2,675,507			2,476,177
Lease liabilities	469,029			70,668
Accrued expenses and other liabilities	1,076,061			1,034,283
Total liabilities	16,695,891			14,331,427
Redeemable noncontrolling interests	483,234			424,046
Equity:
Preferred stock	—			718,498
Common stock	406,014			384,465
Capital in excess of par value	19,740,145			18,424,368
Treasury stock	(74,042		)	(68,499		)
Cumulative net income	6,539,766			6,121,534
Cumulative dividends	(11,516,994		)	(10,818,557		)
Accumulated other comprehensive income (loss)	(100,622		)	(129,769		)
Other equity	188			294
Total Welltower Inc. stockholders’ equity	14,994,455			14,632,334
Noncontrolling interests	975,117			954,265
Total equity	15,969,572			15,586,599
Total liabilities and equity	$	33,148,697		$	30,342,072

 

NOTE: The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands, except per share data) 

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Revenues:
Resident fees and services	$	914,085		$	763,345		$	1,782,370		$	1,499,279
Rental income	385,586			333,601			766,670			676,970
Interest income	17,356			13,462			32,475			28,110
Other income	3,079			15,504			10,836			18,518
Total revenues	1,320,106			1,125,912			2,592,351			2,222,877
Expenses:
Property operating expenses	701,127			568,751			1,371,934			1,125,216
Depreciation and amortization	248,052			236,275			491,984			464,476
Interest expense	141,336			121,416			286,568			244,191
General and administrative expenses	33,741			32,831			69,023			66,536
Loss (gain) on derivatives and financial instruments, net	1,913			(7,460		)	(574		)	(14,633		)
Loss (gain) on extinguishment of debt, net	—			299			15,719			12,006
Provision for loan losses	—			—			18,690			—
Impairment of assets	9,939			4,632			9,939			32,817
Other expenses	21,628			10,058			30,384			13,770
Total expenses	1,157,736			966,802			2,293,667			1,944,379
Income (loss) from continuing operations before income taxes and other items	162,370			159,110			298,684			278,498
Income tax (expense) benefit	(1,599		)	(3,841		)	(3,821		)	(5,429		)
Income (loss) from unconsolidated entities	(9,049		)	1,249			(18,248		)	(1,180		)
Gain (loss) on real estate dispositions, net	(1,682		)	10,755			165,727			348,939
Income (loss) from continuing operations	150,040			167,273			442,342			620,828
Net income	150,040			167,273			442,342			620,828
Less: Preferred stock dividends	—			11,676			—			23,352
Less: Net income (loss) attributable to noncontrolling interests(1)	12,278			1,165			24,110			5,373
Net income (loss) attributable to common stockholders	$	137,762		$	154,432		$	418,232		$	592,103
Average number of common shares outstanding:
Basic	404,607			371,640			398,073			371,552
Diluted	406,673			373,075			400,096			373,186
Earnings per share:
Basic:
Income (loss) from continuing operations	$	0.37		$	0.45		$	1.11		$	1.67
Net income (loss) attributable to common stockholders	$	0.34		$	0.42		$	1.05		$	1.59
Diluted:
Income (loss) from continuing operations	$	0.37		$	0.45		$	1.11		$	1.66
Net income (loss) attributable to common stockholders	$	0.34		$	0.41		$	1.05		$	1.59
Dividends declared and paid per common share	$	0.87		$	0.87		$	1.74		$	1.74

 

⁽¹⁾ Includes amounts attributable to redeemable noncontrolling interests.

4

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands) 

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019		2018
Net income	$	150,040		$	167,273		$	442,342	$	620,828
Other comprehensive income (loss):
Foreign currency translation gain (loss)	(54,024		)	(200,826		)	24,596		(121,802		)
Derivative instruments gain (loss)	100,407			150,703			12,725		88,005
Total other comprehensive income (loss)	46,383			(50,123		)	37,321		(33,797		)
Total comprehensive income (loss)	196,423			117,150			479,663		587,031
Less: Total comprehensive income (loss) attributable to noncontrolling interests(1)	14,665			(7,580		)	32,284		(7,258		)
Total comprehensive income (loss) attributable to common stockholders	$	181,758		$	124,730		$	447,379	$	594,289
(1) Includes amounts attributable to redeemable noncontrolling interests.

5

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands)

	Six Months Ended June 30, 2019
	Preferred Stock			Common Stock		Capital in Excess of Par Value			Treasury Stock			Cumulative Net Income		Cumulative Dividends			Accumulated Other Comprehensive Income (Loss)			Other Equity			Noncontrolling Interests			Total
Balances at December 31, 2018	$	718,498		$	384,465	$	18,424,368		$	(68,499	)	$	6,121,534	$	(10,818,557	)	$	(129,769	)	$	294		$	954,265		$	15,586,599
Comprehensive income:
Net income (loss)												280,470											10,785			291,255
Other comprehensive income																	(14,849		)				5,787			(9,062		)
Total comprehensive income																										282,193
Net change in noncontrolling interests						(8,845		)															(1,497		)	(10,342		)
Amounts related to stock incentive plans, net of forfeitures				120		7,420			(5,993		)									(26		)				1,521
Proceeds from issuance of common stock				7,212		525,408																				532,620
Conversion of preferred stock	(718,498		)	12,712		705,786																				—
Dividends paid:
Common stock dividends														(344,760		)										(344,760		)
Balances at March 31, 2019	$	—		$	404,509	$	19,654,137		$	(74,492	)	$	6,402,004	$	(11,163,317	)	$	(144,618	)	$	268		$	969,340		$	16,047,831
Comprehensive income:
Net income (loss)												137,762											11,349			149,111
Other comprehensive income																	43,996						2,387			46,383
Total comprehensive income																										195,494
Net change in noncontrolling interests						(23,672		)															(7,959		)	(31,631		)
Amounts related to stock incentive plans, net of forfeitures				18		7,959			450											(80		)				8,347
Proceeds from issuance of common stock				1,487		101,721																				103,208
Dividends paid:
Common stock dividends														(353,677		)										(353,677		)
Balances at June 30, 2019	$	—		$	406,014	$	19,740,145		$	(74,042	)	$	6,539,766	$	(11,516,994	)	$	(100,622	)	$	188		$	975,117		$	15,969,572

	Six Months Ended June 30, 2018
	Preferred Stock			Common Stock		Capital in Excess of Par Value			Treasury Stock			Cumulative Net Income		Cumulative Dividends			Accumulated Other Comprehensive Income (Loss)			Other Equity			Noncontrolling Interests			Total
Balances at December 31, 2017	$	718,503		$	372,449	$	17,662,681		$	(64,559	)	$	5,316,580	$	(9,471,712	)	$	(111,465	)	$	670		$	502,305		$	14,925,452
Comprehensive income:
Net income (loss)												449,347											5,191			454,538
Other comprehensive income																	20,212						(3,886		)	16,326
Total comprehensive income																										470,864
Net change in noncontrolling interests						(13,157		)															(2,719		)	(15,876		)
Amounts related to stock incentive plans, net of forfeitures				150		11,085			(4,137		)															7,098
Proceeds from issuance of common stock				130		7,060																				7,190
Conversion of preferred stock	(5		)			5																				—
Dividends paid:
Common stock dividends														(323,726		)										(323,726		)
Preferred stock dividends														(11,676		)										(11,676		)
Balances at March 31, 2018	$	718,498		$	372,729	$	17,667,674		$	(68,696	)	$	5,765,927	$	(9,807,114	)	$	(91,253	)	$	670		$	500,891		$	15,059,326
Comprehensive income:
Net income (loss)												166,108											2,355			168,463
Other comprehensive income																	(41,378		)				(8,745		)	(50,123		)
Total comprehensive income																										118,340
Net change in noncontrolling interests						(14,822		)															(35,937		)	(50,759		)
Amounts related to stock incentive plans, net of forfeitures				18		5,801			35											(11		)				5,843
Proceeds from issuance of common stock				54		2,731																				2,785
Dividends paid:
Common stock dividends														(323,372		)										(323,372		)
Preferred stock dividends														(11,676		)										(11,676		)
Balances at June 30, 2018	$	718,498		$	372,801	$	17,661,384		$	(68,661	)	$	5,932,035	$	(10,142,162	)	$	(132,631	)	$	659		$	458,564		$	14,800,487

6

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

WELLTOWER INC. AND SUBSIDIARIES

(In thousands)

	Six Months Ended
	June 30,
	2019			2018
Operating activities:
Net income	$	442,342		$	620,828
Adjustments to reconcile net income to net cash provided from (used in) operating activities:
Depreciation and amortization	491,984			464,476
Other amortization expenses	9,761			7,984
Provision for loan losses	18,690			—
Impairment of assets	9,939			32,817
Stock-based compensation expense	15,192			16,725
Loss (gain) on derivatives and financial instruments, net	(574		)	(14,633		)
Loss (gain) on extinguishment of debt, net	15,719			12,006
Loss (income) from unconsolidated entities	18,248			1,180
Rental income less than (in excess of) cash received	(53,234		)	13,544
Amortization related to above (below) market leases, net	(2		)	1,363
Loss (gain) on real estate dispositions, net	(165,727		)	(348,939		)
Distributions by unconsolidated entities	46			21
Increase (decrease) in accrued expenses and other liabilities	55,415			46,718
Decrease (increase) in receivables and other assets	(3,317		)	(15,666		)
Net cash provided from (used in) operating activities	854,482			838,424
Investing activities:
Cash disbursed for acquisitions	(2,718,808		)	(595,596		)
Cash disbursed for capital improvements to existing properties	(124,176		)	(111,332		)
Cash disbursed for construction in progress	(155,409		)	(62,978		)
Capitalized interest	(6,256		)	(4,436		)
Investment in real estate loans receivable	(62,935		)	(48,291		)
Principal collected on real estate loans receivable	6,840			91,427
Other investments, net of payments	(17,640		)	(48,212		)
Contributions to unconsolidated entities	(119,001		)	(32,768		)
Distributions by unconsolidated entities	70,844			22,897
Proceeds from (payments on) derivatives	(21,643		)	(27,678		)
Proceeds from sales of real property	616,820			947,218
Net cash provided from (used in) investing activities	(2,531,364		)	130,251
Financing activities:
Net increase (decrease) in unsecured credit facility and commercial paper	722,188			(179,000		)
Proceeds from issuance of senior unsecured notes	2,036,964			545,074
Payments to extinguish senior unsecured notes	(1,050,000		)	(450,000		)
Net proceeds from the issuance of secured debt	295,969			44,606
Payments on secured debt	(178,700		)	(224,958		)
Net proceeds from the issuance of common stock	647,156			10,188
Payments for deferred financing costs and prepayment penalties	(24,177		)	(18,639		)
Contributions by noncontrolling interests(1)	39,122			8,421
Distributions to noncontrolling interests(1)	(64,004		)	(59,484		)
Cash distributions to stockholders	(695,099		)	(670,859		)
Other financing activities	(8,615		)	(5,639		)
Net cash provided from (used in) financing activities	1,720,804			(1,000,290		)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(333		)	(5,305		)
Increase (decrease) in cash, cash equivalents and restricted cash	43,589			(36,920		)
Cash, cash equivalents and restricted cash at beginning of period	316,129			309,303
Cash, cash equivalents and restricted cash at end of period	$	359,718		$	272,383
Supplemental cash flow information:
Interest paid	$	252,714		$	209,156
Income taxes paid (received), net	2,040			4,835
(1) Includes amounts attributable to redeemable noncontrolling interests.

7

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business

Welltower Inc. (the "Company"), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.  Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties.  

2. Accounting Policies and Related Matters

     Basis of Presentation

     The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2019 are not necessarily an indication of the results that may be expected for the year ending December 31, 2019. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2018.

     New Accounting Standards     

• We adopted Accounting Standards Update 2016-02, Leases (Topic 842) ("ASC 842") which requires lessees to recognize assets and liabilities on their consolidated balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their consolidated statement of comprehensive income over the lease term. We adopted ASC 842 as of January 1, 2019, using the modified retrospective approach and have elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, permits us to carry forward our prior conclusions for lease classification and initial direct costs on existing leases. We also made an accounting policy election to keep short-term leases less than twelve months off the balance sheet for all classes of underlying assets.

In July 2018, the FASB issued ASU 2018-11 "Leases (Topic 842): Targeted Improvements" that (1) simplifies transition requirements for both lessees and lessors by adding an option that permits entities to apply the transition provisions of the new standard at its adoption date instead of at the earliest comparative period presented in its financial statements and (2) allows lessors to elect, as a practical expedient, to not separate lease and non-lease components in a contract, and instead to account for as a single lease component, if certain criteria are met. This practical expedient causes an entity to assess whether a contract is predominantly lease or service-based and recognize the entire contract under the relevant accounting guidance (i.e. predominantly lease-based would be accounted for under ASC 842 and predominantly service-based would be accounted for under ASU 2014-09, "Revenue from Contracts with Customers (ASC 606)"). For the year ended December 31, 2018, we recognized revenue for our Seniors Housing Operating resident agreements in accordance with the provisions of the prior lease guidance, ASC 840, "Leases." Upon adoption of ASC 842, we elected the lessor practical expedient described above and recognized revenue for our Seniors Housing Operating segment based upon the predominant component, the non-lease service component. Therefore, beginning on January 1, 2019, we accounted for these resident agreements under ASC 606. The timing and pattern of revenue recognition is substantially the same as that prior to adoption.

The FASB also issued ASU 2018-20 "Leases (Topic 842) - Narrow Improvements for Lessors," which provides lessors the ability to make an accounting policy election not to evaluate whether certain sales taxes and other similar taxes imposed by a governmental authority on a specific lease revenue-producing transaction are the primary obligation of the lessor as owner of the underlying leased asset. A lessor that makes this election will exclude these taxes from the measurement of lease revenue and the associated expense. Upon adoption of ASC 842, we utilized this practical expedient in instances in which real estate taxes are paid directly by our tenants to taxing authorities. For triple-net leasing arrangements in which the tenant remits payment for real estate taxes to us and we pay the taxing authority, we have included the associated revenue and expense in rental income and property operating expenses on the Consolidated Statements of Comprehensive Income. This reporting had no impact on our net income.

For leases in which the Company is the lessee, primarily consisting of ground leases and various office and equipment leases, we recognized upon adoption a right of use asset of $509,386,000 which included the present value of minimum leases payments, existing above and/or below market lease intangible values and existing straight-line rent liabilities

8

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

associated with such leases. We also recognized operating lease liabilities of $357,070,000. The standard did not materially impact our Consolidated Statements of Comprehensive Income or our Consolidated Statement of Cash Flows. See Note 6 for additional details.

The following ASU has been issued but not yet adopted:

• In 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"). This standard requires a new forward-looking “expected loss” model to be used for receivables, held-to-maturity debt, loans, and other instruments. In November 2018, the FASB issued an amendment excluding operating lease receivables accounted for under the new leases standard from the scope of the new credit losses standard. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, and early adoption is permitted for fiscal years beginning after December 15, 2018. We are currently evaluating the impact that the standard will have on our consolidated financial statements. 

3. Real Property Acquisitions and Development 

The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets, liabilities and noncontrolling interests based upon their relative fair values in accordance with our accounting policies. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services and termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income. Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries.

The following is a summary of our real property investment activity by segment for the periods presented (in thousands):

	Six Months Ended
	June 30, 2019												June 30, 2018
	Seniors Housing Operating			Triple-net			Outpatient Medical			Totals			Seniors Housing Operating			Triple-net			Outpatient Medical			Totals
Land and land improvements	$	103,743		$	8,099		$	132,154		$	243,996		$	47,865		$	1,691		$	7,369		$	56,925
Buildings and improvements	1,109,966			96,244			1,198,608			2,404,818			535,921			—			42,673			578,594
Acquired lease intangibles	58,773			—			85,492			144,265			68,084			—			5,852			73,936
Construction in progress	36,174			—			—			36,174			—			—			—			—
Right of use assets, net	—			—			56,073			56,073			—			—			—			—
Receivables and other assets	4,560			—			376			4,936			1,255			—			1			1,256
Total assets acquired(1)	1,313,216			104,343			1,472,703			2,890,262			653,125			1,691			55,895			710,711
Secured debt	(43,209		)	—			—			(43,209		)	(89,973		)	—			—			(89,973		)
Lease liabilities	—			—			(45,287		)	(45,287		)	—			—			—			—
Accrued expenses and other liabilities	(8,677		)	—			(22,506		)	(31,183		)	(14,686		)	(6		)	(632		)	(15,324		)
Total liabilities acquired	(51,886		)	—			(67,793		)	(119,679		)	(104,659		)	(6		)	(632		)	(105,297		)
Noncontrolling interests	(38,830		)	(1,056		)	—			(39,886		)	(9,818		)	—			—			(9,818		)
Non-cash acquisition related activity(2)	(11,889		)	—			—			(11,889		)	—			—			—			—
Cash disbursed for acquisitions	1,210,611			103,287			1,404,910			2,718,808			538,648			1,685			55,263			595,596
Construction in progress additions	110,761			24,066			26,587			161,414			20,704			38,238			11,319			70,261
Less: Capitalized interest	(3,560		)	(908		)	(1,788		)	(6,256		)	(1,783		)	(1,432		)	(1,221		)	(4,436		)
Foreign currency translation	141			65			—			206			1,176			132			—			1,308
Accruals(3)	—			—			45			45			—			—			(4,155		)	(4,155		)
Cash disbursed for construction in progress	107,342			23,223			24,844			155,409			20,097			36,938			5,943			62,978
Capital improvements to existing properties	97,867			7,423			18,886			124,176			76,237			8,569			26,526			111,332
Total cash invested in real property, net of cash acquired	$	1,415,820		$	133,933		$	1,448,640		$	2,998,393		$	634,982		$	47,192		$	87,732		$	769,906

⁽¹⁾ Excludes $ 1,910,000 and $4,392,000 of unrestricted and restricted cash acquired during the six months ended June 30, 2019 and 2018, respectively.

⁽²⁾ Relates to the acquisition of assets previously recognized as investments in unconsolidated entities.

⁽³⁾ Represents non-cash accruals for amounts to be paid in future periods for properties that converted, off-set by amounts paid in the current period.

9

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Construction Activity 

The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):

	Six Months Ended
	June 30, 2019		June 30, 2018
Development projects:
Seniors Housing Operating	$	28,117	$	37,215
Triple-net	—		59,188
Outpatient Medical	—		11,358
Total construction in progress conversions	$	28,117	$	107,761

 

4. Real Estate Intangibles 

The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):

	June 30, 2019			December 31, 2018
Assets:
In place lease intangibles	$	1,473,060		$	1,410,725
Above market tenant leases	69,656			63,935
Below market ground leases (1)	—			64,513
Lease commissions	46,422			41,986
Gross historical cost	1,589,138			1,581,159
Accumulated amortization	(1,163,936		)	(1,197,336		)
Net book value	$	425,202		$	383,823
Weighted-average amortization period in years	8.6			16.0
Liabilities:
Below market tenant leases	$	94,082		$	81,676
Above market ground leases (1)	—			8,540
Gross historical cost	94,082			90,216
Accumulated amortization	(45,147		)	(44,266		)
Net book value	$	48,935		$	45,950
Weighted-average amortization period in years	8.2			14.7

 

⁽¹⁾ Effective on January 1, 2019 with the adoption of ASC 842, above and below market ground lease intangibles are reported within the right of use assets, net line on the Consolidated Balance Sheet.

The following is a summary of real estate intangible amortization for the periods presented (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Rental income related to (above)/below market tenant leases, net	$	73		$	(333	)	$	(82	)	$	(684	)
Amortization related to in place lease intangibles and lease commissions	(28,518		)	(33,763		)	(53,423		)	(66,024		)

10

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):

	Assets		Liabilities
2019	$	84,909	$	4,777
2020	101,374		8,835
2021	51,215		7,865
2022	34,495		7,130
2023	28,361		4,989
Thereafter	124,848		15,339
Total	$	425,202	$	48,935

 

5. Dispositions and Assets Held for Sale

We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At June 30, 2019, 55 Seniors Housing Operating, 30 Triple-net, and four Outpatient Medical properties with an aggregate real estate balance of $1,704,206,000 were classified as held for sale. In addition, secured debt of $37,429,000 and net other assets and liabilities of $58,816,000 related to the held for sale properties. During the six months ended June 30, 2019, we recorded net impairment charges of $9,939,000 on certain held for sale properties for which the carrying value exceeded the fair values, less estimated costs to sell, if applicable. The following is a summary of our real property disposition activity for the periods presented (in thousands):

	Six Months Ended June 30,
	2019			2018
Real estate dispositions:
Seniors Housing Operating	$	8,726		$	2,200
Triple-net	442,865			367,978
Outpatient Medical	—			223,069
Total dispositions	451,591			593,247
Gain (loss) on real estate dispositions, net	165,727			348,939
Net other assets/liabilities disposed	(498		)	5,032
Proceeds from real estate dispositions	$	616,820		$	947,218

     Dispositions and Assets Held for Sale

Pursuant to our adoption of ASU 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity”, operating results attributable to properties sold subsequent to or classified as held for sale after January 1, 2014 and which do not meet the definition of discontinued operations are no longer reclassified on our Consolidated Statements of Comprehensive Income. The following represents the activity related to these properties for the periods presented (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Revenues:
Total revenues	$	112,694	$	121,079	$	228,441	$	249,639
Expenses:
Interest expense	479		579		983		1,200
Property operating expenses	70,244		74,213		146,260		150,120
Provision for depreciation	12,520		18,431		24,897		38,275
Total expenses	83,243		93,223		172,140		189,595
Income (loss) from real estate dispositions, net	$	29,451	$	27,856	$	56,301	$	60,044

 

11

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

6. Leases

We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities. As most of our leases do not provide a rate implicit in the lease agreement, we use our incremental borrowing rate available at lease commencement to determine the present value of lease payments. The incremental borrowing rates were determined using our longer term borrowing rates (actual pricing through 30 years, as well as other longer-term market rates). For leases that commenced prior to January 1, 2019, we used the incremental borrowing rate on December 31, 2018.

We sublease certain real estate to a third party. Our sublease portfolio consists of a finance lease with Genesis HealthCare for seven buildings.

The components of lease expense were as follows for the period presented (in thousands):

	Classification	Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Operating lease cost: (1)
Real estate lease expense	Property operating expenses	$	7,267		$	14,679
Non-real estate lease expense	General and administrative expenses	408			770
Finance lease cost:
Amortization of leased assets	Property operating expenses	2,153			4,245
Interest on lease liabilities	Interest expense	1,166			2,169
Sublease income	Rental income	(1,043		)	(2,087		)
Total		$	9,951		$	19,776

⁽¹⁾ Includes short-term leases which are immaterial.

Maturities of lease liabilities as of June 30, 2019 are as follows (in thousands):

	Operating Leases			Finance Leases
2019	$	9,809		$	4,488
2020	19,625			8,821
2021	19,558			8,485
2022	18,627			7,852
2023	18,707			68,967
Thereafter	1,595,101			86,081
Total lease payments	1,681,427			184,694
Less: Imputed interest	(1,321,129		)	(75,963		)
Total present value of lease liabilities	$	360,298		$	108,731

12

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Supplemental balance sheet information related to leases was as follows for the date indicated (in thousands, except lease terms and discount rate):

	Classification	June 30, 2019
Right of use assets:
Operating leases - real estate	Right of use assets, net	$	386,061
Finance leases	Right of use assets, net	164,281
Real estate right of use assets, net		550,342
Operating leases - corporate	Receivables and other assets	5,055
Total right of use assets, net		$	555,397
Lease liabilities:
Operating leases		$	360,298
Financing leases		108,731
Total		$	469,029
Weighted average remaining lease term (years):
Operating leases		50.0
Finance leases		15.8
Weighted average discount rate:
Operating leases		5.21		%
Finance leases		5.17		%

Supplemental cash flow information related to leases was as follows for the date indicated (in thousands):

	Classification	Six Months Ended June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	Decrease (increase) in receivables and other assets	$	4,627
Operating cash flows from finance leases	Decrease (increase) in receivables and other assets	3,916
Financing cash flows from finance leases	Other financing activities	(1,638		)

Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Leases in our outpatient medical portfolio typically include some form of operating expense reimbursement by the tenant. We recognized $766,670,000 of rental and other revenues related to operating lease payments, of which $94,017,000 was for variable lease payments for the six months ended June 30, 2019, which primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. The following table sets forth the undiscounted cash flows for future minimum lease payments receivable for leases in effect at June 30, 2019 (excluding properties in our Seniors Housing Operating partnerships and excluding any operating expense reimbursements) (in thousands):

2019	$	925,026
2020	1,380,111
2021	1,346,698
2022	1,237,904
2023	1,255,408
Thereafter	9,745,880
Totals	$	15,891,027

7. Real Estate Loans Receivable

Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 for discussion of our accounting policies for real estate loans receivable and related interest income. 

13

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The following is a summary of our net real estate loans receivable (in thousands):

	June 30, 2019			December 31, 2018
Mortgage loans	$	332,770		$	317,443
Other real estate loans	104,596			81,268
Less allowance for losses on loans receivable	(68,372		)	(68,372		)
Totals	$	368,994		$	330,339

The following is a summary of our real estate loan activity for the periods presented (in thousands):

	Six Months Ended
	June 30, 2019							June 30, 2018
		Triple-net		Outpatient Medical		Totals		Seniors Housing Operating		Triple-net			Outpatient Medical		Totals
Advances on real estate loans receivable:
Investments in new loans		$	25,000	$	5,000	$	30,000	$	11,806	$	8,281		$	7,022	$	27,109
Draws on existing loans		20,051		12,884		32,935		—		21,182			—		21,182
Net cash advances on real estate loans		45,051		17,884		62,935		11,806		29,463			7,022		48,291
Receipts on real estate loans receivable:
Loan payoffs		4,384		—		4,384		—		58,557			—		58,557
Principal payments on loans		2,456		—		2,456		—		32,870			—		32,870
Net cash receipts on real estate loans		6,840		—		6,840		—		91,427			—		91,427
Net cash advances (receipts) on real estate loans		$	38,211	$	17,884	$	56,095	$	11,806	$	(61,964	)	$	7,022	$	(43,136	)

 

In 2016, we restructured real estate loans with Genesis HealthCare and recorded a loan loss charge in the amount of $6,935,000 on one of the loans as the present value of expected future cash flows was less than the carrying value of the loan.  In 2017, we recorded an additional loan loss charge of $62,966,000 relating to real estate loans with Genesis HealthCare based on an estimation of expected future cash flows discounted at the effective interest rate of the loans. In March 2019, we recognized a provision for loan losses of $18,690,000 to fully reserve for certain Triple-net real estate loans receivable that were no longer deemed collectible. During the quarter ended June 30, 2019, these loans were written off. As of June 30, 2019, the allowance for loan loss balance of $68,372,000 is deemed to be sufficient to absorb expected losses. At June 30, 2019, we had one real estate loan with an outstanding balance of $2,534,000 on non-accrual status.

The following is a summary of our impaired loans (in thousands):

	Six Months Ended
	June 30, 2019		June 30, 2018
Balance of impaired loans at end of period	$	188,068	$	214,871
Allowance for loan losses	68,372		68,372
Balance of impaired loans not reserved	$	119,696	$	146,499
Average impaired loans for the period	$	197,426	$	252,172
Interest recognized on impaired loans(1)	7,964		8,847

 

⁽¹⁾ Represents cash interest recognized in the period since loans were identified as impaired.

8. Investments in Unconsolidated Entities

We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. The results of operations for these entities have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands): 

14

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	Percentage Ownership(1)	June 30, 2019		December 31, 2018
Seniors Housing Operating	10% to 50%	$	379,886	$	344,982
Triple-net	10% to 49%	9,459		34,284
Outpatient Medical	43% to 50%	130,042		103,648
Total		$	519,387	$	482,914

 

⁽¹⁾ Excludes ownership of in-substance real estate.

At June 30, 2019, the aggregate unamortized basis difference of our joint venture investments of $101,571,000 is primarily attributable to the difference between the amount for which we purchase our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the joint venture. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities. 

9. Credit Concentration

We use consolidated net operating income (“NOI”) as our credit concentration metric. See Note 18 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the six months ended June 30, 2019, excluding our share of NOI in unconsolidated entities (dollars in thousands):

	Number of	Total		Percent of
Concentration by relationship:(1)	Properties	NOI		NOI(2)
Sunrise Senior Living(3)	165	$	174,422	14%
ProMedica	218	107,541		9%
Revera(3)	98	72,928		6%
Genesis HealthCare	60	60,984		5%
Benchmark Senior Living(4)	48	55,530		5%
Remaining portfolio	1,009	749,012		61%
Totals	1,598	$	1,220,417	100%

 

⁽¹⁾ Genesis Healthcare and ProMedica are in our Triple-net segment. Sunrise Senior Living and Revera are in our Seniors Housing Operating segment. Benchmark Senior Living is in both our Triple-net and Seniors Housing Operating segments.

⁽²⁾ NOI with our top five relationships comprised 38% of total NOI for the year ended December 31, 2018.

⁽³⁾ Revera owns a controlling interest in Sunrise Senior Living.

⁽⁴⁾ Please see Note 21 for additional information.

10. Borrowings Under Credit Facilities and Commercial Paper Program 

 At June 30, 2019, we had a primary unsecured credit facility with a consortium of 31 banks that includes a $3,000,000,000 unsecured revolving credit facility ($935,000,000 outstanding at June 30, 2019), a $500,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $500,000,000 unsecured term credit facility by up to an additional $1,000,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at June 30, 2019). Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over LIBOR interest rate (3.22% at June 30, 2019). The applicable margin is based on our debt ratings and was 0.825% at June 30, 2019. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on our debt ratings and was 0.15% at June 30, 2019. The term credit facilities mature on July 19, 2023. The revolving credit facility is scheduled to mature on July 19, 2022 and can be extended for two successive terms of six months each at our option.

In January 2019, we established an unsecured commercial paper program (the "Commercial Paper Program"). Under the terms of the program, we may issue unsecured commercial paper notes with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate face or principal amount outstanding at any time of $1,000,000,000. As of June 30, 2019, there was a balance of $934,188,000 outstanding on the Commercial Paper Program ($935,000,000 in principal outstanding net of an unamortized discount of $812,000), which reduces the borrowing capacity on the unsecured revolving credit facility. The notes bear interest at various floating rates with a weighted average of 2.70% as of June 30, 2019 and a weighted average maturity of 31 days as of June 30, 2019.

The following information relates to aggregate borrowings under the unsecured revolving credit facility and Commercial Paper Program for the periods presented (dollars in thousands): 

15

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Balance outstanding at quarter end	$	1,870,000		$	540,000		$	1,870,000		$	540,000
Maximum amount outstanding at any month end	$	2,880,000		$	685,000		$	2,880,000		$	865,000
Average amount outstanding (total of daily
principal balances divided by days in period)	$	1,807,631		$	562,747		$	1,301,883		$	463,978
Weighted average interest rate (actual interest
expense divided by average borrowings outstanding)	3.08		%	3.04		%	3.11		%	2.91		%

 

11. Senior Unsecured Notes and Secured Debt 

We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of (1) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (2) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. At June 30, 2019, the annual principal payments due on these debt obligations were as follows (in thousands):

	Senior Unsecured Notes(1,2)		Secured Debt (1,3)		Totals
2019	$	—	$	312,291	$	312,291
2020(4)	1,236,665		144,518		1,381,183
2021	450,000		383,425		833,425
2022	600,000		352,410		952,410
2023(5,6)	1,790,971		330,498		2,121,469
Thereafter(7,8)	6,633,920		1,166,840		7,800,760
Totals	$	10,711,556	$	2,689,982	$	13,401,538

 

(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the Consolidated Balance Sheet.

(2) Annual interest rates range from 2.86% to 6.50%.

(3) Annual interest rates range from 1.69% to 12.00%. Carrying value of the properties securing the debt totaled $5,991,142,000 at June 30, 2019.

(4) Includes a $300,000,000 Canadian-denominated 3.35% senior unsecured notes due 2020 (approximately $229,165,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2019) and a $1,000,000,000 unsecured term loan facility that matures on May 28, 2020 which was put in place to bridge the acquisition of the CNL Healthcare Properties portfolio. The unsecured term loan facility was subsequently extinguished in July 2019 with proceeds from the disposition of the Benchmark Senior Living portfolio.

(5) Includes a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $190,971,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2019). The loan matures on July 19, 2023 and bears interest at the Canadian Dealer Offered Rate plus 0.9% (2.86% at June 30, 2019).

(6) Includes a $500,000,000 unsecured term credit facility. The loan matures on July 19, 2023 and bears interest at LIBOR plus 0.9% (3.29% at June 30, 2019).

(7) Includes a £550,000,000 4.80% senior unsecured notes due 2028 (approximately $698,720,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2019).

(8) Includes a £500,000,000 4.50% senior unsecured notes due 2034 (approximately $635,200,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2019).

The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

	Six Months Ended
	June 30, 2019				June 30, 2018
				Weighted Avg.				Weighted Avg.
	Amount			Interest Rate	Amount			Interest Rate
Beginning balance	$	9,699,984		4.48%	$	8,417,447		4.31%
Debt issued	2,050,000			3.58%	550,000			4.25%
Debt extinguished	(1,050,000		)	4.98%	(450,000		)	2.25%
Foreign currency	11,572			3.52%	(55,693		)	4.02%
Ending balance	$	10,711,556		4.24%	$	8,461,754		4.46%

 

16

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands): 

	Six Months Ended
	June 30, 2019				June 30, 2018
				Weighted Avg.				Weighted Avg.
	Amount			Interest Rate	Amount			Interest Rate
Beginning balance	$	2,485,711		3.90%	$	2,618,408		3.76%
Debt issued	295,969			3.52%	44,606			3.38%
Debt assumed	42,000			4.62%	85,192			4.40%
Debt extinguished	(151,473		)	4.42%	(196,573		)	5.66%
Principal payments	(27,227		)	3.74%	(28,385		)	3.91%
Foreign currency	45,002			3.37%	(61,170		)	3.33%
Ending balance	$	2,689,982		3.84%	$	2,462,078		3.76%

 

Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2019, we were in compliance with all of the covenants under our debt agreements. 

12. Derivative Instruments

We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our non-U.S. investments and interest rate risk related to our capital structure. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, cross currency swap contacts, interest rate swaps, interest rate locks, and debt issued in foreign currencies to offset a portion of these risks.

 Foreign Currency Forward Contracts Designated as Cash Flow Hedges

For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is deferred as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings. 

Cash Flow Hedges of Interest Rate Risk

We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements were used to hedge the variable cash flows associated with variable-rate debt.

Periodically, we enter into and designate interest rate locks to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized into income over the life of the related debt, except where a material amount is deemed to be ineffective, which would be immediately reclassified to the consolidated statements of income.

     Foreign Currency Forward Contracts and Cross Currency Swap Contracts Designated as Net Investment Hedges

We use foreign currency forward and cross currency forward swap contracts to hedge a portion of the net investment in foreign subsidiaries against fluctuations in foreign exchange rates. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI. 

During the six months ended June 30, 2019 and 2018, we settled certain net investment hedges generating cash proceeds of $6,716,000 and necessitating cash payments of $27,774,000, respectively. The balance of the cumulative translation adjustment will be reclassified to earnings if the hedged investment is sold or substantially liquidated.

17

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Derivative Contracts Undesignated

We use foreign currency exchange contracts to manage existing exposures to foreign currency exchange risk. Gains and losses resulting from the changes in fair value of these instruments are recorded in interest expense on the Consolidated Statements of Comprehensive Income and are substantially offset by net revaluation impacts on foreign currency denominated balance sheet exposures. In addition, we have several interest rate cap contracts related to variable rate secured debt agreements. Gains and losses resulting from the changes in fair values of these instruments are also recorded in interest expense.

The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands): 

	June 30, 2019			December 31, 2018
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	500,000		$	575,000
Denominated in Pounds Sterling	£	1,340,708		£	890,708
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000		$	250,000
Denominated in Pounds Sterling	£	1,050,000		£	1,050,000
Interest rate swaps designated as cash flow hedges:
Denominated in U.S Dollars (1)	$	1,188,250		$	—
Derivative instruments not designated:
Interest rate caps denominated in U.S. Dollars	$	405,819		$	405,819
Forward purchase contracts denominated in Canadian Dollars	$	(217,500	)	$	(325,000	)
Forward sales contracts denominated in Canadian Dollars	$	280,000		$	405,000
Forward purchase contracts denominated in Pounds Sterling	£	(125,000	)	£	(350,000	)
Forward sales contracts denominated in Pounds Sterling	£	125,000		£	350,000

 

⁽¹⁾ At June 30, 2019 the maximum maturity date was July 15, 2021.

The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):

		Three Months Ended June 30,					Six Months Ended June 30,
	Location	2019			2018		2019			2018
Gain (loss) on derivative instruments designated as hedges recognized in income	Interest expense	$	7,134		$	4,091	$	12,467		$	3,822
Gain (loss) on derivative instruments not designated as hedges recognized in income	Interest expense	$	(1,128	)	$	734	$	(2,666	)	$	2,453
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI	$	100,407		$	150,703	$	12,725		$	88,005

 

13. Commitments and Contingencies

At June 30, 2019, we had 14 outstanding letter of credit obligations totaling $48,111,000 and expiring between 2019 and 2024. At June 30, 2019, we had outstanding construction in progress of $363,160,000 and were committed to providing additional funds of approximately $483,210,000 to complete construction. Purchase obligations include contingent purchase obligations totaling $8,476,000. These contingent purchase obligations relate to unfunded capital improvement obligations and contingent obligations on acquisitions. Rents due from the tenant are increased to reflect the additional investment in the property.

18

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

14. Stockholders’ Equity 

The following is a summary of our stockholders’ equity capital accounts as of the dates indicated: 

	June 30, 2019	December 31, 2018
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	—	14,375,000
Outstanding shares	—	14,369,965
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	406,497,122	384,849,236
Outstanding shares	405,254,113	383,674,603

 

   Preferred Stock The following is a summary of our preferred stock activity during the periods indicated: 

	Six Months Ended
	June 30, 2019			June 30, 2018
			Weighted Avg.			Weighted Avg.
	Shares		Dividend Rate	Shares		Dividend Rate
Beginning balance	14,369,965		6.50%	14,370,060		6.50%
Shares converted	(14,369,965	)	6.50%	(95	)	6.50%
Ending balance	—		—%	14,369,965		6.50%

 

During the six months ended June 30, 2019, we converted all of the outstanding Series I Preferred Stock. Each share was converted into 0.8857 shares of common stock.

     Common Stock In February 2019, we entered into separate amended and restated equity distribution agreements whereby we can offer and sell up to $1,500,000,000 aggregate amount of our common stock ("Equity Shelf Program"). The Equity Shelf Program also allows us to enter into forward sale agreements. As of June 30, 2019, we had $1,360,820,000 of remaining capacity under the Equity Shelf Program, which excludes forward sales agreements outstanding for the sale of 2,194,575 shares with maturity dates in the fourth quarter. We expect to physically settle the forward sales for cash proceeds.

The following is a summary of our common stock issuances during the six months ended June 30, 2019 and 2018 (dollars in thousands, except average price amounts): 

	Shares Issued	Average Price	Gross Proceeds		Net Proceeds
2018 Dividend reinvestment plan issuances	182,910	$55.40	$	10,133	$	10,133
2018 Option exercises	1,026	53.61	55		55
2018 Preferred stock conversions	83		—		—
2018 Stock incentive plans, net of forfeitures	114,037		—		—
2018 Totals	298,056		$	10,188	$	10,188
2019 Dividend reinvestment plan issuances	4,304,712	$75.20	$	323,724	$	320,243
2019 Option exercises	10,736	51.32	551		551
2019 Equity Shelf Program issuances	4,384,045	74.97	328,665		326,362
2019 Preferred stock conversions	12,712,452		—		—
2019 Stock incentive plans, net of forfeitures	167,565		—		—
2019 Totals	21,579,510		$	652,940	$	647,156

 

Dividends  The increase in dividends is primarily attributable to increases in our common shares outstanding, offset by the conversion of the Series I Preferred Stock as described above.  The following is a summary of our dividend payments (in thousands, except per share amounts): 

19

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	Six Months Ended
	June 30, 2019				June 30, 2018
	Per Share		Amount		Per Share		Amount
Common Stock	$	1.7400	$	698,437	$	1.7400	$	647,098
Series I Preferred Stock	—		—		1.6250		23,352
Totals			$	698,437			$	670,450

 

Accumulated Other Comprehensive Income  The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):

	June 30, 2019			December 31, 2018
Foreign currency translation	$	(851,584	)	$	(868,006	)
Derivative instruments	751,502			738,777
Actuarial losses	(540		)	(540		)
Total accumulated other comprehensive loss	$	(100,622	)	$	(129,769	)

15. Stock Incentive Plans

Our 2016 Long-Term Incentive Plan (“2016 Plan”) authorizes up to 10,000,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. Our non-employee directors, officers and key employees are eligible to participate in the 2016 Plan. The 2016 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock, deferred stock units, performance units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $7,662,000 and $15,192,000 for the three and six months ended June 30, 2019, respectfully, and $5,167,000 and $16,725,000 for the same periods in 2018.

16. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Numerator for basic and diluted earnings
per share - net income (loss) attributable
to common stockholders	$	137,762	$	154,432	$	418,232	$	592,103
Denominator for basic earnings per
share - weighted average shares	404,607		371,640		398,073		371,552
Effect of dilutive securities:
Employee stock options	—		14		1		15
Non-vested restricted shares	955		325		911		523
Redeemable shares	1,096		1,096		1,096		1,096
Employee stock purchase program	15		—		15		—
Dilutive potential common shares	2,066		1,435		2,023		1,634
Denominator for diluted earnings per
share - adjusted weighted average shares	406,673		373,075		400,096		373,186
Basic earnings per share	$	0.34	$	0.42	$	1.05	$	1.59
Diluted earnings per share	$	0.34	$	0.41	$	1.05	$	1.59

The Series I Cumulative Convertible Perpetual Preferred Stock were excluded from the 2018 calculation as the effect of the conversions were anti-dilutive. As of June 30, 2019, forward sales agreements outstanding for the sale of 2,194,575 shares of common stock were not included in the computation of diluted earnings per share because such forward sales were anti-dilutive for the period.

17. Disclosure about Fair Value of Financial Instruments 

20

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 U.S. GAAP provides authoritative guidance for measuring and disclosing fair value measurements of assets and liabilities. The guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 for additional information. The guidance describes three levels of inputs that may be used to measure fair value: 

Level 1 - Quoted prices in active markets for identical assets or liabilities. 

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. 

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. 

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value. 

Mortgage Loans and Other Real Estate Loans Receivable — The fair value of mortgage loans and other real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.  

Cash and Cash Equivalents and Restricted Cash — The carrying amount approximates fair value. 

Equity Securities — Equity securities are recorded at their fair value based on Level 1 publicly available trading prices. 

Unsecured Revolving Credit Facility and Commercial Paper Program — The carrying amount of the unsecured revolving credit facility and Commercial Paper Program approximates fair value because the borrowings are interest rate adjustable. 

Senior Unsecured Notes — The fair value of the senior unsecured notes payable was estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable. 

Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable. 

Foreign Currency Forward Contracts, Interest Rate Swaps and Cross Currency Swaps — Foreign currency forward contracts, interest rate swaps and cross currency swaps are recorded in other assets or other liabilities on the balance sheet at fair value that is derived from observable market data, including yield curves and foreign exchange rates (all of our derivatives are Level 2).

Redeemable OP Unitholder Interests — Our redeemable unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances. 

The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

21

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	June 30, 2019				December 31, 2018
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
Mortgage loans receivable	$	264,398	$	274,116	$	249,071	$	257,337
Other real estate loans receivable	104,596		105,706		81,268		82,742
Equity securities	11,860		11,860		11,286		11,286
Cash and cash equivalents	268,666		268,666		215,376		215,376
Restricted cash	91,052		91,052		100,753		100,753
Foreign currency forward contracts, interest rate swaps and cross currency swaps	91,290		91,290		94,729		94,729
Financial liabilities:
Unsecured revolving credit facility and commercial paper note program	$	1,869,188	$	1,869,188	$	1,147,000	$	1,147,000
Senior unsecured notes	10,606,106		11,026,259		9,603,299		10,043,797
Secured debt	2,675,507		2,737,838		2,476,177		2,499,130
Foreign currency forward contracts, interest rate swaps and cross currency swaps	32,249		32,249		71,109		71,109
Redeemable OP unitholder interests	$	121,476	$	121,476	$	103,071	$	103,071

Items Measured at Fair Value on a Recurring Basis 

The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):

	Fair Value Measurements as of June 30, 2019
	Total		Level 1		Level 2		Level 3
Equity securities	$	11,860	$	11,860	$	—	$	—
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability)(1)	59,041		—		59,041		—
Redeemable OP unitholder interests	121,476		—		121,476		—
Totals	$	192,377	$	11,860	$	180,517	$	—

⁽¹⁾ Please see Note 12 for additional information.

Items Measured at Fair Value on a Nonrecurring Basis 

In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis. As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired/assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 7 for impairments of real estate loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of loans receivable using projected payoff valuations based on the expected future cash flows and/or the estimated fair value of collateral, net of sales costs, if the repayment of the loan is expected to be provided solely by the collateral. We estimate the fair value of secured debt assumed in asset acquisitions using current interest rates at which similar borrowings could be obtained on the transaction date. 

18. Segment Reporting

 We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: Seniors Housing Operating, Triple-net and Outpatient Medical. Our seniors housing operating properties include assisted living, independent living/continuing care retirement communities, independent supportive living communities

22

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(Canada), care homes with and without nursing (U.K.) and combinations thereof that are owned and/or operated through RIDEA structures (see Note 19). Under the Triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our outpatient medical properties are typically leased to multiple tenants and generally require a certain level of property management by us.

We evaluate performance based upon consolidated NOI of each segment. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.    

Non-segment revenue consists mainly of interest income on certain non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. There are no intersegment sales or transfers.

23

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands): 

Three Months Ended June 30, 2019:	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	914,085		$	—		$	—		$	—		$	914,085
Rental income	—			222,362			163,224			—			385,586
Interest income	—			17,118			238			—			17,356
Other income	1,444			1,278			(97		)	454			3,079
Total revenues	915,529			240,758			163,365			454			1,320,106
Property operating expenses	637,317			12,823			50,987			—			701,127
Consolidated net operating income	278,212			227,935			112,378			454			618,979
Depreciation and amortization	136,551			56,056			55,445			—			248,052
Interest expense	17,572			3,225			3,386			117,153			141,336
General and administrative expenses	—			—			—			33,741			33,741
Loss (gain) on derivatives and financial instruments, net	—			1,913			—			—			1,913
Impairment of assets	—			(940		)	10,879			—			9,939
Other expenses	11,857			5,560			(4		)	4,215			21,628
Income (loss) from continuing operations before income taxes and other items	112,232			162,121			42,672			(154,655		)	162,370
Income tax (expense) benefit	375			(1,361		)	(586		)	(27		)	(1,599		)
(Loss) income from unconsolidated entities	(17,453		)	6,578			1,826			—			(9,049		)
Gain (loss) on real estate dispositions, net	(550		)	(1,130		)	(2		)	—			(1,682		)
Income (loss) from continuing operations	94,604			166,208			43,910			(154,682		)	150,040
Net income (loss)	$	94,604		$	166,208		$	43,910		$	(154,682	)	$	150,040
Total assets	$	16,440,104		$	9,494,388		$	7,004,561		$	209,644		$	33,148,697

Three Months Ended June 30, 2018:	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	763,345		$	—		$	—		$	—		$	763,345
Rental income	—			197,961			135,640			—			333,601
Interest income	172			13,247			43			—			13,462
Other income	1,650			13,212			144			498			15,504
Total revenues	765,167			224,420			135,827			498			1,125,912
Property operating expenses	525,662			136			42,953			—			568,751
Consolidated net operating income	239,505			224,284			92,874			498			557,161
Depreciation and amortization	134,779			55,309			46,187			—			236,275
Interest expense	16,971			3,800			1,656			98,989			121,416
General and administrative expenses	—			—			—			32,831			32,831
Loss (gain) on derivatives and financial instruments, net	—			(7,460		)	—			—			(7,460		)
Loss (gain) on extinguishment of debt, net	299			—			—			—			299
Impairment of assets	2,212			2,420			—			—			4,632
Other expenses	6,167			957			2,095			839			10,058
Income (loss) from continuing operations before income taxes and other items	79,077			169,258			42,936			(132,161		)	159,110
Income tax (expense) benefit	(2,617		)	(688		)	(378		)	(158		)	(3,841		)
(Loss) income from unconsolidated entities	(5,204		)	5,062			1,391			—			1,249
Gain (loss) on real estate dispositions, net	(1		)	10,759			(3		)	—			10,755
Income (loss) from continuing operations	71,255			184,391			43,946			(132,319		)	167,273
Net income (loss)	$	71,255		$	184,391		$	43,946		$	(132,319	)	$	167,273

24

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Six Months Ended June 30, 2019	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	1,782,370		$	—		$	—		$	—		$	1,782,370
Rental income	—			454,394			312,276			—			766,670
Interest income	—			32,064			411			—			32,475
Other income	5,545			2,541			139			2,611			10,836
Total revenues	1,787,915			488,999			312,826			2,611			2,592,351
Property operating expenses	1,245,003			27,778			99,153			—			1,371,934
Consolidated net operating income	542,912			461,221			213,673			2,611			1,220,417
Depreciation and amortization	268,126			117,404			106,454			—			491,984
Interest expense	35,823			6,665			6,734			237,346			286,568
General and administrative expenses	—			—			—			69,023			69,023
Loss (gain) on derivatives and financial instruments, net	—			(574		)	—			—			(574		)
Loss (gain) on extinguishment of debt, net	—			—			—			15,719			15,719
Provision for loan losses	—			18,690			—			—			18,690
Impairment of assets	—			(940		)	10,879			—			9,939
Other expenses	14,803			8,589			750			6,242			30,384
Income (loss) from continuing operations before income taxes and other items	224,160			311,387			88,856			(325,719		)	298,684
Income tax (expense) benefit	(244		)	(2,312		)	(951		)	(314		)	(3,821		)
(Loss) income from unconsolidated entities	(34,033		)	12,236			3,549			—			(18,248		)
Gain (loss) on real estate dispositions, net	(710		)	166,444			(7		)	—			165,727
Income (loss) from continuing operations	189,173			487,755			91,447			(326,033		)	442,342
Net income (loss)	$	189,173		$	487,755		$	91,447		$	(326,033	)	$	442,342

Six Months Ended June 30, 2018	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	1,499,279		$	—		$	—		$	—		$	1,499,279
Rental income	—			404,792			272,178			—			676,970
Interest income	257			27,798			55			—			28,110
Other income	2,798			14,589			265			866			18,518
Total revenues	1,502,334			447,179			272,498			866			2,222,877
Property operating expenses	1,037,603			157			87,456			—			1,125,216
Consolidated net operating income	464,731			447,022			185,042			866			1,097,661
Depreciation and amortization	260,548			111,341			92,587			—			464,476
Interest expense	33,906			7,242			3,332			199,711			244,191
General and administrative expenses	—			—			—			66,536			66,536
Loss (gain) on derivatives and financial instruments, net	—			(14,633		)	—			—			(14,633		)
Loss (gain) on extinguishment of debt, net	110			(32		)	11,928			—			12,006
Impairment of assets	4,513			28,304			—			—			32,817
Other expenses	5,979			2,077			2,693			3,021			13,770
Income (loss) from continuing operations before income taxes and other items	159,675			312,723			74,502			(268,402		)	278,498
Income tax (expense) benefit	(2,455		)	(1,824		)	(806		)	(344		)	(5,429		)
(Loss) income from unconsolidated entities	(14,684		)	10,883			2,621			—			(1,180		)
Gain (loss) on real estate dispositions, net	4			134,156			214,779			—			348,939
Income (loss) from continuing operations	142,540			455,938			291,096			(268,746		)	620,828
Net income (loss)	$	142,540		$	455,938		$	291,096		$	(268,746	)	$	620,828

25

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands): 

	Three Months Ended								Six Months Ended
	June 30, 2019				June 30, 2018				June 30, 2019				June 30, 2018
Revenues:	Amount		%		Amount		%		Amount		%		Amount		%
United States	$	1,092,376	82.8	%	$	895,734	79.5	%	$	2,136,042	82.4	%	$	1,759,523	79.1	%
United Kingdom	112,647		8.5	%	112,031		10.0	%	225,065		8.7	%	228,556		10.3	%
Canada	115,083		8.7	%	118,147		10.5	%	231,244		8.9	%	234,798		10.6	%
Total	$	1,320,106	100.0	%	$	1,125,912	100.0	%	$	2,592,351	100.0	%	$	2,222,877	100.0	%
	As of
	June 30, 2019				December 31, 2018
Assets:	Amount		%		Amount		%
United States	$	27,496,270	82.9	%	$	24,884,292	82.0	%
United Kingdom	3,173,654		9.6	%	3,078,994		10.1	%
Canada	2,478,773		7.5	%	2,378,786		7.9	%
Total	$	33,148,697	100.0	%	$	30,342,072	100.0	%

19. Income Taxes and Distributions 

     We elected to be taxed as a REIT commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of current year taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes. 

     Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.” A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 

Income taxes reflected in the financial statements primarily represents U.S. federal, state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the six months ended June 30, 2019 and 2018, was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and most of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. The company reflects current and deferred tax liabilities for any such withholding taxes incurred as a result of this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the Internal Revenue Service for the year ended December 31, 2015 and subsequent years and by state taxing authorities for the year ended December 31, 2014 and subsequent years. The Company and its subsidiaries are also subject to audit by the Canada Revenue Agency and provincial authorities generally for periods subsequent to our initial investments in Canada in May 2013, by HM Revenue & Customs for periods subsequent to our initial investments in the United Kingdom in August 2013.

26

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

20. Variable Interest Entities 

We have entered into joint ventures to own certain seniors housing and outpatient medical assets which are deemed to be VIEs. We have concluded that we are the primary beneficiary of these VIEs based on a combination of operational control of the joint venture and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Except for capital contributions associated with the initial joint venture formations, the joint ventures have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):

	June 30, 2019		December 31, 2018
Assets:
Net real estate investments	$	966,417	$	973,813
Cash and cash equivalents	22,491		18,678
Receivables and other assets	15,411		14,600
Total assets(1)	$	1,004,319	$	1,007,091
Liabilities and equity:
Secured debt	$	462,836	$	465,433
Lease liabilities	1,326		—
Accrued expenses and other liabilities	21,922		18,229
Total equity	518,235		523,429
Total liabilities and equity	$	1,004,319	$	1,007,091

(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs.

21. Subsequent Events

Disposition of Benchmark Senior Living On July 16, 2019, we disposed of our Benchmark Senior Living portfolio for a $1.8 billion gross sale price. The portfolio consisted of 48 seniors housing operating properties located in New England. Proceeds were used to extinguish the $1 billion bridge loan (discussed in Note 11) and $24 million of secured debt.

27

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

EXECUTIVE SUMMARY
Company Overview	29
Business Strategy	29
Key Transactions	29
Key Performance Indicators, Trends and Uncertainties	30
Corporate Governance	33
LIQUIDITY AND CAPITAL RESOURCES
Sources and Uses of Cash	33
Off-Balance Sheet Arrangements	34
Contractual Obligations	34
Capital Structure	34
RESULTS OF OPERATIONS
Summary	35
Seniors Housing Operating	35
Triple-net	37
Outpatient Medical	39
Non-Segment/Corporate	41
OTHER
Non-GAAP Financial Measures	42
Critical Accounting Policies	49
Cautionary Statement Regarding Forward-Looking Statements	50

28

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis are based primarily on the unaudited consolidated financial statements of Welltower Inc. for the periods presented and should be read together with the notes thereto contained in this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2018, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” References herein to “we,” “us,” “our,” or the “Company” refer to Welltower Inc. and its subsidiaries unless specifically noted otherwise.

Executive Summary

Company Overview

     Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (U.S.), Canada and the United Kingdom (U.K.), consisting of seniors housing and post-acute communities and outpatient medical properties.

The following table summarizes our consolidated portfolio for the three months ended June 30, 2019 (dollars in thousands):  

			Percentage of		Number of
Type of Property	NOI(1)		NOI		Properties
Seniors Housing Operating	$	278,212	45.0	%	575
Triple-net	227,935		36.8	%	671
Outpatient Medical	112,378		18.2	%	352
Totals	$	618,525	100.0	%	1,598
(1) Represents consolidated NOI and excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount. See Non-GAAP Financial Measures for additional information and reconciliation.

Business Strategy

Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in NOI and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.

Substantially all of our revenues are derived from operating lease rentals, resident fees and services and interest earned on outstanding loans receivable. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our obligors/partners experience operating difficulties and become unable to generate sufficient cash to make payments or operating distributions to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections, and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division manages and monitors the outpatient medical portfolio with a comprehensive process including review of tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs, and market conditions among other things. We evaluate the operating environment in each property’s market to determine the likely trend in operating performance of the facility. When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we generally aim to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.

In addition to our asset management and research efforts, we also aim to structure our relevant investments to mitigate payment risk. Operating leases and loans are normally credit enhanced by guaranties and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.

For the six months ended June 30, 2019, resident fees and services and rental income represented 69% and 30%, respectively, of total revenues. Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment.

Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.

Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and Commercial Paper Program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses and general and administrative expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.

We also continuously evaluate opportunities to finance future investments. New investments are generally funded from temporary borrowings under our unsecured revolving credit facility and Commercial Paper Program, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from NOI and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving credit facility and Commercial Paper Program, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt.

Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also likely that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our unsecured revolving credit facility and Commercial Paper Program. At June 30, 2019, we had $268,666,000 of cash and cash equivalents, $91,052,000 of restricted cash and $1,130,000,000 of available borrowing capacity under our unsecured revolving credit facility.

Key Transactions

     Capital  The following summarizes key capital transaction that occurred during the six months ended June 30, 2019:

• In January 2019, we established an unsecured Commercial Paper Program. Under the terms of the program, we may issue, from time to time, unsecured commercial paper with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate principal amount outstanding at any time of $1,000,000,000.

• In February 2019, we completed the issuance of $500,000,000 of 3.625% senior unsecured notes due 2024 and $550,000,000 of 4.125% senior unsecured notes due 2029 for net proceeds of approximately $1,036,964,000.

• In February 2019, we elected to effect the mandatory conversion of all of the outstanding 6.50% Series I Cumulative Convertible Perpetual Preferred Stock. Each share of convertible stock was converted into 0.8857 shares of common stock.

• During the six months ended June 30, 2019, we extinguished $151,473,000 of secured debt at a blended average interest rate of 4.42% and in March 2019 we repaid our $600,000,000 of 4.125% senior unsecured notes due 2019 and $450,000,000 of 6.125% senior unsecured notes due 2020.

• In May 2019, we drew on a $1,000,000,000 unsecured term loan facility that matures on May 28, 2020 which was put in place to bridge the acquisition of the CNL Healthcare Properties portfolio. The unsecured term loan facility was subsequently extinguished in July 2019 with proceeds from the disposition of the Benchmark Senior Living portfolio.

• During the six months ended June 30, 2019, we entered into amended and restated Equity Shelf Program (as defined below) pursuant to which we may offer and sell up to $1,500,000,000 of common stock from time to time. We sold 10,884,000 shares of common stock under our ATM and DRIP programs, via both cash settle and forward sale agreements, generating expected gross proceeds of approximately $833,444,000.

29

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Investments  The following summarizes our property acquisitions and joint venture investments completed during the six months ended June 30, 2019 (dollars in thousands): 

	Properties	Investment Amount(1)		Capitalization Rates(2)		Book Amount(3)
Seniors Housing Operating	51	$	1,159,864	5.2	%	$	1,308,656
Triple-net	4	102,344		6.4	%	104,343
Outpatient Medical	66	1,399,112		5.7	%	1,472,327
Totals	121	$	2,661,320	5.5	%	$	2,885,326
(1) Represents stated pro rata purchase price including cash and any assumed debt but excludes fair value adjustments pursuant to U.S. GAAP.
(2) Represents annualized contractual or projected net operating income to be received in cash divided by investment amounts.
(3) Represents amounts recorded in Net real estate investments including fair value adjustments pursuant to U.S. GAAP. See Note 3 to our unaudited consolidated financial statements for additional information.

    Dispositions  The following summarizes property dispositions made during the six months ended June 30, 2019 (dollars in thousands): 

	Properties	Proceeds(1)		Capitalization Rates(2)		Book Amount(3)
Seniors Housing Operating(4)	3	$	11,478	2.2	%	$	8,726
Triple-net	35	614,823		6.7	%	442,865
Totals	38	$	626,301	6.7	%	$	451,591
(1) Represents pro rata proceeds received upon disposition including any seller financing.
(2) Represents annualized contractual income that was being received in cash at date of disposition divided by disposition proceeds.
(3) Represents carrying value of net real estate assets at time of disposition. See Note 5 to our unaudited consolidated financial statements for additional information.
(4) Includes the disposition of an unconsolidated real estate investment.

 

     Dividends Our Board of Directors announced the annual cash dividend of $3.48 per common share ($0.87 per share quarterly), consistent with 2018. The dividend declared for the quarter ended June 30, 2019 represents the 193^rd consecutive quarterly dividend payment.

Key Performance Indicators, Trends and Uncertainties

We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, concentration risk and credit strength. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.

     Operating Performance We believe that net income and net income attributable to common stockholders (“NICS”) per the Consolidated Statements of Comprehensive Income are the most appropriate earnings measures. Other useful supplemental measures of our operating performance include funds from operations attributable to common stockholders (“FFO”), consolidated net operating income (“NOI”) and same store NOI (“SSNOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations. These earnings measures (and FFO per share amounts) are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies. The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands, except per share amounts):

30

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

	Three Months Ended
	March 31,		June 30,		September 30,		December 31,		March 31,		June 30,
	2018		2018		2018		2018		2019		2019
Net income (loss)	$	453,555	$	167,273	$	84,226	$	124,696	$	292,302	$	150,040
NICS	437,671		154,432		64,384		101,763		280,470		137,762
FFO	353,220		378,725		285,272		374,966		358,383		390,021
NOI	540,500		557,161		579,222		590,599		601,438		618,979
SSNOI	407,613		417,399		412,269		408,687		416,682		409,789
Per share data (fully diluted):
NICS	$	1.17	$	0.41	$	0.17	$	0.27	$	0.71	$	0.34
FFO	$	0.95	$	1.02	$	0.76	$	0.99	$	0.91	$	0.96

Credit Strength We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and Internal Revenue Code ("IRC") Section 1031 deposits. The coverage ratios indicate our ability to service interest and fixed charges (interest, secured debt principal amortization and preferred dividends). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain a capital structure consistent with our current profile. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations of these measures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented: 

	Three Months Ended
	March, 31	June 30,	September 30,	December 31,	March 31,	June 30,
	2018	2018	2018	2018	2019	2019
Net debt to book capitalization ratio	42%	42%	46%	45%	43%	48%
Net debt to undepreciated book capitalization ratio	35%	36%	39%	38%	36%	41%
Net debt to market capitalization ratio	34%	31%	34%	31%	28%	30%
Interest coverage ratio	6.67x	4.34x	3.38x	3.60x	4.80x	3.74x
Fixed charge coverage ratio	5.49x	3.58x	2.85x	3.05x	4.38x	3.42x

 

      Concentration Risk We evaluate our concentration risk in terms of NOI by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOI could be at risk if certain sectors were to experience downturns. Property mix measures the portion of our NOI that relates to our various property types. Relationship mix measures the portion of our NOI that relates to our current top five relationships. Geographic mix measures the portion of our NOI that relates to our current top five states (or international equivalents). The following table reflects our recent historical trends of concentration risk by NOI for the periods indicated below: 

31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

	Three Months Ended
	March 31,	June 30,	September 30,	December 31,	March 31,	June 30,
	2018	2018	2018	2018	2019	2019
Property mix:(1)
Seniors Housing Operating	42%	43%	46%	43%	44%	45%
Triple-net	41%	40%	38%	40%	39%	37%
Outpatient Medical	17%	17%	16%	17%	17%	18%
Relationship mix:(1)
Sunrise Senior Living(2)	15%	15%	15%	14%	15%	14%
ProMedica	—%	—%	7%	9%	9%	9%
Revera(2)	7%	7%	7%	6%	6%	6%
Genesis HealthCare	6%	6%	6%	6%	5%	5%
Benchmark Senior Living(3)	4%	5%	4%	4%	4%	5%
Remaining relationships	68%	67%	61%	61%	61%	61%
Geographic mix:(1)
California	14%	14%	13%	13%	13%	13%
United Kingdom	10%	9%	9%	9%	9%	8%
Texas	8%	8%	7%	8%	8%	8%
Canada	9%	8%	8%	8%	7%	7%
New Jersey	8%	7%	7%	7%	7%	7%
Remaining geographic areas	51%	54%	56%	55%	56%	57%
(1) Excludes our share of investments in unconsolidated entities and non-segment/corporate NOI. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) Revera owns a controlling interest in Sunrise Senior Living.
(3) The Benchmark Senior Living portfolio was sold in July 2019.

Lease Expirations The following table sets forth information regarding lease expirations for certain portions of our portfolio as of June 30, 2019 (dollars in thousands):

	Expiration Year(1)
	2019			2020			2021			2022			2023			2024			2025			2026			2027			2028			Thereafter
Triple-net:
Properties	30			—			7			11			—			4			48			93			19			19			417
Base rent(2)	$	34,168		$	—		$	12,254		$	9,023		$	—		$	11,096		$	52,542		$	123,519		$	35,571		$	22,128		$	466,866
% of base rent	4.5		%	—		%	1.6		%	1.2		%	—		%	1.4		%	6.8		%	16.1		%	4.6		%	2.9		%	60.9		%
Units/beds	2,540			—			1,316			1,182			—			692			3,033			7,452			2,401			1,979			43,890
% of Units/beds	3.9		%	—		%	2.0		%	1.8		%	—		%	1.1		%	4.7		%	11.6		%	3.7		%	3.1		%	68.1		%
Outpatient Medical:
Square feet	902,986			1,669,510			1,988,685			2,106,936			2,116,845			2,003,818			1,129,172			1,448,787			817,114			880,070			5,746,479
Base rent(2)	$	25,166		$	45,925		$	54,771		$	57,230		$	57,127		$	58,855		$	29,965		$	36,921		$	20,315		$	23,309		$	120,638
% of base rent	4.7		%	8.7		%	10.3		%	10.8		%	10.8		%	11.1		%	5.7		%	7.0		%	3.8		%	4.4		%	22.8		%
Leases	255			412			404			397			426			294			176			190			112			102			266
% of Leases	8.3		%	13.6		%	13.3		%	13.1		%	14.0		%	9.7		%	5.8		%	6.3		%	3.7		%	3.4		%	8.8		%
(1) Excludes investments in unconsolidated entities, developments, land parcels, loans receivable and sub-leases. Investments classified as held for sale are included in the current year.
(2) The most recent monthly cash base rent annualized. Base rent does not include tenant recoveries or amortization of above and below market lease intangibles or other non-cash income.

 

We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Cautionary Statement Regarding Forward-Looking Statements” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2018, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of these risk factors.

32

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Corporate Governance

Maintaining investor confidence and trust is important in today’s business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.welltower.com/investors/governance. The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.

Liquidity and Capital Resources

Sources and Uses of Cash

Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and Commercial Paper Program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below. The following is a summary of our sources and uses of cash flows (dollars in thousands):

	Six Months Ended						Change
	June 30, 2019			June 30, 2018			$			%
Cash, cash equivalents and restricted cash at beginning of period	$	316,129		$	309,303		$	6,826		2	%
Cash provided from (used in) operating activities	854,482			838,424			16,058			2	%
Cash provided from (used in) investing activities	(2,531,364		)	130,251			(2,661,615		)	-2,043	%
Cash provided from (used in) financing activities	1,720,804			(1,000,290		)	2,721,094			272	%
Effect of foreign currency translation	(333		)	(5,305		)	4,972			94	%
Cash, cash equivalents and restricted cash at end of period	$	359,718		$	272,383		$	87,335		32	%

 

     Operating Activities The change in net cash provided from operating activities was immaterial. Please see “Results of Operations” for discussion of net income fluctuations. For the six months ended June 30, 2019 and 2018, cash flow provided from operations exceeded cash distributions to stockholders. 

    Investing Activities  The changes in net cash provided from/used in investing activities are primarily attributable to changes in acquisition and dispositions, which are summarized above in “Key Transactions” and Notes 3 and 5 of our unaudited consolidated financial statements. The following is a summary of cash used in non-acquisition capital improvement activities (dollars in thousands): 

	Six Months Ended				Change
	June 30, 2019		June 30, 2018		$			%
New development	$	155,409	$	62,978	$	92,431		147	%
Recurring capital expenditures, tenant improvements and lease commissions	49,925		35,116		14,809			42	%
Renovations, redevelopments and other capital improvements	74,251		76,216		(1,965		)	-3	%
Total	$	279,585	$	174,310	$	105,275		60	%

The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods. Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization. 

Financing Activities  The changes in net cash provided from/used in financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuance/redemption of common and preferred stock and dividend payments which are summarized above in "Key Transactions". Please refer to Notes 10, 11 and 14 of our unaudited consolidated financial statements for additional information.

33

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Off-Balance Sheet Arrangements 

At June 30, 2019, we had investments in unconsolidated entities with our ownership interests ranging from 10% to 50%. We use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. At June 30, 2019, we had 14 outstanding letter of credit obligations. Please see Notes 8, 12 and 13 to our unaudited consolidated financial statements for additional information.

Contractual Obligations

The following table summarizes our payment requirements under contractual obligations as of June 30, 2019 (in thousands):

	Payments Due by Period
Contractual Obligations	Total		2019		2020-2021		2022-2023		Thereafter
Unsecured credit facility and commercial paper(1,2)	$	1,870,000	$	935,000	$	—	$	935,000	$	—
Senior unsecured notes and term credit facilities:(2)
U.S. Dollar senior unsecured notes	8,450,000		—		1,450,000		1,700,000		5,300,000
Canadian Dollar senior unsecured notes(3)	229,165		—		229,165		—		—
Pounds Sterling senior unsecured notes(3)	1,333,920		—		—		—		1,333,920
U.S. Dollar term credit facility	507,500		—		7,500		500,000		—
Canadian Dollar term credit facility(3)	190,971		—		—		190,971		—
Secured debt:(2,3)
Consolidated	2,689,982		312,291		527,943		682,908		1,166,840
Unconsolidated	770,687		31,538		68,069		53,943		617,137
Contractual interest obligations:(4)
Unsecured credit facility and commercial paper	120,634		15,079		60,317		45,238		—
Senior unsecured notes and term loans(3)	4,038,896		259,830		826,444		711,116		2,241,506
Consolidated secured debt(3)	502,618		49,625		159,559		110,554		182,880
Unconsolidated secured debt(3)	196,781		14,745		52,201		48,783		81,052
Financing lease liabilities(5)	184,511		4,461		17,196		76,773		86,081
Operating lease liabilities(5)	1,542,933		8,637		33,843		31,797		1,468,656
Purchase obligations(6)	491,686		224,234		222,195		41,113		4,144
Other long-term liabilities	492		492		—		—		—
Total contractual obligations	$	23,120,776	$	1,855,932	$	3,654,432	$	5,128,196	$	12,482,216
(1) Relates to our unsecured credit facility and commercial paper with an aggregate commitment of $3,000,000,000. See Note 10 to our unaudited consolidated financial statements for additional information.
(2) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(3) Based on foreign currency exchange rates in effect as of balance sheet date.
(4) Based on variable interest rates in effect as of balance sheet date.
(5) See Note 6 to our unaudited consolidated financial statements for additional information.
(6) See Note 13 to our unaudited consolidated financial statements for additional information.

Capital Structure

Please refer to “Credit Strength” above for a discussion of our leverage and coverage ratio trends. Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2019, we were in compliance with all of the covenants under our debt agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest charged. We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.

On May 17, 2018, we filed with the Securities and Exchange Commission (1) an open-ended automatic or “universal” shelf registration statement covering an indeterminate amount of future offerings of debt securities, common stock, preferred stock, depositary shares, warrants and units and (2) a registration statement in connection with our enhanced dividend reinvestment plan (“DRIP”) under which we may issue up to 15,000,000 shares of common stock. As of July 19, 2019, 4,300,170 shares of common

34

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

stock remained available for issuance under the DRIP registration statement. On February 25, 2019 we entered into separate amended and restated equity distribution agreements with each of Barclays Capital Inc., Citigroup Global Markets Inc., Credit Agricole Securities (USA) Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, UBS Securities LLC and Wells Fargo Securities, LLC relating to the offer and sale from time to time of up to $1,500,000,000 aggregate amount of our common stock (“Equity Shelf Program”). The Equity Shelf Program also allows us to enter into forward sale agreements. As of July 19, 2019, we had $1,360,820,000 of remaining capacity under the Equity Shelf Program, which excludes forward sales agreements outstanding for the sale of 2,556,481 shares with maturity dates in the fourth quarter. We expect to physically settle the forward sales for cash proceeds. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured revolving credit facility and Commercial Paper Program.

Results of Operations

Summary

     Our primary sources of revenue include resident fees and services, rent and interest income. Our primary expenses include depreciation and amortization, interest expense, property operating expenses, general and administrative expenses and other expenses. We evaluate our business and make resource allocations on our three business segments: Seniors Housing Operating, Triple-net and Outpatient Medical. The primary performance measures for our properties are NOI and SSNOI, which are discussed below. Please see Non-GAAP Financial Measures for additional information and reconciliations. The following is a summary of our results of operations (dollars in thousands, except per share amounts):

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			Amount			%		2019			2018			Amount			%
Net income	$	150,040		$	167,273		$	(17,233	)	-10	%	$	442,342		$	620,828		$	(178,486	)	-29	%
NICS	137,762			154,432			(16,670		)	-11	%	418,232			592,103			(173,871		)	-29	%
FFO	390,021			378,725			11,296			3	%	748,404			731,945			16,459			2	%
EBITDA	541,027			528,805			12,222			2	%	1,224,715			1,334,924			(110,209		)	-8	%
NOI	618,979			557,161			61,818			11	%	1,220,417			1,097,661			122,756			11	%
SSNOI	409,789			417,399			(7,610		)	-1.8	%	826,471			825,012			1,459			0.2	%
Per share data (fully diluted):
NICS	$	0.34		$	0.41		$	(0.07	)	-17	%	$	1.05		$	1.59		$	(0.54	)	-34	%
FFO	$	0.96		$	1.02		$	(0.06	)	-6	%	$	1.87		$	1.96		$	(0.09	)	-5	%
Interest coverage ratio	3.74		x	4.34		x	(0.60		)x	-14	%	4.27		x	5.50		x	(1.23		)x	-22	%
Fixed charge coverage ratio	3.42		x	3.58		x	(0.16		)x	-4	%	3.90		x	4.53		x	(0.63		)x	-14	%

Seniors Housing Operating

The following is a summary of our NOI and SSNOI for the Seniors Housing Operating segment (dollars in thousands):

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			$			%		2019			2018			$			%
NOI	$	278,212		$	239,505		$	38,707		16.2	%	$	542,912		$	464,731		$	78,181		16.8	%
Non SSNOI attributable to same store properties	1,384			358			1,026			286.6	%	3,299			627			2,672			426.2	%
NOI attributable to non same store properties(1)	(88,898		)	(45,907		)	(42,991		)	-93.6	%	(159,122		)	(80,572		)	(78,550		)	-97.5	%
SSNOI(2)	$	190,698		$	193,956		$	(3,258	)	-1.7	%	$	387,089		$	384,786		$	2,303		0.6	%

⁽¹⁾ Change is primarily due to the acquisition of 63 properties subsequent to January 1, 2018 and the transition of 81 properties from Triple-net to Seniors Housing Operating.

⁽²⁾ Relates to 365 same store properties.

35

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following is a summary of our Seniors Housing Operating results of operations (dollars in thousands):

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			$			%		2019			2018			$			%
Revenues:
Resident fees and services	$	914,085		$	763,345		$	150,740		20	%	$	1,782,370		$	1,499,279		$	283,091		19	%
Interest income	—			172			(172		)	-100	%	—			257			(257		)	-100	%
Other income	1,444			1,650			(206		)	-12	%	5,545			2,798			2,747			98	%
Total revenues	915,529			765,167			150,362			20	%	1,787,915			1,502,334			285,581			19	%
Property operating expenses	637,317			525,662			111,655			21	%	1,245,003			1,037,603			207,400			20	%
NOI(1)	278,212			239,505			38,707			16	%	542,912			464,731			78,181			17	%
Other expenses:
Depreciation and amortization	136,551			134,779			1,772			1	%	268,126			260,548			7,578			3	%
Interest expense	17,572			16,971			601			4	%	35,823			33,906			1,917			6	%
Loss (gain) on extinguishment of debt, net	—			299			(299		)	-100	%	—			110			(110		)	-100	%
Impairment of assets	—			2,212			(2,212		)	-100	%	—			4,513			(4,513		)	-100	%
Other expenses	11,857			6,167			5,690			92	%	14,803			5,979			8,824			148	%
	165,980			160,428			5,552			3	%	318,752			305,056			13,696			4	%
Income (loss) from continuing operations before income taxes and other items	112,232			79,077			33,155			42	%	224,160			159,675			64,485			40	%
Income tax benefit (expense)	375			(2,617		)	2,992			114	%	(244		)	(2,455		)	2,211			90	%
Income (loss) from unconsolidated entities	(17,453		)	(5,204		)	(12,249		)	-235	%	(34,033		)	(14,684		)	(19,349		)	-132	%
Gain (loss) on real estate dispositions, net	(550		)	(1		)	(549		)	-54,900	%	(710		)	4			(714		)	-17,850	%
Income from continuing operations	94,604			71,255			23,349			33	%	189,173			142,540			46,633			33	%
Net income (loss)	94,604			71,255			23,349			33	%	189,173			142,540			46,633			33	%
Less: Net income (loss) attributable to noncontrolling interests	2,236			(766		)	3,002			392	%	3,977			(1,664		)	5,641			339	%
Net income (loss) attributable to common stockholders	$	92,368		$	72,021		$	20,347		28	%	$	185,196		$	144,204		$	40,992		28	%
(1) See Non-GAAP Financial Measures.

Fluctuations in revenues and property operating expenses are primarily a result of acquisitions, segment transitions and the movement of U.S. and foreign currency exchange rates. The fluctuations in depreciation and amortization are due to acquisitions and variations in amortization of short-lived intangible assets. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. 

During the three and six months ended June 30, 2018, we recorded impairment charges on certain held for sale properties as the carrying value exceeded the estimated fair value less costs to sell. Changes in the gain/loss on sale of properties are related to the volume of property sales and sales prices. Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The increase in other expenses is primarily due to additional noncapitalizable transactions costs from acquisitions and operator transitions. 

During the six months ended June 30, 2019, we completed two seniors housing operating construction projects representing $28,117,000 or $109,405 per unit. The following is a summary of our seniors housing operating construction projects, excluding expansions, pending as of June 30, 2019 (dollars in thousands):

Location	Units	Commitment		Balance		Est. Completion
Taylor, PA	113	$	14,272	$	8,801	4Q19
Wandsworth, UK	97	74,890		51,699		1Q20
Beavercreek, OH	100	12,032		8,361		1Q20
Potomac, MD	120	56,720		11,881		4Q20
	430	$	157,914	80,742
Toronto, ON	Project in planning stage			42,486
Hendon, UK	Project in planning stage			27,539
Barnet, UK	Project in planning stage			24,310
Washington, DC	Project in planning stage			16,412
				$	191,489

 

36

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Interest expense represents secured debt interest expense which fluctuates based on the net effect and timing of assumptions, segment transitions, fluctuations in currency rates, extinguishments and principal amortizations. The following is a summary of our Seniors Housing Operating segment secured debt principal activity (dollars in thousands):

	Three Months Ended										Six Months Ended
	June 30, 2019					June 30, 2018					June 30, 2019					June 30, 2018
				Wtd. Avg.					Wtd. Avg.					Wtd. Avg.					Wtd. Avg.
	Amount			Interest Rate		Amount			Interest Rate		Amount			Interest Rate		Amount			Interest Rate
Beginning balance	$	1,995,343		3.79	%	$	1,931,401		3.68	%	$	1,810,587		3.87	%	$	1,988,700		3.66	%
Debt issued	48,806			2.94	%	24,280			3.06	%	295,969			3.52	%	44,606			3.38	%
Debt assumed	—			0.00	%	—			0.00	%	42,000			4.62	%	85,192			4.40	%
Debt extinguished	(36,903		)	2.74	%	(13,165		)	3.57	%	(151,473		)	4.42	%	(131,175		)	4.85	%
Principal payments	(11,225		)	3.49	%	(12,062		)	3.57	%	(22,430		)	3.44	%	(24,001		)	3.56	%
Foreign currency	22,159			3.31	%	(21,039		)	3.30	%	43,527			3.33	%	(53,907		)	3.29	%
Ending balance	$	2,018,180		3.80	%	$	1,909,415		3.73	%	$	2,018,180		3.80	%	$	1,909,415		3.73	%
Monthly averages	$	1,996,642		3.80	%	$	1,922,640		3.71	%	$	1,950,546		3.82	%	$	1,932,618		3.68	%

 

     The majority of our Seniors Housing Operating properties are formed through partnership interests. Losses from unconsolidated entities are largely attributable to depreciation and amortization of short-lived intangible assets related to certain investments in unconsolidated joint ventures, as well as the disposal of an investment in an unconsolidated entity during the quarter ended June 30, 2019. Net income attributable to noncontrolling interests represents our partners’ share of net income (loss) related to joint ventures.

Triple-net

The following is a summary of our NOI and SSNOI for the Triple-net segment (dollars in thousands):

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			$			%		2019			2018			$			%
NOI	$	227,935		$	224,284		$	3,651		1.6	%	$	461,221		$	447,022		$	14,199		3.2	%
Non SSNOI attributable to same store properties	(8,114		)	(4,068		)	(4,046		)	-99.5	%	(15,707		)	(14,796		)	(911		)	-6.2	%
NOI attributable to non same store properties(1)	(87,819		)	(83,148		)	(4,671		)	-5.6	%	(180,659		)	(164,603		)	(16,056		)	-9.8	%
SSNOI(2)	$	132,002		$	137,068		$	(5,066	)	-3.7	%	$	264,855		$	267,623		$	(2,768	)	-1.0	%

 

⁽¹⁾ Change is primarily due to the acquisition of 237 properties, the transitioning/restructuring of six properties, and the conversion of seven construction projects into revenue-generating properties subsequent to January 1, 2018 and 30 held for sale properties at June 30, 2019.

⁽²⁾ Relates to 388 same store properties.

37

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following is a summary of our results of operations for the Triple-net segment (dollars in thousands):

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			$			%		2019			2018			$			%
Revenues:
Rental income	$	222,362		$	197,961		$	24,401		12	%	$	454,394		$	404,792		$	49,602		12	%
Interest income	17,118			13,247			3,871			29	%	32,064			27,798			4,266			15	%
Other income	1,278			13,212			(11,934		)	-90	%	2,541			14,589			(12,048		)	-83	%
Total revenues	240,758			224,420			16,338			7	%	488,999			447,179			41,820			9	%
Property operating expenses	12,823			136			12,687			9,329	%	27,778			157			27,621			17,593	%
NOI(1)	227,935			224,284			3,651			2	%	461,221			447,022			14,199			3	%
Other expenses:
Depreciation and amortization	56,056			55,309			747			1	%	117,404			111,341			6,063			5	%
Interest expense	3,225			3,800			(575		)	-15	%	6,665			7,242			(577		)	-8	%
Loss (gain) on derivatives and financial instruments, net	1,913			(7,460		)	9,373			126	%	(574		)	(14,633		)	14,059			96	%
Loss (gain) on extinguishment of debt, net	—			—			—			n/a		—			(32		)	32			100	%
Provision for loan losses	—			—			—			n/a		18,690			—			18,690			n/a
Impairment of assets	(940		)	2,420			(3,360		)	-139	%	(940		)	28,304			(29,244		)	-103	%
Other expenses	5,560			957			4,603			481	%	8,589			2,077			6,512			314	%
	65,814			55,026			10,788			20	%	149,834			134,299			15,535			12	%
Income from continuing operations before income taxes and other items	162,121			169,258			(7,137		)	-4	%	311,387			312,723			(1,336		)	—	%
Income tax (expense) benefit	(1,361		)	(688		)	(673		)	-98	%	(2,312		)	(1,824		)	(488		)	-27	%
Income (loss) from unconsolidated entities	6,578			5,062			1,516			30	%	12,236			10,883			1,353			12	%
Gain (loss) on real estate dispositions, net	(1,130		)	10,759			(11,889		)	-111	%	166,444			134,156			32,288			24	%
Income from continuing operations	166,208			184,391			(18,183		)	-10	%	487,755			455,938			31,817			7	%
Net income	166,208			184,391			(18,183		)	-10	%	487,755			455,938			31,817			7	%
Less: Net income (loss) attributable to noncontrolling interests	9,230			1,253			7,977			637	%	18,326			3,216			15,110			470	%
Net income attributable to common stockholders	$	156,978		$	183,138		$	(26,160	)	-14	%	$	469,429		$	452,722		$	16,707		4	%
(1) See Non-GAAP Financial Measures.

 

The increase in rental income is primarily attributable to acquisitions including Quality Care Properties Inc. ("QCP") in July 2018, partially offset by the disposition or segment transition of various properties. In addition, we have recorded certain real estate property taxes on a gross basis, with the offset to property operating expenses, as a result of our ASC 842 adoption on January 1, 2019. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. For the three months ended June 30, 2019, we had 11 leases with rental rate increasers ranging from 0.13% to 0.70% in our Triple-net portfolio. The decrease in other income is primarily due to $10,805,000 of net lease termination fees recognized during the three months ended June 30, 2018.

Depreciation and amortization increased primarily as a result of the acquisitions of triple-net properties exceeding dispositions. To the extent that we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly. 

In March 2019, we recognized a provision for loan losses of $18,690,000 to fully reserve for certain real estate loans receivable that are no longer deemed collectible. During the three and six months ended June 30, 2018, we recorded impairment charges on certain held for sale triple-net properties as the carrying values exceeded the estimated fair value less costs to sell. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices. Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The increase in other expenses is primarily due to additional noncapitalizable transaction costs from acquisitions and operator transitions.

The following is a summary of Triple-net construction projects, excluding expansions, pending as of June 30, 2019 (dollars in thousands): 

38

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Location	Units/Beds	Commitment		Balance		Est. Completion
Westerville, OH	90	$	22,800	$	13,925	3Q19
Union, KY	162	34,600		18,000		1Q20
Droitwich, UK	70	16,090		6,870		2Q20
Thousand Oaks, CA	82	24,763		6,256		4Q20
	404	$	98,253	$	45,051

 

Interest expense represents secured debt interest expense and related fees. The change in interest expense is due to the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The fluctuations in loss (gain) on extinguishment of debt is primarily attributable to the volume of extinguishments and terms of the related secured debt. The fluctuation in loss (gain) on derivatives and financial instruments, net is primarily attributable to the mark-to-market adjustment recorded on the Genesis HealthCare available-for-sale investment. The following is a summary of our Triple-net secured debt principal activity (dollars in thousands):

	Three Months Ended										Six Months Ended
	June 30, 2019					June 30, 2018					June 30, 2019					June 30, 2018
				Wtd. Avg.					Wtd. Avg.					Wtd. Avg.					Wtd. Avg.
	Amount			Interest Rate		Amount			Interest Rate		Amount			Interest Rate		Amount			Interest Rate
Beginning balance	$	292,258		3.62	%	$	347,342		3.50	%	$	288,386		3.63	%	$	347,474		3.55	%
Debt extinguished	—			0.00	%	—			0.00	%	—			0.00	%	(4,107		)	4.94	%
Principal payments	(952		)	5.25	%	(1,055		)	5.57	%	(1,909		)	5.25	%	(2,071		)	5.49	%
Foreign currency	(3,354		)	3.21	%	(12,254		)	2.72	%	1,475			4.77	%	(7,263		)	3.59	%
Ending balance	$	287,952		3.63	%	$	334,033		3.53	%	$	287,952		3.63	%	$	334,033		3.53	%
Monthly averages	$	289,328		3.62	%	$	340,332		3.37	%	$	291,073		3.62	%	$	343,820		3.44	%

A portion of our Triple-net properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interest represents our partners’ share of net income relating to those partnerships where we are the controlling partner. Increases in net income attributable to noncontrolling interest is due primarily to the ProMedica joint venture formed as part of the QCP acquisition.

Outpatient Medical

The following is a summary of our NOI and SSNOI for the Outpatient Medical segment (dollars in thousands):

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			$			%		2019			2018			$			%
NOI	$	112,378		$	92,874		$	19,504		21.0	%	$	213,673		$	185,042		$	28,631		15.5	%
Non SSNOI on same store properties	(1,204		)	(1,397		)	193			13.8	%	(2,767		)	(2,663		)	(104		)	-3.9	%
NOI attributable to non same store properties(1)	(24,085		)	(5,102		)	(18,983		)	-372.1	%	(36,379		)	(9,776		)	(26,603		)	-272.1	%
SSNOI(2)	$	87,089		$	86,375		$	714		0.8	%	$	174,527		$	172,603		$	1,924		1.1	%

 

⁽¹⁾ Change is primarily due to acquisitions of 102 properties and the conversion of 12 construction projects into revenue-generating properties subsequent to

January 1, 2018.

⁽²⁾ Relates to 227 same store properties.

39

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following is a summary of our results of operations for the Outpatient Medical segment (dollars in thousands):

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			$			%		2019			2018			$			%
Revenues:
Rental income	$	163,224		$	135,640		$	27,584		20	%	$	312,276		$	272,178		$	40,098		15	%
Interest income	238			43			195			453	%	411			55			356			647	%
Other income	(97		)	144			(241		)	-167	%	139			265			(126		)	-48	%
Total revenues	163,365			135,827			27,538			20	%	312,826			272,498			40,328			15	%
Property operating expenses	50,987			42,953			8,034			19	%	99,153			87,456			11,697			13	%
NOI(1)	112,378			92,874			19,504			21	%	213,673			185,042			28,631			15	%
Other expenses:
Depreciation and amortization	55,445			46,187			9,258			20	%	106,454			92,587			13,867			15	%
Interest expense	3,386			1,656			1,730			104	%	6,734			3,332			3,402			102	%
Loss (gain) on extinguishment of debt, net	—			—			—			n/a		—			11,928			(11,928		)	-100	%
Impairment of assets	10,879			—			10,879			n/a		10,879			—			10,879			n/a
Other expenses	(4		)	2,095			(2,099		)	-100	%	750			2,693			(1,943		)	-72	%
	69,706			49,938			19,768			40	%	124,817			110,540			14,277			13	%
Income (loss) from continuing operations before income taxes and other items	42,672			42,936			(264		)	-1	%	88,856			74,502			14,354			19	%
Income tax (expense) benefit	(586		)	(378		)	(208		)	-55	%	(951		)	(806		)	(145		)	-18	%
Income from unconsolidated entities	1,826			1,391			435			31	%	3,549			2,621			928			35	%
Gain (loss) on real estate dispositions, net	(2		)	(3		)	1			33	%	(7		)	214,779			(214,786		)	-100	%
Income from continuing operations	43,910			43,946			(36		)	—	%	91,447			291,096			(199,649		)	-69	%
Net income (loss)	43,910			43,946			(36		)	—	%	91,447			291,096			(199,649		)	-69	%
Less: Net income (loss) attributable to noncontrolling interests	812			678			134			20	%	1,807			3,821			(2,014		)	-53	%
Net income (loss) attributable to common stockholders	$	43,098		$	43,268		$	(170	)	—	%	$	89,640		$	287,275		$	(197,635	)	-69	%
(1) See Non-GAAP Financial Measures.

 

The increase in rental income is primarily attributable to acquisitions and development conversions, partially offset by dispositions of outpatient medical properties. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Sales of real property would offset revenue increases and, to the extent that they exceed new acquisitions, could result in decreased revenues. Our leases could renew above or below current rental rates, resulting in an increase or decrease in rental income. For the three months ended June 30, 2019, our consolidated outpatient medical portfolio signed 138,399 square feet of new leases and 332,299 square feet of renewals. The weighted-average term of these leases was seven years, with a rate of $36.64 per square foot and tenant improvement and lease commission costs of $21.40 per square foot. Substantially all of these leases contain an annual fixed or contingent escalation rent structure ranging from 1.5% to 3.9%.  

The fluctuation in property operating expenses is primarily attributable to acquisitions and construction conversions of new outpatient medical facilities, partially offset by dispositions. The fluctuation in depreciation and amortization is primarily due to acquisitions and variations in amortization of short-lived intangible assets. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. Changes in the gain/loss on sale of properties are related to the volume and timing of property sales and sales prices. During the three months ended June 30, 2019 we recorded an impairment charge on certain held for sale outpatient medical properties as the carrying values exceeded the estimated fair value less costs to sell.

40

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following is a summary of the Outpatient Medical construction projects, excluding expansions, pending as of June 30, 2019 (dollars in thousands):

Location	Square Feet	Commitment		Balance		Est. Completion
Lowell, MA	50,668	$	8,300	$	3,599	4Q19
Houston, TX	73,500	23,455		12,230		4Q19
Brooklyn, NY	140,955	105,306		72,435		1Q20
Porter, TX	55,000	20,800		8,737		1Q20
Katy, TX	36,500	12,028		170		2Q20
Total	356,623	$	169,889	$	97,171

Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The fluctuation in losses/gains on debt extinguishment is primarily attributable to the prepayment penalties paid on certain extinguishments in the first quarter of 2018. 

The following is a summary of our outpatient medical secured debt principal activity (dollars in thousands):

	Three Months Ended										Six Months Ended
	June 30, 2019					June 30, 2018					June 30, 2019					June 30, 2018
				Wtd. Ave					Wtd. Ave					Wtd. Ave					Wtd. Ave
	Amount			Interest Rate		Amount			Interest Rate		Amount			Interest Rate		Amount			Interest Rate
Beginning balance	$	385,357		4.25	%	$	217,697		4.14	%	$	386,738		4.20	%	$	279,951		4.72	%
Debt extinguished	—			—	%	—			—	%	—			—	%	(61,291		)	7.43	%
Principal payments	(1,507		)	5.02	%	(690		)	5.90	%	(2,888		)	5.06	%	(1,653		)	6.08	%
Ending balance	$	383,850		4.22	%	$	217,007		4.35	%	$	383,850		4.22	%	$	217,007		4.35	%
Monthly averages	$	384,603		4.24	%	$	217,352		4.27	%	$	386,088		4.24	%	$	226,493		4.30	%

 

A portion of our outpatient medical properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income relating to those partnerships where we are the controlling partner.

Non-Segment/Corporate

The following is a summary of our results of operations for the Non-Segment/Corporate activities (dollars in thousands):  

	Three Months Ended						Change					Six Months Ended						Change
	June 30,			June 30,								June 30,			June 30,
	2019			2018			$			%		2019			2018			$			%
Revenues:
Other income	$	454		$	498		$	(44	)	-9	%	$	2,611		$	866		$	1,745		202	%
Total revenue	454			498			(44		)	-9	%	2,611			866			1,745			202	%
Expenses:
Interest expense	117,153			98,989			18,164			18	%	237,346			199,711			37,635			19	%
General and administrative expenses	33,741			32,831			910			3	%	69,023			66,536			2,487			4	%
Loss (gain) on extinguishment of debt, net	—			—			—			n/a		15,719			—			15,719			n/a
Other expenses	4,215			839			3,376			402	%	6,242			3,021			3,221			107	%
	155,109			132,659			22,450			17	%	328,330			269,268			59,062			22	%
Loss from continuing operations before  income taxes and other items	(154,655		)	(132,161		)	(22,494		)	-17	%	(325,719		)	(268,402		)	(57,317		)	-21	%
Income tax (expense) benefit	(27		)	(158		)	131			83	%	(314		)	(344		)	30			9	%
Loss from continuing operations	(154,682		)	(132,319		)	(22,363		)	-17	%	(326,033		)	(268,746		)	(57,287		)	-21	%
Less: Preferred stock dividends	—			11,676			(11,676		)	-100	%	—			23,352			(23,352		)	-100	%
Net loss attributable to common stockholders	$	(154,682	)	$	(143,995	)	$	(10,687	)	-7	%	$	(326,033	)	$	(292,098	)	$	(33,935	)	-12	%

 

41

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following is a summary of our Non-Segment/Corporate interest expense (dollars in thousands):

	Three Months Ended				Change					Six Months Ended				Change
	June 30,		June 30,							June 30,		June 30,
	2019		2018		$			%		2019		2018		$			%
Senior unsecured notes	$	98,475	$	89,986	$	8,489		9	%	$	207,231	$	183,399	$	23,832		13	%
Secured debt	—		32		(32		)	-100	%	—		70		(70		)	-100	%
Unsecured revolving credit facility and commercial paper note program	15,160		5,768		9,392			163	%	22,678		9,782		12,896			132	%
Loan expense	3,518		3,203		315			10	%	7,437		6,460		977			15	%
Totals	$	117,153	$	98,989	$	18,164		18	%	$	237,346	$	199,711	$	37,635		19	%

 

The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments, as well as the movement of foreign exchange rates and related hedge activity. Please refer to Note 11 for additional information. The change in interest expense on the unsecured revolving credit facility and Commercial Paper Program is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes. Please refer to Note 10 of our unaudited consolidated financial statements for additional information regarding our unsecured revolving credit facility and Commercial Paper Program. The loss on extinguishment recognized during the six months ended June 30, 2019 is due to the early extinguishment of the $600,000,000 of 4.125% senior unsecured notes due 2019 and the $450,000,000 of 6.125% senior unsecured notes due 2020.

General and administrative expenses as a percentage of consolidated revenues for the three months ended June 30, 2019 and 2018 were 2.56% and 2.92%, respectively. Other expenses primarily represent severance-related costs associated with the departure of an executive officer and other key employees.

The decrease in preferred dividends is due to the conversion of all outstanding Series I Cumulative Convertible Perpetual Preferred Stock during the six months ended June 30, 2019.

Other

Non-GAAP Financial Measures

We believe that net income and net income attributable to common stockholders (“NICS”), as defined by U.S. GAAP, are the most appropriate earnings measurements. However, we consider FFO, NOI, SSNOI, EBITDA and Adjusted EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created funds from operations attributable to common stockholders (“FFO”) as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means NICS, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.

Consolidated net operating income (“NOI”) is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our properties.  These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent costs unrelated to property operations. These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets. Same store NOI (“SSNOI”) is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the reporting period subsequent to January 1, 2018. Land parcels, loans, and sub-leases as well as any properties acquired, developed/redeveloped, transitioned, sold or classified as held for sale during that period are excluded from the same store amounts. We believe NOI and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties.

42

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

EBITDA stands for earnings (net income) before interest, taxes, depreciation and amortization. We believe that EBITDA, along with net income and cash flow provided from operating activities, is an important supplemental measure because it provides additional information to assess and evaluate the performance of our operations. We primarily utilize EBITDA to measure our interest coverage ratio, which represents EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA divided by fixed charges. Fixed charges include total interest, secured debt principal amortization and preferred dividends. Covenants in our senior unsecured notes contain financial ratios based on a definition of EBITDA that is specific to those agreements. Failure to satisfy these covenants could result in an event of default that could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Due to the materiality of these debt agreements and the financial covenants, we have disclosed Adjusted EBITDA, which represents EBITDA as defined above excluding unconsolidated entities and adjusted for items per our covenant. We use Adjusted EBITDA to measure our adjusted fixed charge coverage ratio, which represents Adjusted EBITDA divided by fixed charges on a trailing twelve months basis. Fixed charges include total interest (excluding capitalized interest and non-cash interest expenses), secured debt principal amortization and preferred dividends. Our covenant requires an adjusted fixed charge coverage ratio of at least 1.50 times.

Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies. 

	Three Months Ended
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
NOI Reconciliations:	2018			2018			2018			2018			2019			2019
Net income (loss)	$	453,555		$	167,273		$	84,226		$	124,696		$	292,302		$	150,040
Loss (gain) on real estate dispositions, net	(338,184		)	(10,755		)	(24,723		)	(41,913		)	(167,409		)	1,682
Loss (income) from unconsolidated entities	2,429			(1,249		)	(344		)	(195		)	9,199			9,049
Income tax expense (benefit)	1,588			3,841			1,741			1,504			2,222			1,599
Other expenses	3,712			10,058			88,626			10,502			8,756			21,628
Impairment of assets	28,185			4,632			6,740			76,022			—			9,939
Provision for loan losses	—			—			—			—			18,690			—
Loss (gain) on extinguishment of debt, net	11,707			299			4,038			53			15,719			—
Loss (gain) on derivatives and financial instruments, net	(7,173		)	(7,460		)	8,991			1,626			(2,487		)	1,913
General and administrative expenses	33,705			32,831			28,746			31,101			35,282			33,741
Depreciation and amortization	228,201			236,275			243,149			242,834			243,932			248,052
Interest expense	122,775			121,416			138,032			144,369			145,232			141,336
Consolidated net operating income (NOI)	$	540,500		$	557,161		$	579,222		$	590,599		$	601,438		$	618,979
NOI by segment:
Seniors Housing Operating	$	225,226		$	239,505		$	265,846		$	254,445		$	264,700		$	278,212
Triple-net	222,738			224,284			218,684			234,343			233,286			227,935
Outpatient Medical	92,168			92,874			93,997			101,097			101,295			112,378
Non-segment/corporate	368			498			695			714			2,157			454
Total NOI	$	540,500		$	557,161		$	579,222		$	590,599		$	601,438		$	618,979

43

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

			Three Months Ended
			March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
SSNOI Reconciliations:			2018			2018			2018			2018			2019			2019
NOI:
Seniors Housing Operating			$	225,226		$	239,505		$	265,846		$	254,445		$	264,700		$	278,212
Triple-net			222,738			224,284			218,684			234,343			233,286			227,935
Outpatient Medical			92,168			92,874			93,997			101,097			101,295			112,378
Total			540,132			556,663			578,527			589,885			599,281			618,525
Adjustments:
Seniors Housing Operating:
Non SSNOI on same store properties			269			358			211			337			1,915			1,384
NOI attributable to non same store properties			(34,665		)	(45,907		)	(73,739		)	(65,131		)	(70,224		)	(88,898		)
Subtotal			(34,396		)	(45,549		)	(73,528		)	(64,794		)	(68,309		)	(87,514		)
Triple-net:
Non SSNOI on same store properties			(10,728		)	(4,068		)	(5,445		)	(6,384		)	(7,593		)	(8,114		)
NOI attributable to non same store properties			(81,455		)	(83,148		)	(79,874		)	(96,535		)	(92,840		)	(87,819		)
Subtotal			(92,183		)	(87,216		)	(85,319		)	(102,919		)	(100,433		)	(95,933		)
Outpatient Medical:
Non SSNOI on same store properties			(1,266		)	(1,397		)	(1,635		)	(5,706		)	(1,563		)	(1,204		)
NOI attributable to non same store properties			(4,674		)	(5,102		)	(5,776		)	(7,779		)	(12,294		)	(24,085		)
Subtotal			(5,940		)	(6,499		)	(7,411		)	(13,485		)	(13,857		)	(25,289		)
SSNOI:	Properties
Seniors Housing Operating	365		190,830			193,956			192,318			189,651			196,391			190,698
Triple-net	388		130,555			137,068			133,365			131,424			132,853			132,002
Outpatient Medical	227		86,228			86,375			86,586			87,612			87,438			87,089
Total	980		$	407,613		$	417,399		$	412,269		$	408,687		$	416,682		$	409,789
SSNOI Property Reconciliation:
Total properties	1,598
Acquisitions	(402	)
Developments	(30	)
Held for sale	(89	)
Transitions/restructurings	(87	)
Other(1)	(10	)
Same store properties	980
(1) Includes nine land parcels and one loan.

44

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

	Six Months Ended
	June 30,			June 30,
	2018			2019
NOI Reconciliations:
Net income (loss)	$	620,828		$	442,342
Loss (gain) on real estate dispositions, net	(348,939		)	(165,727		)
Loss (income) from unconsolidated entities	1,180			18,248
Income tax expense (benefit)	5,429			3,821
Other expenses	13,770			30,384
Impairment of assets	32,817			9,939
Provision for loan losses	—			18,690
Loss (gain) on extinguishment of debt, net	12,006			15,719
Loss (gain) on derivatives and financial instruments, net	(14,633		)	(574		)
General and administrative expenses	66,536			69,023
Depreciation and amortization	464,476			491,984
Interest expense	244,191			286,568
Consolidated net operating income (NOI)	$	1,097,661		$	1,220,417
NOI by segment:
Seniors Housing Operating	$	464,731		$	542,912
Triple-net	447,022			461,221
Outpatient Medical	185,042			213,673
Non-segment/corporate	866			2,611
Total NOI	$	1,097,661		$	1,220,417

		Six Months Ended
		June 30,			June 30,
SSNOI Reconciliations:		2018			2019
NOI:
Seniors Housing Operating		$	464,731		$	542,912
Triple-net		447,022			461,221
Outpatient Medical		185,042			213,673
Total		1,096,795			1,217,806
Adjustments:
Seniors Housing Operating:
Non SSNOI on same store properties		627			3,299
NOI attributable to non same store properties		(80,572		)	(159,122		)
Subtotal		(79,945		)	(155,823		)
Triple-net:
Non SSNOI on same store properties		(14,796		)	(15,707		)
NOI attributable to non same store properties		(164,603		)	(180,659		)
Subtotal		(179,399		)	(196,366		)
Outpatient Medical:
Non SSNOI on same store properties		(2,663		)	(2,767		)
NOI attributable to non same store properties		(9,776		)	(36,379		)
Subtotal		(12,439		)	(39,146		)
SSNOI:	Properties
Seniors Housing Operating	365	384,786			387,089
Triple-net	388	267,623			264,855
Outpatient Medical	227	172,603			174,527
Total	980	$	825,012		$	826,471

45

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The table below reflects the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization. Amounts are in thousands except for per share data.

	Three Months Ended
		March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
FFO Reconciliations:		2018			2018			2018			2018			2019			2019
Net income attributable to common stockholders		$	437,671		$	154,432		$	64,384		$	101,763		$	280,470		$	137,762
Depreciation and amortization		228,201			236,275			243,149			242,834			243,932			248,052
Impairment of assets		28,185			4,632			6,740			76,022			—			9,939
Loss (gain) on real estate dispositions, net		(338,184		)	(10,755		)	(24,723		)	(41,913		)	(167,409		)	1,682
Noncontrolling interests		(16,353		)	(17,692		)	(17,498		)	(17,650		)	(17,760		)	(18,889		)
Unconsolidated entities		13,700			11,833			13,220			13,910			19,150			11,475
FFO		$	353,220		$	378,725		$	285,272		$	374,966		$	358,383		$	390,021
Average common shares outstanding:
Basic		371,426			371,640			373,023			378,240			391,474			404,607
Diluted		373,257			373,075			374,487			380,002			393,452			406,673
Per share data:
Net income attributable to common stockholders:
Basic		$	1.18		$	0.42		$	0.17		$	0.27		$	0.72		$	0.34
Diluted		1.17			0.41			0.17			0.27			0.71			0.34
FFO
Basic		$	0.95		$	1.02		$	0.76		$	0.99		$	0.92		$	0.96
Diluted		0.95			1.02			0.76			0.99			0.91			0.96

	Six Months Ended
	June 30,			June 30,
FFO Reconciliations:	2018			2019
NICS	$	592,103		$	418,232
Depreciation and amortization	464,476			491,984
Impairment of assets	32,817			9,939
Loss (gain) on real estate dispositions, net	(348,939		)	(165,727		)
Noncontrolling interests	(34,045		)	(36,649		)
Unconsolidated entities	25,533			30,625
FFO	$	731,945		$	748,404
Average common shares outstanding:
Basic	371,552			398,073
Diluted	373,186			400,096
Per share data:
NICS
Basic	$	1.59		$	1.05
Diluted	1.59			1.05
FFO
Basic	$	1.97		$	1.88
Diluted	1.96			1.87

46

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The table below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.

	Three Months Ended
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
EBITDA Reconciliations:	2018			2018			2018			2018			2019			2019
Net income (loss)	$	453,555		$	167,273		$	84,226		$	124,696		$	292,302		$	150,040
Interest expense	122,775			121,416			138,032			144,369			145,232			141,336
Income tax expense (benefit)	1,588			3,841			1,741			1,504			2,222			1,599
Depreciation and amortization	228,201			236,275			243,149			242,834			243,932			248,052
EBITDA	$	806,119		$	528,805		$	467,148		$	513,403		$	683,688		$	541,027
Interest Coverage Ratio:
Interest expense	$	122,775		$	121,416		$	138,032		$	144,369		$	145,232		$	141,336
Non-cash interest expense	(4,179		)	(1,716		)	(1,658		)	(3,307		)	(5,171		)	(752		)
Capitalized interest	2,336			2,100			1,921			1,548			2,327			3,929
Total interest	120,932			121,800			138,295			142,610			142,388			144,513
EBITDA	$	806,119		$	528,805		$	467,148		$	513,403		$	683,688		$	541,027
Interest coverage ratio	6.67		x	4.34		x	3.38		x	3.60		x	4.80		x	3.74		x
Fixed Charge Coverage Ratio:
Total interest	$	120,932		$	121,800		$	138,295		$	142,610		$	142,388		$	144,513
Secured debt principal payments	14,247			14,139			13,908			13,994			13,543			13,684
Preferred dividends	11,676			11,676			11,676			11,676			—			—
Total fixed charges	146,855			147,615			163,879			168,280			155,931			158,197
EBITDA	$	806,119		$	528,805		$	467,148		$	513,403		$	683,688		$	541,027
Fixed charge coverage ratio	5.49		x	3.58		x	2.85		x	3.05		x	4.38		x	3.42		x

	Six Months Ended
	June 30,			June 30,
EBITDA Reconciliations:	2018			2019
Net income (loss)	$	620,828		$	442,342
Interest expense	244,191			286,568
Income tax expense (benefit)	5,429			3,821
Depreciation and amortization	464,476			491,984
EBITDA	$	1,334,924		$	1,224,715
Interest Coverage Ratio:
Interest expense	$	244,191		$	286,568
Non-cash interest expense	(5,895		)	(5,923		)
Capitalized interest	4,436			6,256
Total interest	242,732			286,901
EBITDA	$	1,334,924		$	1,224,715
Interest coverage ratio	5.50		x	4.27		x
Fixed Charge Coverage Ratio:
Total interest	$	242,732		$	286,901
Secured debt principal payments	28,385			27,227
Preferred dividends	23,352			—
Total fixed charges	294,469			314,128
EBITDA	$	1,334,924		$	1,224,715
Fixed charge coverage ratio	4.53		x	3.90		x

47

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.

	Twelve Months Ended
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
Adjusted EBITDA Reconciliations:	2018			2018			2018			2018			2019			2019
Net income	$	656,551		$	620,384		$	615,311		$	829,750		$	668,497		$	651,264
Interest expense	488,800			493,986			509,440			526,592			549,049			568,969
Income tax expense (benefit)	19,471			31,761			32,833			8,674			9,308			7,066
Depreciation and amortization	921,645			933,072			946,083			950,459			966,190			977,967
EBITDA	2,086,467			2,079,203			2,103,667			2,315,475			2,193,044			2,205,266
Loss (income) from unconsolidated entities	62,448			57,221			60,285			641			7,411			17,709
Stock-based compensation expense(1)	25,753			26,158			25,443			27,646			23,618			26,113
Loss (gain) on extinguishment of debt, net	17,593			12,377			16,415			16,097			20,109			19,810
Loss (gain) on real estate dispositions, net	(438,342		)	(406,942		)	(430,043		)	(415,575		)	(244,800		)	(232,363		)
Impairment of assets	141,637			132,638			139,378			115,579			87,394			92,701
Provision for loan losses	62,966			62,966			62,966			—			18,690			18,690
Loss (gain) on derivatives and financial instruments, net	(6,113		)	(14,309		)	(5,642		)	(4,016		)	670			10,043
Other expenses(1)	167,524			171,243			161,655			111,990			117,942			126,994
Additional other income	—			(10,805		)	(10,805		)	(14,832		)	(14,832		)	(4,027		)
Adjusted EBITDA	$	2,119,933		$	2,109,750		$	2,123,319		$	2,153,005		$	2,209,246		$	2,280,936
Adjusted Fixed Charge Coverage Ratio:
Interest expense	$	488,800		$	493,986		$	509,440		$	526,592		$	549,049		$	568,969
Capitalized interest	11,696			10,437			9,813			7,905			7,896			9,725
Non-cash interest expense	(12,858		)	(11,628		)	(10,087		)	(10,860		)	(11,852		)	(10,888		)
Total interest	487,638			492,795			509,166			523,637			545,093			567,806
Adjusted EBITDA	$	2,119,933		$	2,109,750		$	2,123,319		$	2,153,005		$	2,209,246		$	2,280,936
Adjusted interest coverage ratio	4.35		x	4.28		x	4.17		x	4.11		x	4.05		x	4.02		x
Total interest	$	487,638		$	492,795		$	509,166		$	523,637		$	545,093		$	567,806
Secured debt principal payments	62,077			60,258			58,866			56,288			55,584			55,129
Preferred dividends	46,707			46,704			46,704			46,704			35,028			23,352
Total fixed charges	596,422			599,757			614,736			626,629			635,705			646,287
Adjusted EBITDA	$	2,119,933		$	2,109,750		$	2,123,319		$	2,153,005		$	2,209,246		$	2,280,936
Adjusted fixed charge coverage ratio	3.55		x	3.52		x	3.45		x	3.44		x	3.48		x	3.53		x
(1) Certain severance-related costs are included in stock-based compensation and excluded from other expenses.

Our leverage ratios include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt less cash and cash equivalents and any IRC Section 1031 deposits), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock. Our leverage ratios are defined as the proportion of net debt to total capitalization. The table below reflects the reconciliation of our leverage ratios to our balance sheets for the periods presented. Amounts are in thousands, except share price. 

48

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

	As of
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
	2018			2018			2018			2018			2019			2019
Book capitalization:
Unsecured credit facility and commercial paper	$	865,000		$	540,000		$	1,312,000		$	1,147,000		$	419,293		$	1,869,188
Long-term debt obligations(1)	10,484,840			10,895,559			12,192,060			12,150,144			12,371,729			13,390,344
Cash & cash equivalents(2)	(202,824		)	(215,120		)	(191,199		)	(215,376		)	(249,127		)	(268,666		)
Total net debt	11,147,016			11,220,439			13,312,861			13,081,768			12,541,895			14,990,866
Total equity and noncontrolling interests(3)	15,448,201			15,198,644			15,670,065			16,010,645			16,498,376			16,452,806
Book capitalization	$	26,595,217		$	26,419,083		$	28,982,926		$	29,092,413		$	29,040,271		$	31,443,672
Net debt to book capitalization ratio	42		%	42		%	46		%	45		%	43		%	48		%
Undepreciated book capitalization:
Total net debt	$	11,147,016		$	11,220,439		$	13,312,861		$	13,081,768		$	12,541,895		$	14,990,866
Accumulated depreciation and amortization	4,990,780			5,113,928			5,394,274			5,499,958			5,670,111			5,539,435
Total equity and noncontrolling interests(3)	15,448,201			15,198,644			15,670,065			16,010,645			16,498,376			16,452,806
Undepreciated book capitalization	$	31,585,997		$	31,533,011		$	34,377,200		$	34,592,371		$	34,710,382		$	36,983,107
Net debt to undepreciated book capitalization ratio	35		%	36		%	39		%	38		%	36		%	41		%
Market capitalization:
Common shares outstanding	371,971			372,030			375,577			383,675			403,740			405,254
Period end share price	$	54.43		$	62.69		$	64.32		$	69.41		$	77.60		$	81.53
Common equity market capitalization	$	20,246,382		$	23,322,561		$	24,157,113		$	26,630,882		$	31,330,224		$	33,040,359
Total net debt	11,147,016			11,220,439			13,312,861			13,081,768			12,541,895			14,990,866
Noncontrolling interests(3)	889,766			856,721			1,362,380			1,378,311			1,419,885			1,458,351
Preferred stock	718,498			718,498			718,498			718,498			—			—
Enterprise value	$	33,001,662		$	36,118,219		$	39,550,852		$	41,809,459		$	45,292,004		$	49,489,576
Net debt to market capitalization ratio	34		%	31		%	34		%	31		%	28		%	30		%
(1) Amounts include senior unsecured notes, secured debt and lease liabilities related to financing leases, as reflected on our Consolidated Balance Sheet. Operating lease liabilities related to the ASC 842 adoption are excluded.
(2) Inclusive of IRC Section 1031 deposits, if any.
(3) Includes all noncontrolling interests (redeemable and permanent) as reflected on our Consolidated Balance Sheet.

Critical Accounting Policies

Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:

• the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and

• the impact of the estimates and assumptions on financial condition or operating performance is material.

Management has discussed the development and selection of its critical accounting policies with the Audit Committee of the Board of Directors. Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 for further information regarding significant accounting policies that impact us. There have been no material changes to these policies in 2019.

49

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. In particular, these forward-looking statements include, but are not limited to, those relating to the Company’s opportunities to acquire, develop or sell properties; the Company’s ability to close its anticipated acquisitions, investments or dispositions on currently anticipated terms or within currently anticipated timeframes; the expected performance of the Company’s operators/tenants and properties; the Company’s expected occupancy rates; the Company’s ability to declare and to make distributions to shareholders; the Company’s investment and financing opportunities and plans; the Company’s continued qualification as a real estate investment trust (“REIT”); the Company’s ability to access capital markets or other sources of funds; and the Company’s ability to meet its earnings guidance. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the Company’s actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; uncertainty from the expected discontinuance of LIBOR and the transition to any other interest rate benchmark; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the Company’s ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting the Company’s properties; the Company’s ability to re-lease space at similar rates as vacancies occur; the Company’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting the Company’s properties; changes in rules or practices governing the Company’s financial reporting; the movement of U.S. and foreign currency exchange rates; the Company’s ability to maintain its qualification as a REIT; and key management personnel recruitment and retention.  Other important factors are identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates.

We historically borrow on our unsecured revolving credit facility and Commercial Paper Program to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our unsecured revolving credit facility and Commercial Paper Program. We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.

A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):

50

	June 30, 2019					December 31, 2018
	Principal		Change in			Principal		Change in
	balance		fair value			balance		fair value
Senior unsecured notes	$	9,013,085	$	(635,567	)	$	9,009,159	$	(548,558	)
Secured debt	1,536,274		(60,281		)	1,639,983		(59,522		)
Totals	$	10,549,359	$	(695,848	)	$	10,649,142	$	(608,080	)

Our variable rate debt, including our unsecured revolving credit facility and Commercial Paper Program, is reflected at fair value. At June 30, 2019, we had $4,722,179,000 outstanding related to our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $47,222,000. At December 31, 2018, we had $2,683,553,000 outstanding under our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $26,836,000. 

     We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended June 30, 2019, including the impact of existing hedging arrangements, if these exchange rates were to increase or decrease by 10%, our net income from these investments would increase or decrease, as applicable, by less than $12,000,000. We will continue to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts. If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments’ change in fair value. The following table summarizes the results of the analysis performed (dollars in thousands):

	June 30, 2019				December 31, 2018
	Carrying		Change in		Carrying		Change in
	Value		fair value		Value		fair value
Foreign currency forward contracts	$	59,041	$	12,683	$	23,620	$	16,163
Debt designated as hedges	1,524,891		15,249		1,559,159		15,592
Totals	$	1,583,932	$	27,932	$	1,582,779	$	31,755

For additional information regarding fair values of financial instruments, see “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” and Notes 12 and 17 to our unaudited consolidated financial statements.

Item 4. Controls and Procedures

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

 From time to time, there are various legal proceedings pending against us that arise in the ordinary course of our business.  Management does not believe that the resolution of any of these legal proceedings either individually or in the aggregate will have a material adverse effect on our business, results of operations or financial condition. Further, from time to time, we are party to certain legal proceedings for which third parties, such as tenants, operators and/or managers are contractually obligated to indemnify, defend and hold us harmless. In some of these matters, the indemnitors have insurance for the potential damages. In other matters, we are being defended by tenants and other obligated third parties and these indemnitors may not have sufficient insurance, assets, income or resources to satisfy their defense and indemnification obligations to us. The unfavorable resolution of such legal

51

WELLTOWER INC.

 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

proceedings could, individually or in the aggregate, materially adversely affect the indemnitors’ ability to satisfy their respective obligations to us, which, in turn, could have a material adverse effect on our business, results of operations or financial condition.  It is management’s opinion that there are currently no such legal proceedings pending that will, individually or in the aggregate, have such a material adverse effect. Despite management’s view of the ultimate resolution of these legal proceedings, we may have significant legal expenses and costs associated with the defense of such matters. Further, management cannot predict the outcome of these legal proceedings and if management’s expectation regarding such matters is not correct, such proceedings could have a material adverse effect on our business, results of operations or financial condition.

Item 1A. Risk Factors

There have been no material changes from the risk factors identified under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds  

Issuer Purchases of Equity Securities
Period	Total Number of Shares Purchased(1)	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
April 1, 2019 through April 30, 2019	282	$	74.10
May 1, 2019 through May 31, 2019	—	—
June 1, 2019 through June 30, 2019	—	—
Totals	282	$	74.10
(1) During the three months ended June 30, 2019, the company acquired shares of common stock held by employees who tendered owned shares to satisfy tax withholding obligations.
(2) No shares were purchased as part of publicly announced plans or programs.

Item 5. Other Information 

None.

52

Item 6. Exhibits

3.1	Seventh Amended and Restated By-laws of Welltower Inc., (filed with the Commission as Exhibit 3.1 to the Company's Form 8-K filed May 6, 2019 (File No. 001-08923), and incorporated herein by reference thereto).
10.1	Resignation Agreement, dated July 1, 2019, by and between Mercedes T. Kerr and Welltower Inc. *
10.2	Summary of Director Compensation *
31.1	Rule 13a-14(a)/15d-14(a) Certification of Chairman and Chief Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.
32.1	Certification pursuant to 18 U.S.C. Section 1350 by Chairman and Chief Executive Officer.
32.2	Certification pursuant to 18 U.S.C. Section 1350 by Chief Financial Officer.
101.INS	XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
104	The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, formatted in Inline XBRL
*	Management contract or Compensatory Plan or Arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		WELLTOWER INC.
Date:	August 1, 2019	By:	/s/ THOMAS J. DEROSA
		Thomas J. DeRosa,
		Chairman and Chief Executive Officer  (Principal Executive Officer)
Date:	August 1, 2019	By:	/s/ JOHN A. GOODEY
		John A. Goodey,
		Executive Vice President & Chief Financial Officer  (Principal Financial Officer)
Date:	August 1, 2019	By:	/s/ JOSHUA T. FIEWEGER
		Joshua T. Fieweger,
		Senior Vice President & Controller  (Principal Accounting Officer)

53

EX-10.1

EXHIBIT 10.1

RESIGNATION AGREEMENT

This Resignation Agreement (this “Agreement”) is made as of July 1, 2019 by and between Mercedes T. Kerr (“Executive”) and Welltower Inc., a Delaware corporation (the “Company”).

WHEREAS, Executive is currently serving as the Executive Vice President – Business & Relationship Management of the Company;

WHEREAS, Executive has determined that it is in her best interests to resign her positions with the Company, and the Company has agreed with that determination;

WHEREAS, in consideration for Executive’s execution and non-revocation of this Agreement, the Company shall pay to Executive the payments described in this Agreement.

NOW, THEREFORE, in consideration of the promises and mutual covenants herein contained, the parties agree with each other as follows:

1.TERMINATION DATE.

a.    Executive’s last day of employment with the Company is July 1, 2019 (the “Termination Date”). Effective as of the Termination Date, Executive also hereby resigns all other positions Executive holds (i) with the Company, (ii) with any of the Company’s direct and indirect subsidiaries and/or affiliates, or (iii) with any other organization as to any position held at the request of, as a representative of, or for the benefit of the Company. Executive agrees to take any additional necessary steps and sign any additional documentation that may be reasonably requested by the Company, which the Company in good faith shall endeavor to complete within 90 days of the Termination Date, in order to give full effect or confirmation of such resignations.

b.    As of the Termination Date, Executive will have no authority or power to bind the Company or to represent the Company in relation to third parties or to represent to third parties that Executive has authority or power to bind the Company or represent the Company.

2.PAYMENTS UPON TERMINATION. Within sixty (60) days following the Termination Date, or such earlier time as required by law or indicated below in this Section 2, the Company shall provide to Executive the following payments and benefits:

a.    any accrued but unpaid base compensation through the Termination Date;

b.    any accrued but unpaid PTO through the Termination Date;

c.    any nonforfeitable benefits payable to Executive under the terms of any deferred compensation, incentive or other benefit plans maintained by the Company, payable in accordance with the terms of the applicable plan; and

d.    any reasonable expenses incurred by Executive in promoting the Company’s business (including expenses for travel and similar items) in accordance with the business expense policy of the Company that remain unreimbursed as of the Termination Date.

3.PAYMENTS FOLLOWING RESIGNATION. Executive acknowledges and agrees that she is not entitled to any payments in connection with her resignation other than the payments and benefits set forth in Section 2 of this Agreement. The following payments (to which Executive would not otherwise be entitled) are being offered in consideration for Executive’s execution and delivery of this Agreement, including the release attached hereto as Exhibit A (the “Release”), and it becoming effective on or before August 1, 2019, and are subject to Executive’s compliance with the covenants and other obligations set forth in Sections 5(a), 5(b), 5(c), 5(d) and 5(e) of this Agreement, all of which must be satisfied in full in order for the payments set forth below in this Section

3 to be earned. Notwithstanding the foregoing, any benefits payable under the Company’s 2005 Long-Term Incentive Plan, Company’s 2016 – 2018 Long-Term Incentive Program, Company’s 2016 Long-Term Incentive Plan, 2017-2018 Long-Term Incentive Program – Bridge 1, 2017-2019 Long-Term Incentive Program, 2018-2020 Long-Term Incentive Program and 2019-2021 Long-Term Incentive Program shall be governed by the terms of such Plan or Program, as the case may be, and the separate form of Waiver and Release of Claims required thereunder, which is attached hereto as Exhibit B.

a.    a pro-rated portion of the annual bonus that Executive would have earned for 2019 if Executive had remained employed for the entire year, based on the number of days in 2019 that have elapsed as of the Termination Date, payable at the time that the Company pays bonuses to its executive officers for 2019 (but no later than March 15, 2020) with the individual performance component of this annual bonus scored at the target level (Performance Rating of 3);

b.    all of Executive’s restricted stock granted under the Company’s 2016 Long-Term Incentive Plan and restricted stock units granted pursuant to the 2018-2020 Long-Term Incentive Program, in each case that are subject to time-based vesting, shall become fully vested and shall settle in shares of the Company’s common stock par value $1.00 per share; and

c.    the treatment of all of Executive’s outstanding restricted stock, restricted stock units or other equity awards with performance-based vesting shall be determined in accordance with the long-term incentive plan, and any other plans, pursuant to which such awards were granted and the applicable award agreement.

Executive represents that Exhibit C is a correct and complete list of all of Executive’s outstanding restricted stock, restricted stock units or other equity based awards with time-based vesting or performance-based vesting.

The pro-rated bonus payable pursuant to subsection (a) shall be paid after the Compensation Committee of the Board of Directors of the Company has approved bonuses payable for the 2019 calendar year. All payments to be made, vesting restrictions to be lifted, or settlements to occur pursuant to subsections (b) and (c) shall be made to Executive on the first business day following the date that is sixty (60) days following the Termination Date (except as otherwise expressly provided in the applicable award agreement).

4.CONDITIONS OF PAYMENTS.

a.    If this Agreement does not become effective and irrevocable by its terms on or before August 1, 2019, the Company will have no obligation to make the payments set forth in Section 3 of this Agreement.

b.    If Executive violates any of her obligations, covenants or representations described in the first paragraph of Section 3 of this Agreement, including under Section 5(a), 5(b), 5(c), 5(d) or 5(e) of this Agreement, then (i) the Company’s obligations to provide the payments under Section 3 of this Agreement will immediately cease, (ii) Executive shall be obligated to return to the Company any compensation paid or provided to Executive pursuant to Section 3 of this Agreement, and (iii) the Company will be entitled to obtain all other remedies provided by law or in equity.

5.COVENANTS BY EXECUTIVE.

a.Protection of Confidential Information. Executive hereby agrees that except as set forth in the last full paragraph of this Section 5(a) she shall not, directly or indirectly, disclose or make available to any person, firm, corporation, association or other entity for any reason or purpose whatsoever, any Confidential Information (defined below). Executive further agrees that, upon the Termination Date, all Confidential Information in her possession that is in written or other tangible form shall be returned to the Company and shall not be retained by Executive or furnished to any third party, in any form except as provided herein. Notwithstanding the foregoing, this Section 5(a) shall not apply to Confidential Information that (i) was publicly known at the time of disclosure to Executive, (ii) becomes publicly known or available thereafter other than by any means in violation of this

2

Agreement or any other duty owed to the Company by Executive, (iii) is lawfully disclosed to Executive by a third party, or (iv) is required to be disclosed by law or by any court, arbitrator or administrative or legislative body with actual or apparent jurisdiction to order Executive to disclose or make accessible any information. As used in this Agreement, “Confidential Information” means, without limitation, any non-public confidential or proprietary information disclosed to Executive or known by Executive as a consequence of or through Executive’s relationship with the Company, in any form, including electronic media. Confidential Information also includes, but is not limited to, the Company’s business plans and financial information, marketing plans, and business opportunities. Nothing herein shall limit in any way any obligation Executive may have relating to Confidential Information under any other agreement or promise to the Company.

Executive specifically acknowledges that all such Confidential Information, whether reduced to writing, maintained on any form of electronic media, or maintained in the mind or memory of Executive and whether compiled by the Company, and/or Executive, derives independent economic value from not being readily known to or ascertainable by proper means by others who can obtain economic value from its disclosure or use, that reasonable efforts have been made by the Company to maintain the secrecy of such information, that such information is the sole property of the Company and that any retention and use of such information by Executive during her employment with the Company (except in the course of performing her duties and obligations to the Company) or after the Termination Date shall constitute a misappropriation of the Company’s trade secrets.

Executive agrees that Confidential Information gained by Executive during Executive’s association with the Company, has been developed by the Company through substantial expenditures of time, effort and money and constitutes valuable and unique property of the Company. Executive recognizes that because her work for the Company brought her into contact with confidential and proprietary information of the Company, the restrictions of this Section 5(a) are required for the reasonable protection of the Company and its investments. Executive further understands and agrees that the foregoing makes it necessary for the protection of the Company’s business that Executive not compete with the Company for a reasonable period after the Termination Date, as further provided in Section 5(b).

Executive understands that nothing contained in this Agreement limits Executive’s ability to file a charge or complaint with the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (each a “Government Agency”). Executive further understands that this Agreement does not limit Executive’s ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. However, to the maximum extent permitted by law, Executive agrees that if such a charge or complaint is made, Executive shall not be entitled to recover any individual monetary relief or other individual remedies. This Agreement does not limit or prohibit Executive’s right to receive an award for information provided to any Government Agency to the extent that such limitation or prohibition is a violation of law.

Executive affirms that Executive has not divulged any proprietary or Confidential Information of the Company and will continue to maintain the confidentiality of such information consistent with the Company’s policies and Executive’s agreement(s) with the Company and/or common law. Executive further affirms that Executive is not aware of and has not reported any allegations of wrongdoing by the Company or its officers or directors, including any allegations of corporate fraud, to a Government Agency or other person, and therefore has not been retaliated against for reporting any allegations of wrongdoing by the Company or its officers or directors, including any allegations of corporate fraud.

Notwithstanding the foregoing provisions in this Section 5(a), while Executive is employed by Belmont Village Senior Living for the purpose of Executive’s performance of her duties and responsibilities at Belmont Village Senior Living, Executive will not be in violation of this Section 5(a) by using information pertaining to Belmont Village Senior Living reasonably gathered in the course of her employment with Company, but easily and lawfully available through Executive’s employment at Belmont Village Senior Living.

3

b.Non-Competition.

(i)    Executive hereby agrees that she will not, during the period commencing on the Termination Date and ending on the 12-month anniversary thereof (the “Initial Restricted Period”), engage in any business activities on behalf of any enterprise which competes with the Company or any of its affiliates in the business of (A) ownership or operation of Health Care Facilities (as defined below); (B) investment in or lending to Health Care Facilities (including to an owner or developer of Health Care Facilities); (C) management of Health Care Facilities; or (D) provision of any consulting, advisory, research or planning or development services to Health Care Facilities. Executive will be deemed to be engaged in such competitive business activities if she participates in such a business enterprise as an employee, officer, director, consultant, agent, partner, proprietor, or other participant; provided that the ownership of no more than two percent (2%) of the stock of a publicly traded corporation engaged in a competitive business shall not be deemed to be engaging in competitive business activities. If Executive provides services to an enterprise that has some activities that compete with the Company or any of its affiliates in any area described above and other activities that do not compete with the Company or any of its affiliates in any of the areas described above, then so long as Executive provides services exclusively to the portion of such enterprise that does not compete with the Company and its affiliates, Executive will not be deemed to be engaged in a competitive business activity as described in this paragraph. Notwithstanding the foregoing, Executive will not be deemed to be engaged in a competitive business activity as described in this paragraph if she provides services to Belmont Village Senior Living and its controlled affiliates.

(ii)    For a period of six (6) months following the end of the Initial Restricted Period (the “Extended Restricted Period”), Executive will not participate in any of the following entities as an employee, officer, director, consultant, agent, partner, proprietor, or other participant: (A) Ventas, Inc.; (B) HCP, Inc.; (C) Omega Healthcare Investors, Inc.; (D) Medical Properties Trust, Inc.; (E) Healthcare Trust of America, Inc. Class A; (F) Healthcare Realty Trust Incorporated; (G) National Health Investors, Inc.; (H) Sabra Health Care REIT, Inc.; (I) Physicians Realty Trust; (J) Senior Housing Properties Trust; (K) LTC Properties, Inc.; (L) CareTrust REIT Inc.; (M) Universal Health Realty Income Trust; (N) Community Healthcare Trust, Inc.; (O) New Senior Investment Group Inc.; (P) MedEquities Realty Trust, Inc.; (Q) Global Medical REIT Inc; and (R) ReNew Health Group.

(iii)    “Health Care Facilities” means any senior housing facilities or facilities used or intended primarily for the delivery of health care services, including, without limitation, any active adult communities, independent living facilities, assisted living facilities, skilled nursing facilities, inpatient rehabilitation facilities, ambulatory surgery centers, outpatient medical treatment facilities, medical office buildings, hospitals not excluded below, or any similar types of facilities or enterprises, but in any event excluding acute care hospitals or integrated health care delivery systems that include acute care hospitals.

c.Non-Solicit of Employees. During the Initial and Extended Restricted Period[s], Executive will be prohibited, to the fullest extent allowed by applicable law, from directly or indirectly, individually or on behalf of any person or entity, encouraging, inducing, attempting to induce, recruiting, attempting to recruit, soliciting or attempting to solicit or participating in the recruitment for employment, contractor or consulting opportunities anyone who is employed at that time by the Company or any subsidiary or affiliate.

d.Non-Disparagement. Executive will not make or authorize anyone else to make on Executive’s behalf any disparaging or untruthful remarks or statements, whether oral or written, about the Company, its operations or its products, services, affiliates, officers, directors, employees, or agents, or issue any communication that reflects adversely on or encourages any adverse action against the Company. Executive will not make any direct or indirect written or oral statements to the press, television, radio or other media or other external persons or entities concerning any matters pertaining to the business and affairs of the Company, its affiliates or any of its officers or directors. The Company agrees not to make, and shall direct its directors and senior executives not to make on its behalf, any disparaging or untruthful remarks or statements, whether oral or written, about Executive, including comments to the press, television, radio, or other media or other external persons or entities.

e.Return of Company Materials.

4

(i)Definition of Electronic Media Equipment and Electronic Media Systems. For purposes of this Agreement, “Electronic Media Equipment” includes, but is not limited to, computers, external storage devices, thumb drives, handheld electronic devices, telephone equipment, and other electronic media devices. Additionally, “Electronic Media Systems” includes, but is not limited to, computer servers, messaging and email systems or accounts, and web-based services (including cloud-based information storage accounts), whether provided for Executive’s use directly by the Company or by third-party providers on behalf of the Company.

(ii)Return of Company Property. Executive understands and agrees that anything that she created or worked on for the Company while working for the Company belongs solely to the Company and that Executive cannot remove, retain, or use such information without the Company’s express written permission. Accordingly, on or before the Termination Date, Executive will immediately deliver to the Company, and will not keep in her possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Confidential Information, all Company equipment including all Company Electronic Media Equipment, all tangible embodiments of Confidential Information, all electronically stored information and passwords to access such property, Company credit cards, records, data, notes, notebooks, lists, books, client contact information, reports, files, proposals, lists, correspondence, specifications, software, any other documents and property, and reproductions of any of the foregoing items, including, without limitation, those records maintained on a cloud storage network.

(iii)Return of Company Information on Company Electronic Media Equipment. Executive agrees that she has not and will not copy, delete, or alter any information, including personal information voluntarily created or stored, contained in her Company Electronic Media Equipment prior to returning any information to the Company. Notwithstanding the foregoing, Executive is permitted to copy, delete or alter information that is solely personal in nature and not integrated with or incorporated with Company information.

(iv)Return of Company Information on Personal Electronic Media Equipment. In addition, if Executive has used any personal Electronic Media Equipment or personal Electronic Media Systems to create, receive, store, review, prepare or transmit any Company information, including but not limited to, Confidential Information, Executive agrees, on or before the Termination Date, to use her reasonable best efforts to make a prompt and reasonable search for such information in good faith, including reviewing any personal Electronic Media Equipment or personal Electronic Media Systems to locate such information and if she locates such information, she agrees to notify the Company of that fact and then provide the Company with a computer-useable copy of all such Company information from those equipment and systems or a reasonable opportunity to create such a copy; and she further agrees to use her reasonable best efforts to cooperate reasonably with the Company to verify that the necessary copying is completed (including upon request providing a sworn declaration confirming the return of property and deletion of information), and, upon confirmation of compliance by the Company, she agrees to delete and expunge all Company information.

(v)Breach of Section 5(e). To the extent the Company reasonably believes there is a breach of Section 5(e) and to the extent such breach of Section 5(e) is curable, the Company will give Executive written notice of such breach and a period of thirty (30) business days to substantially cure the same. Additionally, to the extent Executive determines she is in breach of Section 5(e), she shall notify the Company and substantially cure such breach within five (5) business days of determining such breach. If Executive substantially cures the breach discussed in this Section 5(e)(v) within such cure period, she will be deemed to be in compliance with Section 5(e).

f.    While employed by the Company and during the Extended Restricted Period, Executive will communicate the contents of this Section 5 to any person, firm, association, partnership, corporation or other entity that Executive intends to be employed by, associated with, or represent.

g.    For the avoidance of doubt, any breach of Section 5(a) through 5(e) of this Agreement, inclusive, shall constitute a material breach of this Agreement. Notwithstanding Section 6 of this Agreement, the parties agree that it would be difficult to fully compensate the Company for damages resulting from the breach or threatened breach of the covenants set forth in Sections 5(a) through 5(e) of this Agreement and accordingly agree

5

that the Company shall be entitled to temporary and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, or to obtain specific performance, without the need to post any bond, to enforce such provisions in any action or proceeding instituted in the United States District Court for the Northern District of Ohio or in any court in the State of Ohio having subject matter jurisdiction. This provision with respect to injunctive relief shall not, however, diminish the Company’s right to claim and recover damages.

6.ARBITRATION. Subject to Section 5(g) hereof, all claims, disputes, questions, or controversies arising out of or relating to this Agreement or Executive’s employment with the Company, including without limitation the construction or application of any of the terms, provisions, or conditions of this Agreement and any claims for any alleged discrimination, harassment, or retaliation in violation of any federal, state or local law, will be resolved exclusively in final and binding arbitration held under the auspices of the American Arbitration Association (“AAA”) and shall be conducted in accordance with the National Rules for the Resolution of Employment Disputes, or successor rules then in effect. The arbitration will be held in New York, New York, and will be conducted and administered by AAA or, in the event AAA does not then conduct arbitration proceedings, a similarly reputable arbitration administrator. Executive and the Company will select a mutually acceptable, neutral arbitrator from among the AAA panel of arbitrators. Except as provided by this Agreement, the Federal Arbitration Act will govern the administration of the arbitration proceedings. The arbitrator will apply the substantive law (and the law of remedies, if applicable) of the State of Ohio, or federal law, if Ohio law is preempted, and the arbitrator is without jurisdiction to apply any different substantive law. Executive and the Company will each be allowed to engage in adequate discovery, the scope of which will be determined by the arbitrator consistent with the nature of the claim[s](s) in dispute. The arbitrator will have the authority to entertain a motion to dismiss and/or a motion for summary judgment by any party and will apply the standards governing such motions under the Federal Rules of Civil Procedure. The arbitrator will render a written award and supporting opinion that will set forth the arbitrator’s findings of fact and conclusions of law. Judgment upon the award may be entered in any court of competent jurisdiction. The Company will pay the arbitrator’s fees, as well as all administrative fees, associated with the arbitration. Each party will be responsible for paying its own attorneys’ fees and costs (including expert witness fees and costs, if any), provided, however, that the arbitrator may award attorney’s fees and costs to the prevailing party, except as prohibited by law. The existence and subject matter of all arbitration proceedings, including, any settlements or awards there under, shall remain confidential. In entering into this Agreement, both parties are waiving the right to a trial by judge or jury.

7.SECTION 409A.

a.    This Agreement is intended to comply with Section 409A of the Code and will be administered and interpreted in a manner intended to comply with Code Section 409A. Any provision that would cause this Agreement or any payment hereof to fail to satisfy Code Section 409A of the Code shall have no force or effect until amended to the minimum extent required to comply with Code Section 409A, which amendment may be retroactive to the extent permitted by Code Section 409A. A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of amounts or benefits that may be considered “deferred compensation” under Code Section 409A (after taking into account all exclusions applicable to such payments or benefits under Code Section 409A) upon or following a termination of employment unless such termination is also a “Separation from Service” within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a “retirement,” “termination,” “termination of employment” or like terms shall mean Separation from Service.

b.    Any payment scheduled to be made under this Agreement that may be considered “deferred compensation” under Code Section 409A (after taking into account all exclusions applicable to such payments or benefits under Code Section 409A), that are otherwise due on or within the six-month period following the Termination Date will accrue during such six-month period and will instead become payable in a lump sum payment on the first business day period following such six-month period. Furthermore, if any other payments of money or other benefits due to Executive under this Agreement could cause the application of an accelerated or additional tax under Code Section 409A, such payments or other benefits shall be deferred if deferral will make such payment or other benefits compliant under Code Section 409A, or otherwise such payment or other benefits shall be restructured, to the extent possible, in a manner, determined by the Company, that does not cause such an

6

accelerated or additional tax. To the extent any reimbursements or in-kind benefits due to Executive under this Agreement constitute “deferred compensation” under Code Section 409A (after taking into account all exclusions applicable to such payments or benefits under Section 409A), any such reimbursements or in-kind benefits shall be paid to Executive in a manner consistent with Treas. Reg. Section 1.409A-3(i)(1)(iv).

c.    Notwithstanding any contrary provision herein, Executive’s right to any payment (including each installment payment) under this Agreement shall be treated as a “separate payment” within the meaning of Code Section 409A.

d.    The Company shall consult with Executive in good faith regarding the implementation of the provisions of this Section 7; provided that the Company shall not have any liability to Executive with respect thereto absent a breach by the Company of this Section 7 and the Company’s employees or representatives shall not have any liability to Executive with respect thereto.

8.COOPERATION. To the extent reasonably requested by the CEO of the Company or the Board of Directors of the Company, Executive shall cooperate with the Company (i) with respect to either (A) any formal or informal inquiry, investigation, litigation or other proceeding involving the Company and a governmental agency related to Executive’s service to the Company or (B) any litigation, arbitration, mediation or other proceeding between the Company and a third party related to Executive’s service to the Company and (ii) otherwise for a period not to exceed beyond July 1, 2020 in connection with matters arising out of Executive’s service to the Company generally; provided that, the Company shall collaborate with Executive to minimize disruption of Executive’s other activities. With regard to all other matters arising out of or related to Executive’s service to the Company, Executive shall endeavor to cooperate with the Company to the extent reasonably requested by the CEO of the Company or the Board of Directors of the Company. The Company shall reimburse Executive for reasonable expenses incurred in connection with such cooperation.

9.NO ADMISSION OF LIABILITY. Nothing in this Agreement will constitute or be construed in any way as an admission of any liability or wrongdoing whatsoever by the Company or Executive.

10.PAYMENT OF SALARY AND RECEIPT OF ALL BENEFITS. Executive acknowledges and represents that, other than the consideration set forth or otherwise referenced in this Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation, PTO, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Executive.

11.INTEGRATED AGREEMENT. This Agreement, including the Release attached as Exhibit A, is intended by the parties to be a complete and final expression of their rights and duties respecting the subject matter of this Agreement and supersedes all prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party hereto, and any prior agreement of the parties hereto in respect of the subject matter contained herein, except as expressly set forth herein (including but not limited to treatment of certain equity awards pursuant to the applicable plans, awards and other operative documents per Section 3(c)). Except as expressly provided herein, nothing in this Agreement is intended to negate Executive's agreement to abide by the Company's policies while serving as an employee of the Company (or thereafter or to the extent provided by such policies), including but not limited to the Company's Code of Business Conduct and Ethics and its Employee Handbook, or any other agreement governing the disclosure and/or use of proprietary information, which Executive signed while working with the Company or its predecessors; nor to waive any of Executive's obligations under state and federal trade secret laws.

12.TAXES AND OTHER WITHHOLDINGS. Notwithstanding any other provision of this Agreement, the Company may withhold from amounts payable hereunder all federal, state, local and foreign taxes and other amounts that are required to be withheld by applicable laws or regulations, and the withholding of any amount shall be treated as payment thereof for purposes of determining whether Executive has been paid amounts to which she is entitled. Executive acknowledges that (i) the Company has made no representation to Executive as to the tax treatment of any compensation or benefits to be paid to Executive under this Agreement and (ii) the

7

Company has no obligation to “gross-up” any amount payable to Executive under this Agreement for taxes payable by Executive thereon.

13.SURVIVAL. Except as mutually agreed in writing in accordance with Section 15 below, the covenants, agreements, representations and warranties contained in or made in Section 4, 5, 6, 8, 9, 10, 11, 15 and this Section 13 of this Agreement shall survive any termination of this Agreement.

14.WAIVER. Neither party shall, by mere lapse of time, without giving notice or taking other action hereunder, be deemed to have waived any breach by the other party of any of the provisions of this Agreement. Further, the waiver by either party of a particular breach of this Agreement by the other shall neither be construed as, nor constitute, a continuing waiver of such breach or of other breaches of the same or any other provision of this Agreement. Neither party waives any obligation of the other party to provide notice as provided by Section 5 of this Agreement.

15.MODIFICATION. This Agreement may not be modified or terminated unless such modification or termination is embodied in writing, signed by the party against whom the modification is to be enforced.

16.NOTICE. Except as otherwise expressly provided in this Agreement, any notice to either party hereunder shall be in writing and sent by overnight courier, certified mail, or registered mail (return receipt requested), postage prepaid, addressed as follows (or to such other address as such party may designate in writing from time to time):

If to the Company:

Welltower Inc.
4500 Dorr Street
Toledo, OH 43615
Attention: General Counsel

If to the Executive, at the address on file with the Company’s Human Resources Department.

The actual date of mailing, as shown by a mailing receipt therefor, shall determine the time at which notice was given.

17.ASSIGNMENT AND SUCCESSORS. The Company shall have the right to assign its rights and obligations under this Agreement to an entity that, directly or indirectly, acquires all or substantially all of the assets or the business of the Company. The rights and obligations of the Company under this Agreement shall inure to the benefit and shall be binding upon the successors and assigns of the Company. Executive shall not have any right to assign her obligations under this Agreement and shall only be entitled to assign her rights under this Agreement upon her death (in which case any payments or benefits provided hereunder will be provided to her designated beneficiary or, if no such beneficiary has been designated, to her estate), solely to the extent permitted by this Agreement, or as otherwise agreed to by the Company.

18.SEVERABILITY. Each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement. Moreover, if any provision contained in this Agreement is determined by an arbitrator or court of competent jurisdiction to be unenforceable because it is excessively broad in scope, whether as to duration, activity, geographic application, subject or otherwise, it shall be construed, by limiting or reducing it to the extent legally permitted, so as to be enforceable to the extent compatible with then applicable law in order to achieve the intent of the parties.

19.GOVERNING LAW. This Agreement will be construed, interpreted, governed and enforced in accordance with the laws of the State of Ohio, without regard to its conflict of laws principles.

8

20.COUNTERPARTS. This Agreement may be executed in counterparts and delivered by means of facsimile or portable document format (PDF), each of which when so executed and delivered shall be an original, but all such counterparts together shall constitute one and the same instrument.

21.ATTORNEYS’ FEES. The Company will reimburse Executive, upon presentation of an invoice therefor, in an amount not to exceed Twenty Thousand Dollars ($20,000), for attorneys’ fees and costs incurred by Executive in connection with the review, negotiation and documentation of this Agreement on Executive’s behalf.

[Signature Page Follows]

9

IN WITNESS WHEREOF, the Company has caused this Agreement to be duly executed, and the Executive has hereunto set her hand, effective as of the day and year first written above.

WELLTOWER, INC			EXECUTIVE
By:	/s/Christy Contardi Stone		/s/Mercedes T. Kerr
Name:	Christy Contardi Stone		Mercedes T. Kerr
Title:	Senior Vice President - Human Capital
Date:	July 1, 2019	Date:	July 1, 2019

10

EX-10.2

EXHIBIT 10.2

Welltower Inc.

Non-Employee Director Compensation

Effective May 1, 2019

For each calendar year, each non-employee member of the Board of Directors of Welltower Inc. (the “Company”) will receive an annual retainer of $95,000, payable in equal quarterly installments. If there is a non-employee director serving as the Chairman of the Board, such individual will receive an additional retainer of $125,000. The independent Lead Director, if any, will receive an annual retainer of $75,000, payable in equal quarterly installments. Each non-employee member of the Executive Committee will receive an additional retainer of $7,500. Additionally, the chairs of the Audit Committee, the Compensation Committee, the Nominating/Corporate Governance Committee and the Investment Committee will receive additional retainers of $25,000, $20,000, $15,000 and $20,000, respectively. If the Board of Directors holds more than four meetings in a year, each non-employee member of the Board will receive $1,500 for each meeting attended in excess of four meetings. With respect to the Audit, Compensation, Executive, Nominating/Corporate Governance and Investment Committees, if any of these committees holds more than four meetings in a year, each non-employee member of these committees will receive $1,000 for each meeting attended in excess of four meetings.

Each of the non-employee directors will receive, in each calendar year, a grant of deferred stock units with a value of $160,000, pursuant to the Company’s 2016 Long-Term Incentive Plan. The deferred stock units will be convertible into shares of common stock of the Company on the anniversary of the date of the grant. Recipients of the deferred stock units also will be entitled to dividend equivalent rights.

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHAIRMAN AND CHIEF EXECUTIVE OFFICER

I, Thomas J. DeRosa, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Welltower Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2019

/s/ THOMAS J. DEROSA

Thomas J. DeRosa, 

Chairman and Chief Executive Officer 

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, John A. Goodey, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Welltower Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2019

/s/ JOHN A. GOODEY

John A. Goodey, 

Chief Financial Officer 

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

I, Thomas J. DeRosa, the Chairman and Chief Executive Officer of Welltower Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended June 30, 2019 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ THOMAS J. DEROSA

Thomas J. DeRosa, 

Chairman and Chief Executive Officer

 Date: August 1, 2019

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

I, John A. Goodey, the Chief Financial Officer of Welltower Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended June 30, 2019 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JOHN A. GOODEY

John A. Goodey, 

Chief Financial Officer

 Date: August 1, 2019

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover Page - shares	6 Months Ended
	Jun. 30, 2019	Jul. 19, 2019
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2019
Document Transition Report	false
Entity File Number	1-8923
Entity Registrant Name	WELLTOWER INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	34-1096634
Entity Address, Address Line One	4500 Dorr Street
Entity Address, City or Town	Toledo,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43615
City Area Code	(419)
Local Phone Number	247-2800
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock Shares Outstanding		405,246,816
Entity Central Index Key	0000766704
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Common stock, $1.00 par value per share
Document Information [Line Items]
Title of 12(b) Security	Common stock, $1.00 par value per share
Trading Symbol	WELL
Security Exchange Name	NYSE
4.800% Notes due 2028
Document Information [Line Items]
Title of 12(b) Security	4.800% Notes due 2028
Trading Symbol	WELL28
Security Exchange Name	NYSE
4.500% Notes due 2034
Document Information [Line Items]
Title of 12(b) Security	4.500% Notes due 2034
Trading Symbol	WELL34
Security Exchange Name	NYSE

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018	[1]
Real property owned:
Land and land improvements	$ 3,337,234	$ 3,205,091
Buildings and improvements	28,691,274	28,019,502
Acquired lease intangibles	1,589,138	1,581,159
Real property held for sale, net of accumulated depreciation	1,704,206	590,271
Construction in progress	363,160	194,365
Less accumulated depreciation and amortization	(5,539,435)	(5,499,958)
Net real property owned	30,145,577	28,090,430
Right of use assets, net	550,342
Real estate loans receivable, net of allowance	368,994	330,339
Net real estate investments	31,064,913	28,420,769
Other assets:
Investments in unconsolidated entities	519,387	482,914
Goodwill	68,321	68,321
Cash and cash equivalents	268,666	215,376
Restricted cash	91,052	100,753
Straight-line rent receivable	419,501	367,093
Receivables and other assets	716,857	686,846
Total other assets	2,083,784	1,921,303
Total assets	33,148,697	30,342,072
Liabilities:
Unsecured credit facility and commercial paper	1,869,188	1,147,000
Senior unsecured notes	10,606,106	9,603,299
Secured debt	2,675,507	2,476,177
Lease liabilities	469,029	70,668
Accrued expenses and other liabilities	1,076,061	1,034,283
Total liabilities	16,695,891	14,331,427
Redeemable noncontrolling interests	483,234	424,046
Equity:
Preferred stock	0	718,498
Common stock	406,014	384,465
Capital in excess of par value	19,740,145	18,424,368
Treasury stock	(74,042)	(68,499)
Cumulative net income	6,539,766	6,121,534
Cumulative dividends	(11,516,994)	(10,818,557)
Accumulated other comprehensive income (loss)	(100,622)	(129,769)
Other equity	188	294
Total Welltower Inc. stockholders’ equity	14,994,455	14,632,334
Noncontrolling interests	975,117	954,265
Total equity	15,969,572	15,586,599
Total liabilities and equity	$ 33,148,697	$ 30,342,072

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues:
Rental income		$ 385,586		$ 766,670
Rental income			$ 333,601		$ 676,970
Total revenues		1,320,106	1,125,912	2,592,351	2,222,877
Expenses:
Property operating expenses		701,127	568,751	1,371,934	1,125,216
Depreciation and amortization		248,052	236,275	491,984	464,476
Interest expense		141,336	121,416	286,568	244,191
General and administrative expenses		33,741	32,831	69,023	66,536
Loss (gain) on derivatives and financial instruments, net		1,913	(7,460)	(574)	(14,633)
Loss (gain) on extinguishment of debt, net		0	299	15,719	12,006
Provision for loan losses		0	0	18,690	0
Impairment of assets		9,939	4,632	9,939	32,817
Other expenses		21,628	10,058	30,384	13,770
Total expenses		1,157,736	966,802	2,293,667	1,944,379
Income (loss) from continuing operations before income taxes and other items		162,370	159,110	298,684	278,498
Income tax (expense) benefit		(1,599)	(3,841)	(3,821)	(5,429)
Income (loss) from unconsolidated entities		(9,049)	1,249	(18,248)	(1,180)
Gain (loss) on real estate dispositions, net		(1,682)	10,755	165,727	348,939
Income (loss) from continuing operations		150,040	167,273	442,342	620,828
Net income (loss)		150,040	167,273	442,342	620,828
Less: Preferred stock dividends		0	11,676	0	23,352
Less: Net income (loss) attributable to noncontrolling interests	[1]	12,278	1,165	24,110	5,373
Net income (loss) attributable to common stockholders		$ 137,762	$ 154,432	$ 418,232	$ 592,103
Average number of common shares outstanding:
Basic (in shares)		404,607	371,640	398,073	371,552
Diluted (in shares)		406,673	373,075	400,096	373,186
Basic:
Income (loss) from continuing operations (in USD per share)		$ 0.37	$ 0.45	$ 1.11	$ 1.67
Net income (loss) attributable to common stockholders (in USD per share)		0.34	0.42	1.05	1.59
Diluted:
Income (loss) from continuing operations (in USD per share)		0.37	0.45	1.11	1.66
Net income (loss) attributable to common stockholders (in USD per share)		0.34	0.41	1.05	1.59
Dividends declared and paid per common share (in USD per share)		$ 0.87	$ 0.87	$ 1.7400	$ 1.7400
Net income		$ 150,040	$ 167,273	$ 442,342	$ 620,828
Other comprehensive income (loss):
Foreign currency translation gain (loss)		(54,024)	(200,826)	24,596	(121,802)
Derivative instruments gain (loss)		100,407	150,703	12,725	88,005
Total other comprehensive income (loss)		46,383	(50,123)	37,321	(33,797)
Total comprehensive income (loss)		196,423	117,150	479,663	587,031
Less: Total comprehensive income (loss) attributable to noncontrolling interests(1)		14,665	(7,580)	32,284	(7,258)
Total comprehensive income (loss) attributable to common stockholders		181,758	124,730	447,379	594,289
Resident fees and services
Revenues:
Revenue from contract with customer		914,085	763,345	1,782,370	1,499,279
Interest income
Revenues:
Revenue from contract with customer		17,356	13,462	32,475	28,110
Other income
Revenues:
Revenue from contract with customer		$ 3,079	$ 15,504	$ 10,836	$ 18,518

[1] Includes amounts attributable to redeemable noncontrolling interests.

XML

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total		Preferred Stock	Common Stock	Capital in Excess of Par Value	Treasury Stock	Cumulative Net Income	Cumulative Dividends	Accumulated Other Comprehensive Income (Loss)	Other Equity	Noncontrolling Interests
Balances at beginning of period at Dec. 31, 2017	$ 14,925,452		$ 718,503	$ 372,449	$ 17,662,681	$ (64,559)	$ 5,316,580	$ (9,471,712)	$ (111,465)	$ 670	$ 502,305
Comprehensive income:
Net income (loss)	454,538						449,347				5,191
Other comprehensive income	16,326								20,212		(3,886)
Total comprehensive income	470,864
Net change in noncontrolling interests	(15,876)				(13,157)						(2,719)
Amounts related to stock incentive plans, net of forfeitures	7,098			150	11,085	(4,137)
Proceeds from issuance of common stock	7,190			130	7,060
Conversion of preferred stock	0		(5)		5
Dividends paid:
Common stock dividends	(323,726)							(323,726)
Preferred stock dividends	(11,676)							(11,676)
Balances at end of period at Mar. 31, 2018	15,059,326		718,498	372,729	17,667,674	(68,696)	5,765,927	(9,807,114)	(91,253)	670	500,891
Balances at beginning of period at Dec. 31, 2017	14,925,452		718,503	372,449	17,662,681	(64,559)	5,316,580	(9,471,712)	(111,465)	670	502,305
Comprehensive income:
Other comprehensive income	(33,797)
Balances at end of period at Jun. 30, 2018	14,800,487		718,498	372,801	17,661,384	(68,661)	5,932,035	(10,142,162)	(132,631)	659	458,564
Balances at beginning of period at Mar. 31, 2018	15,059,326		718,498	372,729	17,667,674	(68,696)	5,765,927	(9,807,114)	(91,253)	670	500,891
Comprehensive income:
Net income (loss)	168,463						166,108				2,355
Other comprehensive income	(50,123)								(41,378)		(8,745)
Total comprehensive income	118,340
Net change in noncontrolling interests	(50,759)				(14,822)						(35,937)
Amounts related to stock incentive plans, net of forfeitures	5,843			18	5,801	35				(11)
Proceeds from issuance of common stock	2,785			54	2,731
Dividends paid:
Common stock dividends	(323,372)							(323,372)
Preferred stock dividends	(11,676)							(11,676)
Balances at end of period at Jun. 30, 2018	14,800,487		718,498	372,801	17,661,384	(68,661)	5,932,035	(10,142,162)	(132,631)	659	458,564
Balances at beginning of period at Dec. 31, 2018	15,586,599	[1]	718,498	384,465	18,424,368	(68,499)	6,121,534	(10,818,557)	(129,769)	294	954,265
Comprehensive income:
Net income (loss)	291,255						280,470				10,785
Other comprehensive income	(9,062)								(14,849)		5,787
Total comprehensive income	282,193
Net change in noncontrolling interests	(10,342)				(8,845)						(1,497)
Amounts related to stock incentive plans, net of forfeitures	1,521			120	7,420	(5,993)				(26)
Proceeds from issuance of common stock	532,620			7,212	525,408
Conversion of preferred stock	0		(718,498)	12,712	705,786
Dividends paid:
Common stock dividends	(344,760)							(344,760)
Balances at end of period at Mar. 31, 2019	16,047,831		0	404,509	19,654,137	(74,492)	6,402,004	(11,163,317)	(144,618)	268	969,340
Balances at beginning of period at Dec. 31, 2018	15,586,599	[1]	718,498	384,465	18,424,368	(68,499)	6,121,534	(10,818,557)	(129,769)	294	954,265
Comprehensive income:
Other comprehensive income	37,321
Balances at end of period at Jun. 30, 2019	15,969,572		0	406,014	19,740,145	(74,042)	6,539,766	(11,516,994)	(100,622)	188	975,117
Balances at beginning of period at Mar. 31, 2019	16,047,831		0	404,509	19,654,137	(74,492)	6,402,004	(11,163,317)	(144,618)	268	969,340
Comprehensive income:
Net income (loss)	149,111						137,762				11,349
Other comprehensive income	46,383								43,996		2,387
Total comprehensive income	195,494
Net change in noncontrolling interests	(31,631)				(23,672)						(7,959)
Amounts related to stock incentive plans, net of forfeitures	8,347			18	7,959	450				(80)
Proceeds from issuance of common stock	103,208			1,487	101,721
Dividends paid:
Common stock dividends	(353,677)							(353,677)
Balances at end of period at Jun. 30, 2019	$ 15,969,572		$ 0	$ 406,014	$ 19,740,145	$ (74,042)	$ 6,539,766	$ (11,516,994)	$ (100,622)	$ 188	$ 975,117

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands		6 Months Ended
		Jun. 30, 2019	Jun. 30, 2018
Operating activities:
Net income		$ 442,342	$ 620,828
Adjustments to reconcile net income to net cash provided from (used in) operating activities:
Depreciation and amortization		491,984	464,476
Other amortization expenses		9,761	7,984
Provision for loan losses		18,690	0
Impairment of assets		9,939	32,817
Stock-based compensation expense		15,192	16,725
Loss (gain) on derivatives and financial instruments, net		(574)	(14,633)
Loss (gain) on extinguishment of debt, net		15,719	12,006
Loss (income) from unconsolidated entities		18,248	1,180
Rental income less than (in excess of) cash received		(53,234)	13,544
Amortization related to above (below) market leases, net		(2)	1,363
Loss (gain) on real estate dispositions, net		(165,727)	(348,939)
Distributions by unconsolidated entities		46	21
Increase (decrease) in accrued expenses and other liabilities		55,415	46,718
Decrease (increase) in receivables and other assets		(3,317)	(15,666)
Net cash provided from (used in) operating activities		854,482	838,424
Investing activities:
Cash disbursed for acquisitions		(2,718,808)	(595,596)
Cash disbursed for capital improvements to existing properties		(124,176)	(111,332)
Cash disbursed for construction in progress		(155,409)	(62,978)
Capitalized interest		(6,256)	(4,436)
Investment in real estate loans receivable		(62,935)	(48,291)
Principal collected on real estate loans receivable		6,840	91,427
Other investments, net of payments		(17,640)	(48,212)
Contributions to unconsolidated entities		(119,001)	(32,768)
Distributions by unconsolidated entities		70,844	22,897
Proceeds from (payments on) derivatives		(21,643)	(27,678)
Proceeds from sales of real property		616,820	947,218
Net cash provided from (used in) investing activities		(2,531,364)	130,251
Financing activities:
Net increase (decrease) in unsecured credit facility and commercial paper		722,188	(179,000)
Proceeds from issuance of senior unsecured notes		2,036,964	545,074
Payments to extinguish senior unsecured notes		(1,050,000)	(450,000)
Net proceeds from the issuance of secured debt		295,969	44,606
Payments on secured debt		(178,700)	(224,958)
Net proceeds from the issuance of common stock		647,156	10,188
Payments for deferred financing costs and prepayment penalties		(24,177)	(18,639)
Contributions by noncontrolling interests	[1]	39,122	8,421
Distributions to noncontrolling interests	[1]	(64,004)	(59,484)
Cash distributions to stockholders		(695,099)	(670,859)
Other financing activities		(8,615)	(5,639)
Net cash provided from (used in) financing activities		1,720,804	(1,000,290)
Effect of foreign currency translation on cash, cash equivalents and restricted cash		(333)	(5,305)
Increase (decrease) in cash, cash equivalents and restricted cash		43,589	(36,920)
Cash, cash equivalents and restricted cash at beginning of period		316,129	309,303
Cash, cash equivalents and restricted cash at end of period		359,718	272,383
Supplemental cash flow information:
Interest paid		252,714	209,156
Income taxes paid (received), net		$ 2,040	$ 4,835

[1] Includes amounts attributable to redeemable noncontrolling interests.

XML

Business

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Business

BusinessWelltower Inc. (the "Company"), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.  Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties.

XML

Accounting Policies and Related Matters

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Accounting Policies and Related Matters

Accounting Policies and Related Matters

     Basis of Presentation

     The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2019 are not necessarily an indication of the results that may be expected for the year ending December 31, 2019. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2018.

     New Accounting Standards     

• We adopted Accounting Standards Update 2016-02, Leases (Topic 842) ("ASC 842") which requires lessees to recognize assets and liabilities on their consolidated balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their consolidated statement of comprehensive income over the lease term. We adopted ASC 842 as of January 1, 2019, using the modified retrospective approach and have elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, permits us to carry forward our prior conclusions for lease classification and initial direct costs on existing leases. We also made an accounting policy election to keep short-term leases less than twelve months off the balance sheet for all classes of underlying assets.

In July 2018, the FASB issued ASU 2018-11 "Leases (Topic 842): Targeted Improvements" that (1) simplifies transition requirements for both lessees and lessors by adding an option that permits entities to apply the transition provisions of the new standard at its adoption date instead of at the earliest comparative period presented in its financial statements and (2) allows lessors to elect, as a practical expedient, to not separate lease and non-lease components in a contract, and instead to account for as a single lease component, if certain criteria are met. This practical expedient causes an entity to assess whether a contract is predominantly lease or service-based and recognize the entire contract under the relevant accounting guidance (i.e. predominantly lease-based would be accounted for under ASC 842 and predominantly service-based would be accounted for under ASU 2014-09, "Revenue from Contracts with Customers (ASC 606)"). For the year ended December 31, 2018, we recognized revenue for our Seniors Housing Operating resident agreements in accordance with the provisions of the prior lease guidance, ASC 840, "Leases." Upon adoption of ASC 842, we elected the lessor practical expedient described above and recognized revenue for our Seniors Housing Operating segment based upon the predominant component, the non-lease service component. Therefore, beginning on January 1, 2019, we accounted for these resident agreements under ASC 606. The timing and pattern of revenue recognition is substantially the same as that prior to adoption.

The FASB also issued ASU 2018-20 "Leases (Topic 842) - Narrow Improvements for Lessors," which provides lessors the ability to make an accounting policy election not to evaluate whether certain sales taxes and other similar taxes imposed by a governmental authority on a specific lease revenue-producing transaction are the primary obligation of the lessor as owner of the underlying leased asset. A lessor that makes this election will exclude these taxes from the measurement of lease revenue and the associated expense. Upon adoption of ASC 842, we utilized this practical expedient in instances in which real estate taxes are paid directly by our tenants to taxing authorities. For triple-net leasing arrangements in which the tenant remits payment for real estate taxes to us and we pay the taxing authority, we have included the associated revenue and expense in rental income and property operating expenses on the Consolidated Statements of Comprehensive Income. This reporting had no impact on our net income.

For leases in which the Company is the lessee, primarily consisting of ground leases and various office and equipment leases, we recognized upon adoption a right of use asset of $509,386,000 which included the present value of minimum leases payments, existing above and/or below market lease intangible values and existing straight-line rent liabilities

associated with such leases. We also recognized operating lease liabilities of $357,070,000. The standard did not materially impact our Consolidated Statements of Comprehensive Income or our Consolidated Statement of Cash Flows. See Note 6 for additional details.

The following ASU has been issued but not yet adopted:

•

In 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"). This standard requires a new forward-looking “expected loss” model to be used for receivables, held-to-maturity debt, loans, and other instruments. In November 2018, the FASB issued an amendment excluding operating lease receivables accounted for under the new leases standard from the scope of the new credit losses standard. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, and early adoption is permitted for fiscal years beginning after December 15, 2018. We are currently evaluating the impact that the standard will have on our consolidated financial statements.

XML

Real Property Acquisitions and Development

6 Months Ended

Jun. 30, 2019

Real Estate [Abstract]

Real Property Acquisitions and Development

Real Property Acquisitions and Development 

The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets, liabilities and noncontrolling interests based upon their relative fair values in accordance with our accounting policies. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services and termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income. Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries.

The following is a summary of our real property investment activity by segment for the periods presented (in thousands):

	Six Months Ended
	June 30, 2019												June 30, 2018
	Seniors Housing Operating			Triple-net			Outpatient Medical			Totals			Seniors Housing Operating			Triple-net			Outpatient Medical			Totals
Land and land improvements	$	103,743		$	8,099		$	132,154		$	243,996		$	47,865		$	1,691		$	7,369		$	56,925
Buildings and improvements	1,109,966			96,244			1,198,608			2,404,818			535,921			—			42,673			578,594
Acquired lease intangibles	58,773			—			85,492			144,265			68,084			—			5,852			73,936
Construction in progress	36,174			—			—			36,174			—			—			—			—
Right of use assets, net	—			—			56,073			56,073			—			—			—			—
Receivables and other assets	4,560			—			376			4,936			1,255			—			1			1,256
Total assets acquired(1)	1,313,216			104,343			1,472,703			2,890,262			653,125			1,691			55,895			710,711
Secured debt	(43,209		)	—			—			(43,209		)	(89,973		)	—			—			(89,973		)
Lease liabilities	—			—			(45,287		)	(45,287		)	—			—			—			—
Accrued expenses and other liabilities	(8,677		)	—			(22,506		)	(31,183		)	(14,686		)	(6		)	(632		)	(15,324		)
Total liabilities acquired	(51,886		)	—			(67,793		)	(119,679		)	(104,659		)	(6		)	(632		)	(105,297		)
Noncontrolling interests	(38,830		)	(1,056		)	—			(39,886		)	(9,818		)	—			—			(9,818		)
Non-cash acquisition related activity(2)	(11,889		)	—			—			(11,889		)	—			—			—			—
Cash disbursed for acquisitions	1,210,611			103,287			1,404,910			2,718,808			538,648			1,685			55,263			595,596
Construction in progress additions	110,761			24,066			26,587			161,414			20,704			38,238			11,319			70,261
Less: Capitalized interest	(3,560		)	(908		)	(1,788		)	(6,256		)	(1,783		)	(1,432		)	(1,221		)	(4,436		)
Foreign currency translation	141			65			—			206			1,176			132			—			1,308
Accruals(3)	—			—			45			45			—			—			(4,155		)	(4,155		)
Cash disbursed for construction in progress	107,342			23,223			24,844			155,409			20,097			36,938			5,943			62,978
Capital improvements to existing properties	97,867			7,423			18,886			124,176			76,237			8,569			26,526			111,332
Total cash invested in real property, net of cash acquired	$	1,415,820		$	133,933		$	1,448,640		$	2,998,393		$	634,982		$	47,192		$	87,732		$	769,906

⁽¹⁾ Excludes $ 1,910,000 and $4,392,000 of unrestricted and restricted cash acquired during the six months ended June 30, 2019 and 2018, respectively.

⁽²⁾ Relates to the acquisition of assets previously recognized as investments in unconsolidated entities.

⁽³⁾ Represents non-cash accruals for amounts to be paid in future periods for properties that converted, off-set by amounts paid in the current period.

Construction Activity 

The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):

	Six Months Ended
	June 30, 2019		June 30, 2018
Development projects:
Seniors Housing Operating	$	28,117	$	37,215
Triple-net	—		59,188
Outpatient Medical	—		11,358
Total construction in progress conversions	$	28,117	$	107,761

XML

Real Estate Intangibles

6 Months Ended

Jun. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Real Estate Intangibles

Real Estate Intangibles 

The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):

	June 30, 2019			December 31, 2018
Assets:
In place lease intangibles	$	1,473,060		$	1,410,725
Above market tenant leases	69,656			63,935
Below market ground leases (1)	—			64,513
Lease commissions	46,422			41,986
Gross historical cost	1,589,138			1,581,159
Accumulated amortization	(1,163,936		)	(1,197,336		)
Net book value	$	425,202		$	383,823
Weighted-average amortization period in years	8.6			16.0
Liabilities:
Below market tenant leases	$	94,082		$	81,676
Above market ground leases (1)	—			8,540
Gross historical cost	94,082			90,216
Accumulated amortization	(45,147		)	(44,266		)
Net book value	$	48,935		$	45,950
Weighted-average amortization period in years	8.2			14.7

 

⁽¹⁾ Effective on January 1, 2019 with the adoption of ASC 842, above and below market ground lease intangibles are reported within the right of use assets, net line on the Consolidated Balance Sheet.

The following is a summary of real estate intangible amortization for the periods presented (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Rental income related to (above)/below market tenant leases, net	$	73		$	(333	)	$	(82	)	$	(684	)
Amortization related to in place lease intangibles and lease commissions	(28,518		)	(33,763		)	(53,423		)	(66,024		)

The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):

	Assets		Liabilities
2019	$	84,909	$	4,777
2020	101,374		8,835
2021	51,215		7,865
2022	34,495		7,130
2023	28,361		4,989
Thereafter	124,848		15,339
Total	$	425,202	$	48,935

XML

Dispositions and Assets Held for Sale

6 Months Ended

Jun. 30, 2019

Discontinued Operations and Disposal Groups [Abstract]

Dispositions and Assets Held for Sale

Dispositions and Assets Held for Sale

We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At June 30, 2019, 55 Seniors Housing Operating, 30 Triple-net, and four Outpatient Medical properties with an aggregate real estate balance of $1,704,206,000 were classified as held for sale. In addition, secured debt of $37,429,000 and net other assets and liabilities of $58,816,000 related to the held for sale properties. During the six months ended June 30, 2019, we recorded net impairment charges of $9,939,000 on certain held for sale properties for which the carrying value exceeded the fair values, less estimated costs to sell, if applicable. The following is a summary of our real property disposition activity for the periods presented (in thousands):

	Six Months Ended June 30,
	2019			2018
Real estate dispositions:
Seniors Housing Operating	$	8,726		$	2,200
Triple-net	442,865			367,978
Outpatient Medical	—			223,069
Total dispositions	451,591			593,247
Gain (loss) on real estate dispositions, net	165,727			348,939
Net other assets/liabilities disposed	(498		)	5,032
Proceeds from real estate dispositions	$	616,820		$	947,218

     Dispositions and Assets Held for Sale

Pursuant to our adoption of ASU 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity”, operating results attributable to properties sold subsequent to or classified as held for sale after January 1, 2014 and which do not meet the definition of discontinued operations are no longer reclassified on our Consolidated Statements of Comprehensive Income. The following represents the activity related to these properties for the periods presented (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Revenues:
Total revenues	$	112,694	$	121,079	$	228,441	$	249,639
Expenses:
Interest expense	479		579		983		1,200
Property operating expenses	70,244		74,213		146,260		150,120
Provision for depreciation	12,520		18,431		24,897		38,275
Total expenses	83,243		93,223		172,140		189,595
Income (loss) from real estate dispositions, net	$	29,451	$	27,856	$	56,301	$	60,044

XML

Leases

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Leases

Leases

We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities. As most of our leases do not provide a rate implicit in the lease agreement, we use our incremental borrowing rate available at lease commencement to determine the present value of lease payments. The incremental borrowing rates were determined using our longer term borrowing rates (actual pricing through 30 years, as well as other longer-term market rates). For leases that commenced prior to January 1, 2019, we used the incremental borrowing rate on December 31, 2018.

We sublease certain real estate to a third party. Our sublease portfolio consists of a finance lease with Genesis HealthCare for seven buildings.

The components of lease expense were as follows for the period presented (in thousands):

	Classification	Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Operating lease cost: (1)
Real estate lease expense	Property operating expenses	$	7,267		$	14,679
Non-real estate lease expense	General and administrative expenses	408			770
Finance lease cost:
Amortization of leased assets	Property operating expenses	2,153			4,245
Interest on lease liabilities	Interest expense	1,166			2,169
Sublease income	Rental income	(1,043		)	(2,087		)
Total		$	9,951		$	19,776

⁽¹⁾ Includes short-term leases which are immaterial.

Maturities of lease liabilities as of June 30, 2019 are as follows (in thousands):

	Operating Leases			Finance Leases
2019	$	9,809		$	4,488
2020	19,625			8,821
2021	19,558			8,485
2022	18,627			7,852
2023	18,707			68,967
Thereafter	1,595,101			86,081
Total lease payments	1,681,427			184,694
Less: Imputed interest	(1,321,129		)	(75,963		)
Total present value of lease liabilities	$	360,298		$	108,731

Supplemental balance sheet information related to leases was as follows for the date indicated (in thousands, except lease terms and discount rate):

	Classification	June 30, 2019
Right of use assets:
Operating leases - real estate	Right of use assets, net	$	386,061
Finance leases	Right of use assets, net	164,281
Real estate right of use assets, net		550,342
Operating leases - corporate	Receivables and other assets	5,055
Total right of use assets, net		$	555,397
Lease liabilities:
Operating leases		$	360,298
Financing leases		108,731
Total		$	469,029
Weighted average remaining lease term (years):
Operating leases		50.0
Finance leases		15.8
Weighted average discount rate:
Operating leases		5.21		%
Finance leases		5.17		%

Supplemental cash flow information related to leases was as follows for the date indicated (in thousands):

	Classification	Six Months Ended June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	Decrease (increase) in receivables and other assets	$	4,627
Operating cash flows from finance leases	Decrease (increase) in receivables and other assets	3,916
Financing cash flows from finance leases	Other financing activities	(1,638		)

Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Leases in our outpatient medical portfolio typically include some form of operating expense reimbursement by the tenant. We recognized $766,670,000 of rental and other revenues related to operating lease payments, of which $94,017,000 was for variable lease payments for the six months ended June 30, 2019, which primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. The following table sets forth the undiscounted cash flows for future minimum lease payments receivable for leases in effect at June 30, 2019 (excluding properties in our Seniors Housing Operating partnerships and excluding any operating expense reimbursements) (in thousands):

2019	$	925,026
2020	1,380,111
2021	1,346,698
2022	1,237,904
2023	1,255,408
Thereafter	9,745,880
Totals	$	15,891,027

Leases

Leases

We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities. As most of our leases do not provide a rate implicit in the lease agreement, we use our incremental borrowing rate available at lease commencement to determine the present value of lease payments. The incremental borrowing rates were determined using our longer term borrowing rates (actual pricing through 30 years, as well as other longer-term market rates). For leases that commenced prior to January 1, 2019, we used the incremental borrowing rate on December 31, 2018.

We sublease certain real estate to a third party. Our sublease portfolio consists of a finance lease with Genesis HealthCare for seven buildings.

The components of lease expense were as follows for the period presented (in thousands):

	Classification	Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Operating lease cost: (1)
Real estate lease expense	Property operating expenses	$	7,267		$	14,679
Non-real estate lease expense	General and administrative expenses	408			770
Finance lease cost:
Amortization of leased assets	Property operating expenses	2,153			4,245
Interest on lease liabilities	Interest expense	1,166			2,169
Sublease income	Rental income	(1,043		)	(2,087		)
Total		$	9,951		$	19,776

⁽¹⁾ Includes short-term leases which are immaterial.

Maturities of lease liabilities as of June 30, 2019 are as follows (in thousands):

	Operating Leases			Finance Leases
2019	$	9,809		$	4,488
2020	19,625			8,821
2021	19,558			8,485
2022	18,627			7,852
2023	18,707			68,967
Thereafter	1,595,101			86,081
Total lease payments	1,681,427			184,694
Less: Imputed interest	(1,321,129		)	(75,963		)
Total present value of lease liabilities	$	360,298		$	108,731

Supplemental balance sheet information related to leases was as follows for the date indicated (in thousands, except lease terms and discount rate):

	Classification	June 30, 2019
Right of use assets:
Operating leases - real estate	Right of use assets, net	$	386,061
Finance leases	Right of use assets, net	164,281
Real estate right of use assets, net		550,342
Operating leases - corporate	Receivables and other assets	5,055
Total right of use assets, net		$	555,397
Lease liabilities:
Operating leases		$	360,298
Financing leases		108,731
Total		$	469,029
Weighted average remaining lease term (years):
Operating leases		50.0
Finance leases		15.8
Weighted average discount rate:
Operating leases		5.21		%
Finance leases		5.17		%

Supplemental cash flow information related to leases was as follows for the date indicated (in thousands):

	Classification	Six Months Ended June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	Decrease (increase) in receivables and other assets	$	4,627
Operating cash flows from finance leases	Decrease (increase) in receivables and other assets	3,916
Financing cash flows from finance leases	Other financing activities	(1,638		)

Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Leases in our outpatient medical portfolio typically include some form of operating expense reimbursement by the tenant. We recognized $766,670,000 of rental and other revenues related to operating lease payments, of which $94,017,000 was for variable lease payments for the six months ended June 30, 2019, which primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. The following table sets forth the undiscounted cash flows for future minimum lease payments receivable for leases in effect at June 30, 2019 (excluding properties in our Seniors Housing Operating partnerships and excluding any operating expense reimbursements) (in thousands):

2019	$	925,026
2020	1,380,111
2021	1,346,698
2022	1,237,904
2023	1,255,408
Thereafter	9,745,880
Totals	$	15,891,027

Leases

Leases

We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities. As most of our leases do not provide a rate implicit in the lease agreement, we use our incremental borrowing rate available at lease commencement to determine the present value of lease payments. The incremental borrowing rates were determined using our longer term borrowing rates (actual pricing through 30 years, as well as other longer-term market rates). For leases that commenced prior to January 1, 2019, we used the incremental borrowing rate on December 31, 2018.

We sublease certain real estate to a third party. Our sublease portfolio consists of a finance lease with Genesis HealthCare for seven buildings.

The components of lease expense were as follows for the period presented (in thousands):

	Classification	Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Operating lease cost: (1)
Real estate lease expense	Property operating expenses	$	7,267		$	14,679
Non-real estate lease expense	General and administrative expenses	408			770
Finance lease cost:
Amortization of leased assets	Property operating expenses	2,153			4,245
Interest on lease liabilities	Interest expense	1,166			2,169
Sublease income	Rental income	(1,043		)	(2,087		)
Total		$	9,951		$	19,776

⁽¹⁾ Includes short-term leases which are immaterial.

Maturities of lease liabilities as of June 30, 2019 are as follows (in thousands):

	Operating Leases			Finance Leases
2019	$	9,809		$	4,488
2020	19,625			8,821
2021	19,558			8,485
2022	18,627			7,852
2023	18,707			68,967
Thereafter	1,595,101			86,081
Total lease payments	1,681,427			184,694
Less: Imputed interest	(1,321,129		)	(75,963		)
Total present value of lease liabilities	$	360,298		$	108,731

Supplemental balance sheet information related to leases was as follows for the date indicated (in thousands, except lease terms and discount rate):

	Classification	June 30, 2019
Right of use assets:
Operating leases - real estate	Right of use assets, net	$	386,061
Finance leases	Right of use assets, net	164,281
Real estate right of use assets, net		550,342
Operating leases - corporate	Receivables and other assets	5,055
Total right of use assets, net		$	555,397
Lease liabilities:
Operating leases		$	360,298
Financing leases		108,731
Total		$	469,029
Weighted average remaining lease term (years):
Operating leases		50.0
Finance leases		15.8
Weighted average discount rate:
Operating leases		5.21		%
Finance leases		5.17		%

Supplemental cash flow information related to leases was as follows for the date indicated (in thousands):

	Classification	Six Months Ended June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	Decrease (increase) in receivables and other assets	$	4,627
Operating cash flows from finance leases	Decrease (increase) in receivables and other assets	3,916
Financing cash flows from finance leases	Other financing activities	(1,638		)

Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Leases in our outpatient medical portfolio typically include some form of operating expense reimbursement by the tenant. We recognized $766,670,000 of rental and other revenues related to operating lease payments, of which $94,017,000 was for variable lease payments for the six months ended June 30, 2019, which primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. The following table sets forth the undiscounted cash flows for future minimum lease payments receivable for leases in effect at June 30, 2019 (excluding properties in our Seniors Housing Operating partnerships and excluding any operating expense reimbursements) (in thousands):

2019	$	925,026
2020	1,380,111
2021	1,346,698
2022	1,237,904
2023	1,255,408
Thereafter	9,745,880
Totals	$	15,891,027

XML

Real Estate Loans Receivable

6 Months Ended

Jun. 30, 2019

Receivables [Abstract]

Real Estate Loans Receivable

Real Estate Loans Receivable

Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 for discussion of our accounting policies for real estate loans receivable and related interest income. 

The following is a summary of our net real estate loans receivable (in thousands):

	June 30, 2019			December 31, 2018
Mortgage loans	$	332,770		$	317,443
Other real estate loans	104,596			81,268
Less allowance for losses on loans receivable	(68,372		)	(68,372		)
Totals	$	368,994		$	330,339

The following is a summary of our real estate loan activity for the periods presented (in thousands):

	Six Months Ended
	June 30, 2019							June 30, 2018
		Triple-net		Outpatient Medical		Totals		Seniors Housing Operating		Triple-net			Outpatient Medical		Totals
Advances on real estate loans receivable:
Investments in new loans		$	25,000	$	5,000	$	30,000	$	11,806	$	8,281		$	7,022	$	27,109
Draws on existing loans		20,051		12,884		32,935		—		21,182			—		21,182
Net cash advances on real estate loans		45,051		17,884		62,935		11,806		29,463			7,022		48,291
Receipts on real estate loans receivable:
Loan payoffs		4,384		—		4,384		—		58,557			—		58,557
Principal payments on loans		2,456		—		2,456		—		32,870			—		32,870
Net cash receipts on real estate loans		6,840		—		6,840		—		91,427			—		91,427
Net cash advances (receipts) on real estate loans		$	38,211	$	17,884	$	56,095	$	11,806	$	(61,964	)	$	7,022	$	(43,136	)

 

In 2016, we restructured real estate loans with Genesis HealthCare and recorded a loan loss charge in the amount of $6,935,000 on one of the loans as the present value of expected future cash flows was less than the carrying value of the loan.  In 2017, we recorded an additional loan loss charge of $62,966,000 relating to real estate loans with Genesis HealthCare based on an estimation of expected future cash flows discounted at the effective interest rate of the loans. In March 2019, we recognized a provision for loan losses of $18,690,000 to fully reserve for certain Triple-net real estate loans receivable that were no longer deemed collectible. During the quarter ended June 30, 2019, these loans were written off. As of June 30, 2019, the allowance for loan loss balance of $68,372,000 is deemed to be sufficient to absorb expected losses. At June 30, 2019, we had one real estate loan with an outstanding balance of $2,534,000 on non-accrual status.

The following is a summary of our impaired loans (in thousands):

	Six Months Ended
	June 30, 2019		June 30, 2018
Balance of impaired loans at end of period	$	188,068	$	214,871
Allowance for loan losses	68,372		68,372
Balance of impaired loans not reserved	$	119,696	$	146,499
Average impaired loans for the period	$	197,426	$	252,172
Interest recognized on impaired loans(1)	7,964		8,847

 

⁽¹⁾ Represents cash interest recognized in the period since loans were identified as impaired.

XML

Investments in Unconsolidated Entities

6 Months Ended

Jun. 30, 2019

Equity Method Investments and Joint Ventures [Abstract]

Investments in Unconsolidated Entities

Investments in Unconsolidated Entities

We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. The results of operations for these entities have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands): 

	Percentage Ownership(1)	June 30, 2019		December 31, 2018
Seniors Housing Operating	10% to 50%	$	379,886	$	344,982
Triple-net	10% to 49%	9,459		34,284
Outpatient Medical	43% to 50%	130,042		103,648
Total		$	519,387	$	482,914

 

⁽¹⁾ Excludes ownership of in-substance real estate.

At June 30, 2019, the aggregate unamortized basis difference of our joint venture investments of $101,571,000 is primarily attributable to the difference between the amount for which we purchase our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the joint venture. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.

XML

Credit Concentration

6 Months Ended

Jun. 30, 2019

Risks and Uncertainties [Abstract]

Credit Concentration

Credit Concentration

We use consolidated net operating income (“NOI”) as our credit concentration metric. See Note 18 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the six months ended June 30, 2019, excluding our share of NOI in unconsolidated entities (dollars in thousands):

	Number of	Total		Percent of
Concentration by relationship:(1)	Properties	NOI		NOI(2)
Sunrise Senior Living(3)	165	$	174,422	14%
ProMedica	218	107,541		9%
Revera(3)	98	72,928		6%
Genesis HealthCare	60	60,984		5%
Benchmark Senior Living(4)	48	55,530		5%
Remaining portfolio	1,009	749,012		61%
Totals	1,598	$	1,220,417	100%

 

⁽¹⁾ Genesis Healthcare and ProMedica are in our Triple-net segment. Sunrise Senior Living and Revera are in our Seniors Housing Operating segment. Benchmark Senior Living is in both our Triple-net and Seniors Housing Operating segments.

⁽²⁾ NOI with our top five relationships comprised 38% of total NOI for the year ended December 31, 2018.

⁽³⁾ Revera owns a controlling interest in Sunrise Senior Living.

⁽⁴⁾ Please see Note 21 for additional information.

XML

Borrowings Under Credit Facilities and Commercial Paper Program

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Borrowings Under Credit Facilities and Commercial Paper Program

Borrowings Under Credit Facilities and Commercial Paper Program 

 At June 30, 2019, we had a primary unsecured credit facility with a consortium of 31 banks that includes a $3,000,000,000 unsecured revolving credit facility ($935,000,000 outstanding at June 30, 2019), a $500,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $500,000,000 unsecured term credit facility by up to an additional $1,000,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at June 30, 2019). Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over LIBOR interest rate (3.22% at June 30, 2019). The applicable margin is based on our debt ratings and was 0.825% at June 30, 2019. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on our debt ratings and was 0.15% at June 30, 2019. The term credit facilities mature on July 19, 2023. The revolving credit facility is scheduled to mature on July 19, 2022 and can be extended for two successive terms of six months each at our option.

In January 2019, we established an unsecured commercial paper program (the "Commercial Paper Program"). Under the terms of the program, we may issue unsecured commercial paper notes with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate face or principal amount outstanding at any time of $1,000,000,000. As of June 30, 2019, there was a balance of $934,188,000 outstanding on the Commercial Paper Program ($935,000,000 in principal outstanding net of an unamortized discount of $812,000), which reduces the borrowing capacity on the unsecured revolving credit facility. The notes bear interest at various floating rates with a weighted average of 2.70% as of June 30, 2019 and a weighted average maturity of 31 days as of June 30, 2019.

The following information relates to aggregate borrowings under the unsecured revolving credit facility and Commercial Paper Program for the periods presented (dollars in thousands): 

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Balance outstanding at quarter end	$	1,870,000		$	540,000		$	1,870,000		$	540,000
Maximum amount outstanding at any month end	$	2,880,000		$	685,000		$	2,880,000		$	865,000
Average amount outstanding (total of daily
principal balances divided by days in period)	$	1,807,631		$	562,747		$	1,301,883		$	463,978
Weighted average interest rate (actual interest
expense divided by average borrowings outstanding)	3.08		%	3.04		%	3.11		%	2.91		%

XML

Senior Unsecured Notes and Secured Debt

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Senior Unsecured Notes and Secured Debt

Senior Unsecured Notes and Secured Debt 

We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of (1) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (2) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. At June 30, 2019, the annual principal payments due on these debt obligations were as follows (in thousands):

	Senior Unsecured Notes(1,2)		Secured Debt (1,3)		Totals
2019	$	—	$	312,291	$	312,291
2020(4)	1,236,665		144,518		1,381,183
2021	450,000		383,425		833,425
2022	600,000		352,410		952,410
2023(5,6)	1,790,971		330,498		2,121,469
Thereafter(7,8)	6,633,920		1,166,840		7,800,760
Totals	$	10,711,556	$	2,689,982	$	13,401,538

 

(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the Consolidated Balance Sheet.

(2) Annual interest rates range from 2.86% to 6.50%.

(3) Annual interest rates range from 1.69% to 12.00%. Carrying value of the properties securing the debt totaled $5,991,142,000 at June 30, 2019.

(4) Includes a $300,000,000 Canadian-denominated 3.35% senior unsecured notes due 2020 (approximately $229,165,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2019) and a $1,000,000,000 unsecured term loan facility that matures on May 28, 2020 which was put in place to bridge the acquisition of the CNL Healthcare Properties portfolio. The unsecured term loan facility was subsequently extinguished in July 2019 with proceeds from the disposition of the Benchmark Senior Living portfolio.

(5) Includes a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $190,971,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2019). The loan matures on July 19, 2023 and bears interest at the Canadian Dealer Offered Rate plus 0.9% (2.86% at June 30, 2019).

(6) Includes a $500,000,000 unsecured term credit facility. The loan matures on July 19, 2023 and bears interest at LIBOR plus 0.9% (3.29% at June 30, 2019).

(7) Includes a £550,000,000 4.80% senior unsecured notes due 2028 (approximately $698,720,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2019).

(8) Includes a £500,000,000 4.50% senior unsecured notes due 2034 (approximately $635,200,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2019).

The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

	Six Months Ended
	June 30, 2019				June 30, 2018
				Weighted Avg.				Weighted Avg.
	Amount			Interest Rate	Amount			Interest Rate
Beginning balance	$	9,699,984		4.48%	$	8,417,447		4.31%
Debt issued	2,050,000			3.58%	550,000			4.25%
Debt extinguished	(1,050,000		)	4.98%	(450,000		)	2.25%
Foreign currency	11,572			3.52%	(55,693		)	4.02%
Ending balance	$	10,711,556		4.24%	$	8,461,754		4.46%

 

The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands): 

	Six Months Ended
	June 30, 2019				June 30, 2018
				Weighted Avg.				Weighted Avg.
	Amount			Interest Rate	Amount			Interest Rate
Beginning balance	$	2,485,711		3.90%	$	2,618,408		3.76%
Debt issued	295,969			3.52%	44,606			3.38%
Debt assumed	42,000			4.62%	85,192			4.40%
Debt extinguished	(151,473		)	4.42%	(196,573		)	5.66%
Principal payments	(27,227		)	3.74%	(28,385		)	3.91%
Foreign currency	45,002			3.37%	(61,170		)	3.33%
Ending balance	$	2,689,982		3.84%	$	2,462,078		3.76%

 

Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2019, we were in compliance with all of the covenants under our debt agreements.

XML

Derivative Instruments

6 Months Ended

Jun. 30, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

Derivative Instruments

We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our non-U.S. investments and interest rate risk related to our capital structure. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, cross currency swap contacts, interest rate swaps, interest rate locks, and debt issued in foreign currencies to offset a portion of these risks.

 Foreign Currency Forward Contracts Designated as Cash Flow Hedges

For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is deferred as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings. 

Cash Flow Hedges of Interest Rate Risk

We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements were used to hedge the variable cash flows associated with variable-rate debt.

Periodically, we enter into and designate interest rate locks to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized into income over the life of the related debt, except where a material amount is deemed to be ineffective, which would be immediately reclassified to the consolidated statements of income.

     Foreign Currency Forward Contracts and Cross Currency Swap Contracts Designated as Net Investment Hedges

We use foreign currency forward and cross currency forward swap contracts to hedge a portion of the net investment in foreign subsidiaries against fluctuations in foreign exchange rates. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI. 

During the six months ended June 30, 2019 and 2018, we settled certain net investment hedges generating cash proceeds of $6,716,000 and necessitating cash payments of $27,774,000, respectively. The balance of the cumulative translation adjustment will be reclassified to earnings if the hedged investment is sold or substantially liquidated.

Derivative Contracts Undesignated

We use foreign currency exchange contracts to manage existing exposures to foreign currency exchange risk. Gains and losses resulting from the changes in fair value of these instruments are recorded in interest expense on the Consolidated Statements of Comprehensive Income and are substantially offset by net revaluation impacts on foreign currency denominated balance sheet exposures. In addition, we have several interest rate cap contracts related to variable rate secured debt agreements. Gains and losses resulting from the changes in fair values of these instruments are also recorded in interest expense.

The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands): 

	June 30, 2019			December 31, 2018
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	500,000		$	575,000
Denominated in Pounds Sterling	£	1,340,708		£	890,708
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000		$	250,000
Denominated in Pounds Sterling	£	1,050,000		£	1,050,000
Interest rate swaps designated as cash flow hedges:
Denominated in U.S Dollars (1)	$	1,188,250		$	—
Derivative instruments not designated:
Interest rate caps denominated in U.S. Dollars	$	405,819		$	405,819
Forward purchase contracts denominated in Canadian Dollars	$	(217,500	)	$	(325,000	)
Forward sales contracts denominated in Canadian Dollars	$	280,000		$	405,000
Forward purchase contracts denominated in Pounds Sterling	£	(125,000	)	£	(350,000	)
Forward sales contracts denominated in Pounds Sterling	£	125,000		£	350,000

 

⁽¹⁾ At June 30, 2019 the maximum maturity date was July 15, 2021.

The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):

		Three Months Ended June 30,					Six Months Ended June 30,
	Location	2019			2018		2019			2018
Gain (loss) on derivative instruments designated as hedges recognized in income	Interest expense	$	7,134		$	4,091	$	12,467		$	3,822
Gain (loss) on derivative instruments not designated as hedges recognized in income	Interest expense	$	(1,128	)	$	734	$	(2,666	)	$	2,453
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI	$	100,407		$	150,703	$	12,725		$	88,005

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

At June 30, 2019, we had 14 outstanding letter of credit obligations totaling $48,111,000 and expiring between 2019 and 2024. At June 30, 2019, we had outstanding construction in progress of $363,160,000 and were committed to providing additional funds of approximately $483,210,000 to complete construction. Purchase obligations include contingent purchase obligations totaling $8,476,000. These contingent purchase obligations relate to unfunded capital improvement obligations and contingent obligations on acquisitions. Rents due from the tenant are increased to reflect the additional investment in the property.

XML

Stockholders' Equity

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity 

The following is a summary of our stockholders’ equity capital accounts as of the dates indicated: 

	June 30, 2019	December 31, 2018
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	—	14,375,000
Outstanding shares	—	14,369,965
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	406,497,122	384,849,236
Outstanding shares	405,254,113	383,674,603

 

   Preferred Stock The following is a summary of our preferred stock activity during the periods indicated: 

	Six Months Ended
	June 30, 2019			June 30, 2018
			Weighted Avg.			Weighted Avg.
	Shares		Dividend Rate	Shares		Dividend Rate
Beginning balance	14,369,965		6.50%	14,370,060		6.50%
Shares converted	(14,369,965	)	6.50%	(95	)	6.50%
Ending balance	—		—%	14,369,965		6.50%

 

During the six months ended June 30, 2019, we converted all of the outstanding Series I Preferred Stock. Each share was converted into 0.8857 shares of common stock.

     Common Stock In February 2019, we entered into separate amended and restated equity distribution agreements whereby we can offer and sell up to $1,500,000,000 aggregate amount of our common stock ("Equity Shelf Program"). The Equity Shelf Program also allows us to enter into forward sale agreements. As of June 30, 2019, we had $1,360,820,000 of remaining capacity under the Equity Shelf Program, which excludes forward sales agreements outstanding for the sale of 2,194,575 shares with maturity dates in the fourth quarter. We expect to physically settle the forward sales for cash proceeds.

The following is a summary of our common stock issuances during the six months ended June 30, 2019 and 2018 (dollars in thousands, except average price amounts): 

	Shares Issued	Average Price	Gross Proceeds		Net Proceeds
2018 Dividend reinvestment plan issuances	182,910	$55.40	$	10,133	$	10,133
2018 Option exercises	1,026	53.61	55		55
2018 Preferred stock conversions	83		—		—
2018 Stock incentive plans, net of forfeitures	114,037		—		—
2018 Totals	298,056		$	10,188	$	10,188
2019 Dividend reinvestment plan issuances	4,304,712	$75.20	$	323,724	$	320,243
2019 Option exercises	10,736	51.32	551		551
2019 Equity Shelf Program issuances	4,384,045	74.97	328,665		326,362
2019 Preferred stock conversions	12,712,452		—		—
2019 Stock incentive plans, net of forfeitures	167,565		—		—
2019 Totals	21,579,510		$	652,940	$	647,156

 

Dividends  The increase in dividends is primarily attributable to increases in our common shares outstanding, offset by the conversion of the Series I Preferred Stock as described above.  The following is a summary of our dividend payments (in thousands, except per share amounts): 

	Six Months Ended
	June 30, 2019				June 30, 2018
	Per Share		Amount		Per Share		Amount
Common Stock	$	1.7400	$	698,437	$	1.7400	$	647,098
Series I Preferred Stock	—		—		1.6250		23,352
Totals			$	698,437			$	670,450

 

Accumulated Other Comprehensive Income  The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):

	June 30, 2019			December 31, 2018
Foreign currency translation	$	(851,584	)	$	(868,006	)
Derivative instruments	751,502			738,777
Actuarial losses	(540		)	(540		)
Total accumulated other comprehensive loss	$	(100,622	)	$	(129,769	)

XML

Stock Incentive Plans

6 Months Ended

Jun. 30, 2019

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Incentive Plans

Stock Incentive Plans

Our 2016 Long-Term Incentive Plan (“2016 Plan”) authorizes up to 10,000,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. Our non-employee directors, officers and key employees are eligible to participate in the 2016 Plan. The 2016 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock, deferred stock units, performance units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $7,662,000 and $15,192,000 for the three and six months ended June 30, 2019, respectfully, and $5,167,000 and $16,725,000 for the same periods in 2018.

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Numerator for basic and diluted earnings
per share - net income (loss) attributable
to common stockholders	$	137,762	$	154,432	$	418,232	$	592,103
Denominator for basic earnings per
share - weighted average shares	404,607		371,640		398,073		371,552
Effect of dilutive securities:
Employee stock options	—		14		1		15
Non-vested restricted shares	955		325		911		523
Redeemable shares	1,096		1,096		1,096		1,096
Employee stock purchase program	15		—		15		—
Dilutive potential common shares	2,066		1,435		2,023		1,634
Denominator for diluted earnings per
share - adjusted weighted average shares	406,673		373,075		400,096		373,186
Basic earnings per share	$	0.34	$	0.42	$	1.05	$	1.59
Diluted earnings per share	$	0.34	$	0.41	$	1.05	$	1.59

The Series I Cumulative Convertible Perpetual Preferred Stock were excluded from the 2018 calculation as the effect of the conversions were anti-dilutive. As of June 30, 2019, forward sales agreements outstanding for the sale of 2,194,575 shares of common stock were not included in the computation of diluted earnings per share because such forward sales were anti-dilutive for the period.

XML

Disclosure about Fair Value of Financial Instruments

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Disclosure about Fair Value of Financial Instruments

Disclosure about Fair Value of Financial Instruments 

 U.S. GAAP provides authoritative guidance for measuring and disclosing fair value measurements of assets and liabilities. The guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 for additional information. The guidance describes three levels of inputs that may be used to measure fair value: 

Level 1 - Quoted prices in active markets for identical assets or liabilities. 

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. 

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. 

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value. 

Mortgage Loans and Other Real Estate Loans Receivable — The fair value of mortgage loans and other real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.  

Cash and Cash Equivalents and Restricted Cash — The carrying amount approximates fair value. 

Equity Securities — Equity securities are recorded at their fair value based on Level 1 publicly available trading prices. 

Unsecured Revolving Credit Facility and Commercial Paper Program — The carrying amount of the unsecured revolving credit facility and Commercial Paper Program approximates fair value because the borrowings are interest rate adjustable. 

Senior Unsecured Notes — The fair value of the senior unsecured notes payable was estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable. 

Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable. 

Foreign Currency Forward Contracts, Interest Rate Swaps and Cross Currency Swaps — Foreign currency forward contracts, interest rate swaps and cross currency swaps are recorded in other assets or other liabilities on the balance sheet at fair value that is derived from observable market data, including yield curves and foreign exchange rates (all of our derivatives are Level 2).

Redeemable OP Unitholder Interests — Our redeemable unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances. 

The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

	June 30, 2019				December 31, 2018
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
Mortgage loans receivable	$	264,398	$	274,116	$	249,071	$	257,337
Other real estate loans receivable	104,596		105,706		81,268		82,742
Equity securities	11,860		11,860		11,286		11,286
Cash and cash equivalents	268,666		268,666		215,376		215,376
Restricted cash	91,052		91,052		100,753		100,753
Foreign currency forward contracts, interest rate swaps and cross currency swaps	91,290		91,290		94,729		94,729
Financial liabilities:
Unsecured revolving credit facility and commercial paper note program	$	1,869,188	$	1,869,188	$	1,147,000	$	1,147,000
Senior unsecured notes	10,606,106		11,026,259		9,603,299		10,043,797
Secured debt	2,675,507		2,737,838		2,476,177		2,499,130
Foreign currency forward contracts, interest rate swaps and cross currency swaps	32,249		32,249		71,109		71,109
Redeemable OP unitholder interests	$	121,476	$	121,476	$	103,071	$	103,071

Items Measured at Fair Value on a Recurring Basis 

The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):

	Fair Value Measurements as of June 30, 2019
	Total		Level 1		Level 2		Level 3
Equity securities	$	11,860	$	11,860	$	—	$	—
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability)(1)	59,041		—		59,041		—
Redeemable OP unitholder interests	121,476		—		121,476		—
Totals	$	192,377	$	11,860	$	180,517	$	—

⁽¹⁾ Please see Note 12 for additional information.

Items Measured at Fair Value on a Nonrecurring Basis 

In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis. As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired/assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 7 for impairments of real estate loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of loans receivable using projected payoff valuations based on the expected future cash flows and/or the estimated fair value of collateral, net of sales costs, if the repayment of the loan is expected to be provided solely by the collateral. We estimate the fair value of secured debt assumed in asset acquisitions using current interest rates at which similar borrowings could be obtained on the transaction date.

XML

Segment Reporting

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Segment Reporting

Segment Reporting

 We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: Seniors Housing Operating, Triple-net and Outpatient Medical. Our seniors housing operating properties include assisted living, independent living/continuing care retirement communities, independent supportive living communities

(Canada), care homes with and without nursing (U.K.) and combinations thereof that are owned and/or operated through RIDEA structures (see Note 19). Under the Triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our outpatient medical properties are typically leased to multiple tenants and generally require a certain level of property management by us.

We evaluate performance based upon consolidated NOI of each segment. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.    

Non-segment revenue consists mainly of interest income on certain non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. There are no intersegment sales or transfers.

Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands): 

Three Months Ended June 30, 2019:	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	914,085		$	—		$	—		$	—		$	914,085
Rental income	—			222,362			163,224			—			385,586
Interest income	—			17,118			238			—			17,356
Other income	1,444			1,278			(97		)	454			3,079
Total revenues	915,529			240,758			163,365			454			1,320,106
Property operating expenses	637,317			12,823			50,987			—			701,127
Consolidated net operating income	278,212			227,935			112,378			454			618,979
Depreciation and amortization	136,551			56,056			55,445			—			248,052
Interest expense	17,572			3,225			3,386			117,153			141,336
General and administrative expenses	—			—			—			33,741			33,741
Loss (gain) on derivatives and financial instruments, net	—			1,913			—			—			1,913
Impairment of assets	—			(940		)	10,879			—			9,939
Other expenses	11,857			5,560			(4		)	4,215			21,628
Income (loss) from continuing operations before income taxes and other items	112,232			162,121			42,672			(154,655		)	162,370
Income tax (expense) benefit	375			(1,361		)	(586		)	(27		)	(1,599		)
(Loss) income from unconsolidated entities	(17,453		)	6,578			1,826			—			(9,049		)
Gain (loss) on real estate dispositions, net	(550		)	(1,130		)	(2		)	—			(1,682		)
Income (loss) from continuing operations	94,604			166,208			43,910			(154,682		)	150,040
Net income (loss)	$	94,604		$	166,208		$	43,910		$	(154,682	)	$	150,040
Total assets	$	16,440,104		$	9,494,388		$	7,004,561		$	209,644		$	33,148,697

Three Months Ended June 30, 2018:	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	763,345		$	—		$	—		$	—		$	763,345
Rental income	—			197,961			135,640			—			333,601
Interest income	172			13,247			43			—			13,462
Other income	1,650			13,212			144			498			15,504
Total revenues	765,167			224,420			135,827			498			1,125,912
Property operating expenses	525,662			136			42,953			—			568,751
Consolidated net operating income	239,505			224,284			92,874			498			557,161
Depreciation and amortization	134,779			55,309			46,187			—			236,275
Interest expense	16,971			3,800			1,656			98,989			121,416
General and administrative expenses	—			—			—			32,831			32,831
Loss (gain) on derivatives and financial instruments, net	—			(7,460		)	—			—			(7,460		)
Loss (gain) on extinguishment of debt, net	299			—			—			—			299
Impairment of assets	2,212			2,420			—			—			4,632
Other expenses	6,167			957			2,095			839			10,058
Income (loss) from continuing operations before income taxes and other items	79,077			169,258			42,936			(132,161		)	159,110
Income tax (expense) benefit	(2,617		)	(688		)	(378		)	(158		)	(3,841		)
(Loss) income from unconsolidated entities	(5,204		)	5,062			1,391			—			1,249
Gain (loss) on real estate dispositions, net	(1		)	10,759			(3		)	—			10,755
Income (loss) from continuing operations	71,255			184,391			43,946			(132,319		)	167,273
Net income (loss)	$	71,255		$	184,391		$	43,946		$	(132,319	)	$	167,273

Six Months Ended June 30, 2019	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	1,782,370		$	—		$	—		$	—		$	1,782,370
Rental income	—			454,394			312,276			—			766,670
Interest income	—			32,064			411			—			32,475
Other income	5,545			2,541			139			2,611			10,836
Total revenues	1,787,915			488,999			312,826			2,611			2,592,351
Property operating expenses	1,245,003			27,778			99,153			—			1,371,934
Consolidated net operating income	542,912			461,221			213,673			2,611			1,220,417
Depreciation and amortization	268,126			117,404			106,454			—			491,984
Interest expense	35,823			6,665			6,734			237,346			286,568
General and administrative expenses	—			—			—			69,023			69,023
Loss (gain) on derivatives and financial instruments, net	—			(574		)	—			—			(574		)
Loss (gain) on extinguishment of debt, net	—			—			—			15,719			15,719
Provision for loan losses	—			18,690			—			—			18,690
Impairment of assets	—			(940		)	10,879			—			9,939
Other expenses	14,803			8,589			750			6,242			30,384
Income (loss) from continuing operations before income taxes and other items	224,160			311,387			88,856			(325,719		)	298,684
Income tax (expense) benefit	(244		)	(2,312		)	(951		)	(314		)	(3,821		)
(Loss) income from unconsolidated entities	(34,033		)	12,236			3,549			—			(18,248		)
Gain (loss) on real estate dispositions, net	(710		)	166,444			(7		)	—			165,727
Income (loss) from continuing operations	189,173			487,755			91,447			(326,033		)	442,342
Net income (loss)	$	189,173		$	487,755		$	91,447		$	(326,033	)	$	442,342

Six Months Ended June 30, 2018	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	1,499,279		$	—		$	—		$	—		$	1,499,279
Rental income	—			404,792			272,178			—			676,970
Interest income	257			27,798			55			—			28,110
Other income	2,798			14,589			265			866			18,518
Total revenues	1,502,334			447,179			272,498			866			2,222,877
Property operating expenses	1,037,603			157			87,456			—			1,125,216
Consolidated net operating income	464,731			447,022			185,042			866			1,097,661
Depreciation and amortization	260,548			111,341			92,587			—			464,476
Interest expense	33,906			7,242			3,332			199,711			244,191
General and administrative expenses	—			—			—			66,536			66,536
Loss (gain) on derivatives and financial instruments, net	—			(14,633		)	—			—			(14,633		)
Loss (gain) on extinguishment of debt, net	110			(32		)	11,928			—			12,006
Impairment of assets	4,513			28,304			—			—			32,817
Other expenses	5,979			2,077			2,693			3,021			13,770
Income (loss) from continuing operations before income taxes and other items	159,675			312,723			74,502			(268,402		)	278,498
Income tax (expense) benefit	(2,455		)	(1,824		)	(806		)	(344		)	(5,429		)
(Loss) income from unconsolidated entities	(14,684		)	10,883			2,621			—			(1,180		)
Gain (loss) on real estate dispositions, net	4			134,156			214,779			—			348,939
Income (loss) from continuing operations	142,540			455,938			291,096			(268,746		)	620,828
Net income (loss)	$	142,540		$	455,938		$	291,096		$	(268,746	)	$	620,828

Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands): 

	Three Months Ended								Six Months Ended
	June 30, 2019				June 30, 2018				June 30, 2019				June 30, 2018
Revenues:	Amount		%		Amount		%		Amount		%		Amount		%
United States	$	1,092,376	82.8	%	$	895,734	79.5	%	$	2,136,042	82.4	%	$	1,759,523	79.1	%
United Kingdom	112,647		8.5	%	112,031		10.0	%	225,065		8.7	%	228,556		10.3	%
Canada	115,083		8.7	%	118,147		10.5	%	231,244		8.9	%	234,798		10.6	%
Total	$	1,320,106	100.0	%	$	1,125,912	100.0	%	$	2,592,351	100.0	%	$	2,222,877	100.0	%
	As of
	June 30, 2019				December 31, 2018
Assets:	Amount		%		Amount		%
United States	$	27,496,270	82.9	%	$	24,884,292	82.0	%
United Kingdom	3,173,654		9.6	%	3,078,994		10.1	%
Canada	2,478,773		7.5	%	2,378,786		7.9	%
Total	$	33,148,697	100.0	%	$	30,342,072	100.0	%

XML

Income Taxes and Distributions

6 Months Ended

Jun. 30, 2019

Income Tax Disclosure [Abstract]

Income Taxes And Distributions

Income Taxes and Distributions 

     We elected to be taxed as a REIT commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of current year taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes. 

     Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.” A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 

Income taxes reflected in the financial statements primarily represents U.S. federal, state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the six months ended June 30, 2019 and 2018, was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and most of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. The company reflects current and deferred tax liabilities for any such withholding taxes incurred as a result of this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the Internal Revenue Service for the year ended December 31, 2015 and subsequent years and by state taxing authorities for the year ended December 31, 2014 and subsequent years. The Company and its subsidiaries are also subject to audit by the Canada Revenue Agency and provincial authorities generally for periods subsequent to our initial investments in Canada in May 2013, by HM Revenue & Customs for periods subsequent to our initial investments in the United Kingdom in August 2013.

XML

Variable Interest Entities

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Variable Interest Entities

Variable Interest Entities 

We have entered into joint ventures to own certain seniors housing and outpatient medical assets which are deemed to be VIEs. We have concluded that we are the primary beneficiary of these VIEs based on a combination of operational control of the joint venture and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Except for capital contributions associated with the initial joint venture formations, the joint ventures have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):

	June 30, 2019		December 31, 2018
Assets:
Net real estate investments	$	966,417	$	973,813
Cash and cash equivalents	22,491		18,678
Receivables and other assets	15,411		14,600
Total assets(1)	$	1,004,319	$	1,007,091
Liabilities and equity:
Secured debt	$	462,836	$	465,433
Lease liabilities	1,326		—
Accrued expenses and other liabilities	21,922		18,229
Total equity	518,235		523,429
Total liabilities and equity	$	1,004,319	$	1,007,091

(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs.

XML

Subsequent Events

6 Months Ended

Jun. 30, 2019

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Disposition of Benchmark Senior Living On July 16, 2019, we disposed of our Benchmark Senior Living portfolio for a $1.8 billion gross sale price. The portfolio consisted of 48 seniors housing operating properties located in New England. Proceeds were used to extinguish the $1 billion bridge loan (discussed in Note 11) and $24 million of secured debt.

XML

Accounting Policies and Related Matters (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

     The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2019 are not necessarily an indication of the results that may be expected for the year ending December 31, 2019. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2018.

New Accounting Standards

New Accounting Standards     

• We adopted Accounting Standards Update 2016-02, Leases (Topic 842) ("ASC 842") which requires lessees to recognize assets and liabilities on their consolidated balance sheet related to the rights and obligations created by most leases, while continuing to recognize expenses on their consolidated statement of comprehensive income over the lease term. We adopted ASC 842 as of January 1, 2019, using the modified retrospective approach and have elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, permits us to carry forward our prior conclusions for lease classification and initial direct costs on existing leases. We also made an accounting policy election to keep short-term leases less than twelve months off the balance sheet for all classes of underlying assets.

In July 2018, the FASB issued ASU 2018-11 "Leases (Topic 842): Targeted Improvements" that (1) simplifies transition requirements for both lessees and lessors by adding an option that permits entities to apply the transition provisions of the new standard at its adoption date instead of at the earliest comparative period presented in its financial statements and (2) allows lessors to elect, as a practical expedient, to not separate lease and non-lease components in a contract, and instead to account for as a single lease component, if certain criteria are met. This practical expedient causes an entity to assess whether a contract is predominantly lease or service-based and recognize the entire contract under the relevant accounting guidance (i.e. predominantly lease-based would be accounted for under ASC 842 and predominantly service-based would be accounted for under ASU 2014-09, "Revenue from Contracts with Customers (ASC 606)"). For the year ended December 31, 2018, we recognized revenue for our Seniors Housing Operating resident agreements in accordance with the provisions of the prior lease guidance, ASC 840, "Leases." Upon adoption of ASC 842, we elected the lessor practical expedient described above and recognized revenue for our Seniors Housing Operating segment based upon the predominant component, the non-lease service component. Therefore, beginning on January 1, 2019, we accounted for these resident agreements under ASC 606. The timing and pattern of revenue recognition is substantially the same as that prior to adoption.

The FASB also issued ASU 2018-20 "Leases (Topic 842) - Narrow Improvements for Lessors," which provides lessors the ability to make an accounting policy election not to evaluate whether certain sales taxes and other similar taxes imposed by a governmental authority on a specific lease revenue-producing transaction are the primary obligation of the lessor as owner of the underlying leased asset. A lessor that makes this election will exclude these taxes from the measurement of lease revenue and the associated expense. Upon adoption of ASC 842, we utilized this practical expedient in instances in which real estate taxes are paid directly by our tenants to taxing authorities. For triple-net leasing arrangements in which the tenant remits payment for real estate taxes to us and we pay the taxing authority, we have included the associated revenue and expense in rental income and property operating expenses on the Consolidated Statements of Comprehensive Income. This reporting had no impact on our net income.

For leases in which the Company is the lessee, primarily consisting of ground leases and various office and equipment leases, we recognized upon adoption a right of use asset of $509,386,000 which included the present value of minimum leases payments, existing above and/or below market lease intangible values and existing straight-line rent liabilities

associated with such leases. We also recognized operating lease liabilities of $357,070,000. The standard did not materially impact our Consolidated Statements of Comprehensive Income or our Consolidated Statement of Cash Flows. See Note 6 for additional details.

The following ASU has been issued but not yet adopted:

•

In 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"). This standard requires a new forward-looking “expected loss” model to be used for receivables, held-to-maturity debt, loans, and other instruments. In November 2018, the FASB issued an amendment excluding operating lease receivables accounted for under the new leases standard from the scope of the new credit losses standard. ASU 2016-13 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2019, and early adoption is permitted for fiscal years beginning after December 15, 2018. We are currently evaluating the impact that the standard will have on our consolidated financial statements. 

XML

Real Property Acquisitions and Development (Tables)

6 Months Ended

Jun. 30, 2019

Real Estate [Abstract]

Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities

The following is a summary of our real property investment activity by segment for the periods presented (in thousands):

	Six Months Ended
	June 30, 2019												June 30, 2018
	Seniors Housing Operating			Triple-net			Outpatient Medical			Totals			Seniors Housing Operating			Triple-net			Outpatient Medical			Totals
Land and land improvements	$	103,743		$	8,099		$	132,154		$	243,996		$	47,865		$	1,691		$	7,369		$	56,925
Buildings and improvements	1,109,966			96,244			1,198,608			2,404,818			535,921			—			42,673			578,594
Acquired lease intangibles	58,773			—			85,492			144,265			68,084			—			5,852			73,936
Construction in progress	36,174			—			—			36,174			—			—			—			—
Right of use assets, net	—			—			56,073			56,073			—			—			—			—
Receivables and other assets	4,560			—			376			4,936			1,255			—			1			1,256
Total assets acquired(1)	1,313,216			104,343			1,472,703			2,890,262			653,125			1,691			55,895			710,711
Secured debt	(43,209		)	—			—			(43,209		)	(89,973		)	—			—			(89,973		)
Lease liabilities	—			—			(45,287		)	(45,287		)	—			—			—			—
Accrued expenses and other liabilities	(8,677		)	—			(22,506		)	(31,183		)	(14,686		)	(6		)	(632		)	(15,324		)
Total liabilities acquired	(51,886		)	—			(67,793		)	(119,679		)	(104,659		)	(6		)	(632		)	(105,297		)
Noncontrolling interests	(38,830		)	(1,056		)	—			(39,886		)	(9,818		)	—			—			(9,818		)
Non-cash acquisition related activity(2)	(11,889		)	—			—			(11,889		)	—			—			—			—
Cash disbursed for acquisitions	1,210,611			103,287			1,404,910			2,718,808			538,648			1,685			55,263			595,596
Construction in progress additions	110,761			24,066			26,587			161,414			20,704			38,238			11,319			70,261
Less: Capitalized interest	(3,560		)	(908		)	(1,788		)	(6,256		)	(1,783		)	(1,432		)	(1,221		)	(4,436		)
Foreign currency translation	141			65			—			206			1,176			132			—			1,308
Accruals(3)	—			—			45			45			—			—			(4,155		)	(4,155		)
Cash disbursed for construction in progress	107,342			23,223			24,844			155,409			20,097			36,938			5,943			62,978
Capital improvements to existing properties	97,867			7,423			18,886			124,176			76,237			8,569			26,526			111,332
Total cash invested in real property, net of cash acquired	$	1,415,820		$	133,933		$	1,448,640		$	2,998,393		$	634,982		$	47,192		$	87,732		$	769,906

⁽¹⁾ Excludes $ 1,910,000 and $4,392,000 of unrestricted and restricted cash acquired during the six months ended June 30, 2019 and 2018, respectively.

⁽²⁾ Relates to the acquisition of assets previously recognized as investments in unconsolidated entities.

⁽³⁾ Represents non-cash accruals for amounts to be paid in future periods for properties that converted, off-set by amounts paid in the current period.

The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):

	Six Months Ended
	June 30, 2019		June 30, 2018
Development projects:
Seniors Housing Operating	$	28,117	$	37,215
Triple-net	—		59,188
Outpatient Medical	—		11,358
Total construction in progress conversions	$	28,117	$	107,761

XML

Real Estate Intangibles (Tables)

6 Months Ended

Jun. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Real Estate Intangibles Excluding Those Classified as Held For Sale

The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):

	June 30, 2019			December 31, 2018
Assets:
In place lease intangibles	$	1,473,060		$	1,410,725
Above market tenant leases	69,656			63,935
Below market ground leases (1)	—			64,513
Lease commissions	46,422			41,986
Gross historical cost	1,589,138			1,581,159
Accumulated amortization	(1,163,936		)	(1,197,336		)
Net book value	$	425,202		$	383,823
Weighted-average amortization period in years	8.6			16.0
Liabilities:
Below market tenant leases	$	94,082		$	81,676
Above market ground leases (1)	—			8,540
Gross historical cost	94,082			90,216
Accumulated amortization	(45,147		)	(44,266		)
Net book value	$	48,935		$	45,950
Weighted-average amortization period in years	8.2			14.7

 

⁽¹⁾ Effective on January 1, 2019 with the adoption of ASC 842, above and below market ground lease intangibles are reported within the right of use assets, net line on the Consolidated Balance Sheet.

Summary of Real Estate Intangible Amortization

The following is a summary of real estate intangible amortization for the periods presented (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Rental income related to (above)/below market tenant leases, net	$	73		$	(333	)	$	(82	)	$	(684	)
Amortization related to in place lease intangibles and lease commissions	(28,518		)	(33,763		)	(53,423		)	(66,024		)

Schedule of Future Estimated Aggregate Amortization of Intangible Assets and Liabilities

The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):

	Assets		Liabilities
2019	$	84,909	$	4,777
2020	101,374		8,835
2021	51,215		7,865
2022	34,495		7,130
2023	28,361		4,989
Thereafter	124,848		15,339
Total	$	425,202	$	48,935

XML

Dispositions and Assets Held for Sale (Tables)

6 Months Ended

Jun. 30, 2019

Discontinued Operations and Disposal Groups [Abstract]

Summary of Real Property Disposition Activity

The following is a summary of our real property disposition activity for the periods presented (in thousands):

	Six Months Ended June 30,
	2019			2018
Real estate dispositions:
Seniors Housing Operating	$	8,726		$	2,200
Triple-net	442,865			367,978
Outpatient Medical	—			223,069
Total dispositions	451,591			593,247
Gain (loss) on real estate dispositions, net	165,727			348,939
Net other assets/liabilities disposed	(498		)	5,032
Proceeds from real estate dispositions	$	616,820		$	947,218

Dispositions and Assets Held for Sale

The following represents the activity related to these properties for the periods presented (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Revenues:
Total revenues	$	112,694	$	121,079	$	228,441	$	249,639
Expenses:
Interest expense	479		579		983		1,200
Property operating expenses	70,244		74,213		146,260		150,120
Provision for depreciation	12,520		18,431		24,897		38,275
Total expenses	83,243		93,223		172,140		189,595
Income (loss) from real estate dispositions, net	$	29,451	$	27,856	$	56,301	$	60,044

XML

Leases (Tables)

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Components of Lease Expense, Lease Terms and Discount Rate, and Supplemental Cash Flow Information

The components of lease expense were as follows for the period presented (in thousands):

	Classification	Three Months Ended June 30, 2019			Six Months Ended June 30, 2019
Operating lease cost: (1)
Real estate lease expense	Property operating expenses	$	7,267		$	14,679
Non-real estate lease expense	General and administrative expenses	408			770
Finance lease cost:
Amortization of leased assets	Property operating expenses	2,153			4,245
Interest on lease liabilities	Interest expense	1,166			2,169
Sublease income	Rental income	(1,043		)	(2,087		)
Total		$	9,951		$	19,776

Supplemental balance sheet information related to leases was as follows for the date indicated (in thousands, except lease terms and discount rate):

	Classification	June 30, 2019
Right of use assets:
Operating leases - real estate	Right of use assets, net	$	386,061
Finance leases	Right of use assets, net	164,281
Real estate right of use assets, net		550,342
Operating leases - corporate	Receivables and other assets	5,055
Total right of use assets, net		$	555,397
Lease liabilities:
Operating leases		$	360,298
Financing leases		108,731
Total		$	469,029
Weighted average remaining lease term (years):
Operating leases		50.0
Finance leases		15.8
Weighted average discount rate:
Operating leases		5.21		%
Finance leases		5.17		%

Supplemental cash flow information related to leases was as follows for the date indicated (in thousands):

	Classification	Six Months Ended June 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	Decrease (increase) in receivables and other assets	$	4,627
Operating cash flows from finance leases	Decrease (increase) in receivables and other assets	3,916
Financing cash flows from finance leases	Other financing activities	(1,638		)

Maturities of Lease Liabilities, Operating Leases

Maturities of lease liabilities as of June 30, 2019 are as follows (in thousands):

	Operating Leases			Finance Leases
2019	$	9,809		$	4,488
2020	19,625			8,821
2021	19,558			8,485
2022	18,627			7,852
2023	18,707			68,967
Thereafter	1,595,101			86,081
Total lease payments	1,681,427			184,694
Less: Imputed interest	(1,321,129		)	(75,963		)
Total present value of lease liabilities	$	360,298		$	108,731

Maturities of Lease Liabilities, Finance Leases

Maturities of lease liabilities as of June 30, 2019 are as follows (in thousands):

	Operating Leases			Finance Leases
2019	$	9,809		$	4,488
2020	19,625			8,821
2021	19,558			8,485
2022	18,627			7,852
2023	18,707			68,967
Thereafter	1,595,101			86,081
Total lease payments	1,681,427			184,694
Less: Imputed interest	(1,321,129		)	(75,963		)
Total present value of lease liabilities	$	360,298		$	108,731

Supplemental Balance Sheet Information Related to Leases

Supplemental balance sheet information related to leases was as follows for the date indicated (in thousands, except lease terms and discount rate):

	Classification	June 30, 2019
Right of use assets:
Operating leases - real estate	Right of use assets, net	$	386,061
Finance leases	Right of use assets, net	164,281
Real estate right of use assets, net		550,342
Operating leases - corporate	Receivables and other assets	5,055
Total right of use assets, net		$	555,397
Lease liabilities:
Operating leases		$	360,298
Financing leases		108,731
Total		$	469,029
Weighted average remaining lease term (years):
Operating leases		50.0
Finance leases		15.8
Weighted average discount rate:
Operating leases		5.21		%
Finance leases		5.17		%

Undiscounted Cash Flows for Future Minimum Lease Payments Receivable

The following table sets forth the undiscounted cash flows for future minimum lease payments receivable for leases in effect at June 30, 2019 (excluding properties in our Seniors Housing Operating partnerships and excluding any operating expense reimbursements) (in thousands):

2019	$	925,026
2020	1,380,111
2021	1,346,698
2022	1,237,904
2023	1,255,408
Thereafter	9,745,880
Totals	$	15,891,027

XML

Real Estate Loans Receivable (Tables)

6 Months Ended

Jun. 30, 2019

Receivables [Abstract]

Summary Of Real Estate Loans Receivable

The following is a summary of our net real estate loans receivable (in thousands):

	June 30, 2019			December 31, 2018
Mortgage loans	$	332,770		$	317,443
Other real estate loans	104,596			81,268
Less allowance for losses on loans receivable	(68,372		)	(68,372		)
Totals	$	368,994		$	330,339

Summary of Real Estate Loan Activity

The following is a summary of our real estate loan activity for the periods presented (in thousands):

	Six Months Ended
	June 30, 2019							June 30, 2018
		Triple-net		Outpatient Medical		Totals		Seniors Housing Operating		Triple-net			Outpatient Medical		Totals
Advances on real estate loans receivable:
Investments in new loans		$	25,000	$	5,000	$	30,000	$	11,806	$	8,281		$	7,022	$	27,109
Draws on existing loans		20,051		12,884		32,935		—		21,182			—		21,182
Net cash advances on real estate loans		45,051		17,884		62,935		11,806		29,463			7,022		48,291
Receipts on real estate loans receivable:
Loan payoffs		4,384		—		4,384		—		58,557			—		58,557
Principal payments on loans		2,456		—		2,456		—		32,870			—		32,870
Net cash receipts on real estate loans		6,840		—		6,840		—		91,427			—		91,427
Net cash advances (receipts) on real estate loans		$	38,211	$	17,884	$	56,095	$	11,806	$	(61,964	)	$	7,022	$	(43,136	)

 

Summary of Impaired Loans

The following is a summary of our impaired loans (in thousands):

	Six Months Ended
	June 30, 2019		June 30, 2018
Balance of impaired loans at end of period	$	188,068	$	214,871
Allowance for loan losses	68,372		68,372
Balance of impaired loans not reserved	$	119,696	$	146,499
Average impaired loans for the period	$	197,426	$	252,172
Interest recognized on impaired loans(1)	7,964		8,847

 

⁽¹⁾ Represents cash interest recognized in the period since loans were identified as impaired.

XML

Investments in Unconsolidated Entities (Tables)

6 Months Ended

Jun. 30, 2019

Equity Method Investments and Joint Ventures [Abstract]

Summary of Investments in Unconsolidated Entities

The following is a summary of our investments in unconsolidated entities (dollars in thousands): 

	Percentage Ownership(1)	June 30, 2019		December 31, 2018
Seniors Housing Operating	10% to 50%	$	379,886	$	344,982
Triple-net	10% to 49%	9,459		34,284
Outpatient Medical	43% to 50%	130,042		103,648
Total		$	519,387	$	482,914

 

⁽¹⁾ Excludes ownership of in-substance real estate.

XML

Credit Concentration (Tables)

6 Months Ended

Jun. 30, 2019

Risks and Uncertainties [Abstract]

Summary of Credit Concentration

The following table summarizes certain information about our credit concentration for the six months ended June 30, 2019, excluding our share of NOI in unconsolidated entities (dollars in thousands):

	Number of	Total		Percent of
Concentration by relationship:(1)	Properties	NOI		NOI(2)
Sunrise Senior Living(3)	165	$	174,422	14%
ProMedica	218	107,541		9%
Revera(3)	98	72,928		6%
Genesis HealthCare	60	60,984		5%
Benchmark Senior Living(4)	48	55,530		5%
Remaining portfolio	1,009	749,012		61%
Totals	1,598	$	1,220,417	100%

 

⁽¹⁾ Genesis Healthcare and ProMedica are in our Triple-net segment. Sunrise Senior Living and Revera are in our Seniors Housing Operating segment. Benchmark Senior Living is in both our Triple-net and Seniors Housing Operating segments.

⁽²⁾ NOI with our top five relationships comprised 38% of total NOI for the year ended December 31, 2018.

⁽³⁾ Revera owns a controlling interest in Sunrise Senior Living.

⁽⁴⁾ Please see Note 21 for additional information.

XML

Borrowings Under Credit Facilities and Commercial Paper Program (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Aggregate Borrowings Under Unsecured Revolving Credit Facility and Commercial Paper

The following information relates to aggregate borrowings under the unsecured revolving credit facility and Commercial Paper Program for the periods presented (dollars in thousands): 

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2019			2018			2019			2018
Balance outstanding at quarter end	$	1,870,000		$	540,000		$	1,870,000		$	540,000
Maximum amount outstanding at any month end	$	2,880,000		$	685,000		$	2,880,000		$	865,000
Average amount outstanding (total of daily
principal balances divided by days in period)	$	1,807,631		$	562,747		$	1,301,883		$	463,978
Weighted average interest rate (actual interest
expense divided by average borrowings outstanding)	3.08		%	3.04		%	3.11		%	2.91		%

 

XML

Senior Unsecured Notes and Secured Debt (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Annual Principal Payments Due on Debt Obligations

At June 30, 2019, the annual principal payments due on these debt obligations were as follows (in thousands):

	Senior Unsecured Notes(1,2)		Secured Debt (1,3)		Totals
2019	$	—	$	312,291	$	312,291
2020(4)	1,236,665		144,518		1,381,183
2021	450,000		383,425		833,425
2022	600,000		352,410		952,410
2023(5,6)	1,790,971		330,498		2,121,469
Thereafter(7,8)	6,633,920		1,166,840		7,800,760
Totals	$	10,711,556	$	2,689,982	$	13,401,538

 

(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the Consolidated Balance Sheet.

(2) Annual interest rates range from 2.86% to 6.50%.

(3) Annual interest rates range from 1.69% to 12.00%. Carrying value of the properties securing the debt totaled $5,991,142,000 at June 30, 2019.

(4) Includes a $300,000,000 Canadian-denominated 3.35% senior unsecured notes due 2020 (approximately $229,165,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2019) and a $1,000,000,000 unsecured term loan facility that matures on May 28, 2020 which was put in place to bridge the acquisition of the CNL Healthcare Properties portfolio. The unsecured term loan facility was subsequently extinguished in July 2019 with proceeds from the disposition of the Benchmark Senior Living portfolio.

(5) Includes a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $190,971,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2019). The loan matures on July 19, 2023 and bears interest at the Canadian Dealer Offered Rate plus 0.9% (2.86% at June 30, 2019).

(6) Includes a $500,000,000 unsecured term credit facility. The loan matures on July 19, 2023 and bears interest at LIBOR plus 0.9% (3.29% at June 30, 2019).

(7) Includes a £550,000,000 4.80% senior unsecured notes due 2028 (approximately $698,720,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2019).

(8) Includes a £500,000,000 4.50% senior unsecured notes due 2034 (approximately $635,200,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2019).

Summary of Principal Activity

The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

	Six Months Ended
	June 30, 2019				June 30, 2018
				Weighted Avg.				Weighted Avg.
	Amount			Interest Rate	Amount			Interest Rate
Beginning balance	$	9,699,984		4.48%	$	8,417,447		4.31%
Debt issued	2,050,000			3.58%	550,000			4.25%
Debt extinguished	(1,050,000		)	4.98%	(450,000		)	2.25%
Foreign currency	11,572			3.52%	(55,693		)	4.02%
Ending balance	$	10,711,556		4.24%	$	8,461,754		4.46%

 

The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands): 

	Six Months Ended
	June 30, 2019				June 30, 2018
				Weighted Avg.				Weighted Avg.
	Amount			Interest Rate	Amount			Interest Rate
Beginning balance	$	2,485,711		3.90%	$	2,618,408		3.76%
Debt issued	295,969			3.52%	44,606			3.38%
Debt assumed	42,000			4.62%	85,192			4.40%
Debt extinguished	(151,473		)	4.42%	(196,573		)	5.66%
Principal payments	(27,227		)	3.74%	(28,385		)	3.91%
Foreign currency	45,002			3.37%	(61,170		)	3.33%
Ending balance	$	2,689,982		3.84%	$	2,462,078		3.76%

XML

Derivative Instruments (Tables)

6 Months Ended

Jun. 30, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Notional Amount of Derivatives and Other Financial Instruments

The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands): 

	June 30, 2019			December 31, 2018
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	500,000		$	575,000
Denominated in Pounds Sterling	£	1,340,708		£	890,708
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000		$	250,000
Denominated in Pounds Sterling	£	1,050,000		£	1,050,000
Interest rate swaps designated as cash flow hedges:
Denominated in U.S Dollars (1)	$	1,188,250		$	—
Derivative instruments not designated:
Interest rate caps denominated in U.S. Dollars	$	405,819		$	405,819
Forward purchase contracts denominated in Canadian Dollars	$	(217,500	)	$	(325,000	)
Forward sales contracts denominated in Canadian Dollars	$	280,000		$	405,000
Forward purchase contracts denominated in Pounds Sterling	£	(125,000	)	£	(350,000	)
Forward sales contracts denominated in Pounds Sterling	£	125,000		£	350,000

 

⁽¹⁾ At June 30, 2019 the maximum maturity date was July 15, 2021.

Impact of Derivative Instruments on the Consolidated Statements of Comprehensive Income

The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):

		Three Months Ended June 30,					Six Months Ended June 30,
	Location	2019			2018		2019			2018
Gain (loss) on derivative instruments designated as hedges recognized in income	Interest expense	$	7,134		$	4,091	$	12,467		$	3,822
Gain (loss) on derivative instruments not designated as hedges recognized in income	Interest expense	$	(1,128	)	$	734	$	(2,666	)	$	2,453
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI	$	100,407		$	150,703	$	12,725		$	88,005

XML

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Summary of Stockholders' Equity Capital Accounts

The following is a summary of our stockholders’ equity capital accounts as of the dates indicated: 

	June 30, 2019	December 31, 2018
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	—	14,375,000
Outstanding shares	—	14,369,965
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	406,497,122	384,849,236
Outstanding shares	405,254,113	383,674,603

 

The following is a summary of our preferred stock activity during the periods indicated: 

	Six Months Ended
	June 30, 2019			June 30, 2018
			Weighted Avg.			Weighted Avg.
	Shares		Dividend Rate	Shares		Dividend Rate
Beginning balance	14,369,965		6.50%	14,370,060		6.50%
Shares converted	(14,369,965	)	6.50%	(95	)	6.50%
Ending balance	—		—%	14,369,965		6.50%

The following is a summary of our common stock issuances during the six months ended June 30, 2019 and 2018 (dollars in thousands, except average price amounts): 

	Shares Issued	Average Price	Gross Proceeds		Net Proceeds
2018 Dividend reinvestment plan issuances	182,910	$55.40	$	10,133	$	10,133
2018 Option exercises	1,026	53.61	55		55
2018 Preferred stock conversions	83		—		—
2018 Stock incentive plans, net of forfeitures	114,037		—		—
2018 Totals	298,056		$	10,188	$	10,188
2019 Dividend reinvestment plan issuances	4,304,712	$75.20	$	323,724	$	320,243
2019 Option exercises	10,736	51.32	551		551
2019 Equity Shelf Program issuances	4,384,045	74.97	328,665		326,362
2019 Preferred stock conversions	12,712,452		—		—
2019 Stock incentive plans, net of forfeitures	167,565		—		—
2019 Totals	21,579,510		$	652,940	$	647,156

Summary of Dividend Payments

The following is a summary of our dividend payments (in thousands, except per share amounts): 

	Six Months Ended
	June 30, 2019				June 30, 2018
	Per Share		Amount		Per Share		Amount
Common Stock	$	1.7400	$	698,437	$	1.7400	$	647,098
Series I Preferred Stock	—		—		1.6250		23,352
Totals			$	698,437			$	670,450

Summary of Accumulated Other Comprehensive Income (Loss)

The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):

	June 30, 2019			December 31, 2018
Foreign currency translation	$	(851,584	)	$	(868,006	)
Derivative instruments	751,502			738,777
Actuarial losses	(540		)	(540		)
Total accumulated other comprehensive loss	$	(100,622	)	$	(129,769	)

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019		2018
Numerator for basic and diluted earnings
per share - net income (loss) attributable
to common stockholders	$	137,762	$	154,432	$	418,232	$	592,103
Denominator for basic earnings per
share - weighted average shares	404,607		371,640		398,073		371,552
Effect of dilutive securities:
Employee stock options	—		14		1		15
Non-vested restricted shares	955		325		911		523
Redeemable shares	1,096		1,096		1,096		1,096
Employee stock purchase program	15		—		15		—
Dilutive potential common shares	2,066		1,435		2,023		1,634
Denominator for diluted earnings per
share - adjusted weighted average shares	406,673		373,075		400,096		373,186
Basic earnings per share	$	0.34	$	0.42	$	1.05	$	1.59
Diluted earnings per share	$	0.34	$	0.41	$	1.05	$	1.59

XML

Disclosure about Fair Value of Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Carrying Amounts and Estimated Fair Values of Financial Instruments

The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

	June 30, 2019				December 31, 2018
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
Mortgage loans receivable	$	264,398	$	274,116	$	249,071	$	257,337
Other real estate loans receivable	104,596		105,706		81,268		82,742
Equity securities	11,860		11,860		11,286		11,286
Cash and cash equivalents	268,666		268,666		215,376		215,376
Restricted cash	91,052		91,052		100,753		100,753
Foreign currency forward contracts, interest rate swaps and cross currency swaps	91,290		91,290		94,729		94,729
Financial liabilities:
Unsecured revolving credit facility and commercial paper note program	$	1,869,188	$	1,869,188	$	1,147,000	$	1,147,000
Senior unsecured notes	10,606,106		11,026,259		9,603,299		10,043,797
Secured debt	2,675,507		2,737,838		2,476,177		2,499,130
Foreign currency forward contracts, interest rate swaps and cross currency swaps	32,249		32,249		71,109		71,109
Redeemable OP unitholder interests	$	121,476	$	121,476	$	103,071	$	103,071

Summary of Items Measured at Fair Value on a Recurring Basis

The following summarizes items measured at fair value on a recurring basis (in thousands):

	Fair Value Measurements as of June 30, 2019
	Total		Level 1		Level 2		Level 3
Equity securities	$	11,860	$	11,860	$	—	$	—
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability)(1)	59,041		—		59,041		—
Redeemable OP unitholder interests	121,476		—		121,476		—
Totals	$	192,377	$	11,860	$	180,517	$	—

⁽¹⁾ Please see Note 12 for additional information.

XML

Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Summary Information for Reportable Segments

Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands): 

Three Months Ended June 30, 2019:	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	914,085		$	—		$	—		$	—		$	914,085
Rental income	—			222,362			163,224			—			385,586
Interest income	—			17,118			238			—			17,356
Other income	1,444			1,278			(97		)	454			3,079
Total revenues	915,529			240,758			163,365			454			1,320,106
Property operating expenses	637,317			12,823			50,987			—			701,127
Consolidated net operating income	278,212			227,935			112,378			454			618,979
Depreciation and amortization	136,551			56,056			55,445			—			248,052
Interest expense	17,572			3,225			3,386			117,153			141,336
General and administrative expenses	—			—			—			33,741			33,741
Loss (gain) on derivatives and financial instruments, net	—			1,913			—			—			1,913
Impairment of assets	—			(940		)	10,879			—			9,939
Other expenses	11,857			5,560			(4		)	4,215			21,628
Income (loss) from continuing operations before income taxes and other items	112,232			162,121			42,672			(154,655		)	162,370
Income tax (expense) benefit	375			(1,361		)	(586		)	(27		)	(1,599		)
(Loss) income from unconsolidated entities	(17,453		)	6,578			1,826			—			(9,049		)
Gain (loss) on real estate dispositions, net	(550		)	(1,130		)	(2		)	—			(1,682		)
Income (loss) from continuing operations	94,604			166,208			43,910			(154,682		)	150,040
Net income (loss)	$	94,604		$	166,208		$	43,910		$	(154,682	)	$	150,040
Total assets	$	16,440,104		$	9,494,388		$	7,004,561		$	209,644		$	33,148,697

Three Months Ended June 30, 2018:	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	763,345		$	—		$	—		$	—		$	763,345
Rental income	—			197,961			135,640			—			333,601
Interest income	172			13,247			43			—			13,462
Other income	1,650			13,212			144			498			15,504
Total revenues	765,167			224,420			135,827			498			1,125,912
Property operating expenses	525,662			136			42,953			—			568,751
Consolidated net operating income	239,505			224,284			92,874			498			557,161
Depreciation and amortization	134,779			55,309			46,187			—			236,275
Interest expense	16,971			3,800			1,656			98,989			121,416
General and administrative expenses	—			—			—			32,831			32,831
Loss (gain) on derivatives and financial instruments, net	—			(7,460		)	—			—			(7,460		)
Loss (gain) on extinguishment of debt, net	299			—			—			—			299
Impairment of assets	2,212			2,420			—			—			4,632
Other expenses	6,167			957			2,095			839			10,058
Income (loss) from continuing operations before income taxes and other items	79,077			169,258			42,936			(132,161		)	159,110
Income tax (expense) benefit	(2,617		)	(688		)	(378		)	(158		)	(3,841		)
(Loss) income from unconsolidated entities	(5,204		)	5,062			1,391			—			1,249
Gain (loss) on real estate dispositions, net	(1		)	10,759			(3		)	—			10,755
Income (loss) from continuing operations	71,255			184,391			43,946			(132,319		)	167,273
Net income (loss)	$	71,255		$	184,391		$	43,946		$	(132,319	)	$	167,273

Six Months Ended June 30, 2019	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	1,782,370		$	—		$	—		$	—		$	1,782,370
Rental income	—			454,394			312,276			—			766,670
Interest income	—			32,064			411			—			32,475
Other income	5,545			2,541			139			2,611			10,836
Total revenues	1,787,915			488,999			312,826			2,611			2,592,351
Property operating expenses	1,245,003			27,778			99,153			—			1,371,934
Consolidated net operating income	542,912			461,221			213,673			2,611			1,220,417
Depreciation and amortization	268,126			117,404			106,454			—			491,984
Interest expense	35,823			6,665			6,734			237,346			286,568
General and administrative expenses	—			—			—			69,023			69,023
Loss (gain) on derivatives and financial instruments, net	—			(574		)	—			—			(574		)
Loss (gain) on extinguishment of debt, net	—			—			—			15,719			15,719
Provision for loan losses	—			18,690			—			—			18,690
Impairment of assets	—			(940		)	10,879			—			9,939
Other expenses	14,803			8,589			750			6,242			30,384
Income (loss) from continuing operations before income taxes and other items	224,160			311,387			88,856			(325,719		)	298,684
Income tax (expense) benefit	(244		)	(2,312		)	(951		)	(314		)	(3,821		)
(Loss) income from unconsolidated entities	(34,033		)	12,236			3,549			—			(18,248		)
Gain (loss) on real estate dispositions, net	(710		)	166,444			(7		)	—			165,727
Income (loss) from continuing operations	189,173			487,755			91,447			(326,033		)	442,342
Net income (loss)	$	189,173		$	487,755		$	91,447		$	(326,033	)	$	442,342

Six Months Ended June 30, 2018	Seniors Housing Operating			Triple-net			Outpatient Medical			Non-segment / Corporate			Total
Resident fees and services	$	1,499,279		$	—		$	—		$	—		$	1,499,279
Rental income	—			404,792			272,178			—			676,970
Interest income	257			27,798			55			—			28,110
Other income	2,798			14,589			265			866			18,518
Total revenues	1,502,334			447,179			272,498			866			2,222,877
Property operating expenses	1,037,603			157			87,456			—			1,125,216
Consolidated net operating income	464,731			447,022			185,042			866			1,097,661
Depreciation and amortization	260,548			111,341			92,587			—			464,476
Interest expense	33,906			7,242			3,332			199,711			244,191
General and administrative expenses	—			—			—			66,536			66,536
Loss (gain) on derivatives and financial instruments, net	—			(14,633		)	—			—			(14,633		)
Loss (gain) on extinguishment of debt, net	110			(32		)	11,928			—			12,006
Impairment of assets	4,513			28,304			—			—			32,817
Other expenses	5,979			2,077			2,693			3,021			13,770
Income (loss) from continuing operations before income taxes and other items	159,675			312,723			74,502			(268,402		)	278,498
Income tax (expense) benefit	(2,455		)	(1,824		)	(806		)	(344		)	(5,429		)
(Loss) income from unconsolidated entities	(14,684		)	10,883			2,621			—			(1,180		)
Gain (loss) on real estate dispositions, net	4			134,156			214,779			—			348,939
Income (loss) from continuing operations	142,540			455,938			291,096			(268,746		)	620,828
Net income (loss)	$	142,540		$	455,938		$	291,096		$	(268,746	)	$	620,828

Summary of Geographic Information

The following is a summary of geographic information for the periods presented (dollars in thousands): 

	Three Months Ended								Six Months Ended
	June 30, 2019				June 30, 2018				June 30, 2019				June 30, 2018
Revenues:	Amount		%		Amount		%		Amount		%		Amount		%
United States	$	1,092,376	82.8	%	$	895,734	79.5	%	$	2,136,042	82.4	%	$	1,759,523	79.1	%
United Kingdom	112,647		8.5	%	112,031		10.0	%	225,065		8.7	%	228,556		10.3	%
Canada	115,083		8.7	%	118,147		10.5	%	231,244		8.9	%	234,798		10.6	%
Total	$	1,320,106	100.0	%	$	1,125,912	100.0	%	$	2,592,351	100.0	%	$	2,222,877	100.0	%
	As of
	June 30, 2019				December 31, 2018
Assets:	Amount		%		Amount		%
United States	$	27,496,270	82.9	%	$	24,884,292	82.0	%
United Kingdom	3,173,654		9.6	%	3,078,994		10.1	%
Canada	2,478,773		7.5	%	2,378,786		7.9	%
Total	$	33,148,697	100.0	%	$	30,342,072	100.0	%

XML

Variable Interest Entities (Tables)

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Variable Interest Entities

Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):

	June 30, 2019		December 31, 2018
Assets:
Net real estate investments	$	966,417	$	973,813
Cash and cash equivalents	22,491		18,678
Receivables and other assets	15,411		14,600
Total assets(1)	$	1,004,319	$	1,007,091
Liabilities and equity:
Secured debt	$	462,836	$	465,433
Lease liabilities	1,326		—
Accrued expenses and other liabilities	21,922		18,229
Total equity	518,235		523,429
Total liabilities and equity	$	1,004,319	$	1,007,091

(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs.

XML

Accounting Policies and Related Matters (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Lease liabilities	$ 360,298
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right of use assets		$ 509,386
Lease liabilities		$ 357,070

XML

Real Property Acquisitions and Development - Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Business Acquisition [Line Items]
Land and land improvements	$ 243,996	$ 56,925
Buildings and improvements	2,404,818	578,594
Acquired lease intangibles	144,265	73,936
Construction in progress	36,174	0
Right of use assets, net	56,073	0
Receivables and other assets	4,936	1,256
Total assets acquired	2,890,262	710,711
Secured debt	(43,209)	(89,973)
Lease liabilities	(45,287)
Accrued expenses and other liabilities	(31,183)	(15,324)
Total liabilities acquired	(119,679)	(105,297)
Noncontrolling interests	(39,886)	(9,818)
Non-cash acquisition related activity	(11,889)	0
Cash disbursed for acquisitions	2,718,808	595,596
Construction in progress additions	161,414	70,261
Less: Capitalized interest	(6,256)	(4,436)
Foreign currency translation	206	1,308
Accruals	45	(4,155)
Cash disbursed for construction in progress	155,409	62,978
Capital improvements to existing properties	124,176	111,332
Total cash invested in real property, net of cash acquired	2,998,393	769,906
Cash acquired from acquisition	1,910	4,392,000
Seniors Housing Operating
Business Acquisition [Line Items]
Land and land improvements	103,743	47,865
Buildings and improvements	1,109,966	535,921
Acquired lease intangibles	58,773	68,084
Construction in progress	36,174	0
Right of use assets, net	0	0
Receivables and other assets	4,560	1,255
Total assets acquired	1,313,216	653,125
Secured debt	(43,209)	(89,973)
Lease liabilities	0
Accrued expenses and other liabilities	(8,677)	(14,686)
Total liabilities acquired	(51,886)	(104,659)
Noncontrolling interests	(38,830)	(9,818)
Non-cash acquisition related activity	(11,889)	0
Cash disbursed for acquisitions	1,210,611	538,648
Construction in progress additions	110,761	20,704
Less: Capitalized interest	(3,560)	(1,783)
Foreign currency translation	141	1,176
Accruals	0	0
Cash disbursed for construction in progress	107,342	20,097
Capital improvements to existing properties	97,867	76,237
Total cash invested in real property, net of cash acquired	1,415,820	634,982
Triple-net
Business Acquisition [Line Items]
Land and land improvements	8,099	1,691
Buildings and improvements	96,244	0
Acquired lease intangibles	0	0
Construction in progress	0	0
Right of use assets, net	0	0
Receivables and other assets	0	0
Total assets acquired	104,343	1,691
Secured debt	0	0
Lease liabilities	0
Accrued expenses and other liabilities	0	(6)
Total liabilities acquired	0	(6)
Noncontrolling interests	(1,056)	0
Non-cash acquisition related activity	0	0
Cash disbursed for acquisitions	103,287	1,685
Construction in progress additions	24,066	38,238
Less: Capitalized interest	(908)	(1,432)
Foreign currency translation	65	132
Accruals	0	0
Cash disbursed for construction in progress	23,223	36,938
Capital improvements to existing properties	7,423	8,569
Total cash invested in real property, net of cash acquired	133,933	47,192
Outpatient Medical
Business Acquisition [Line Items]
Land and land improvements	132,154	7,369
Buildings and improvements	1,198,608	42,673
Acquired lease intangibles	85,492	5,852
Construction in progress	0	0
Right of use assets, net	56,073	0
Receivables and other assets	376	1
Total assets acquired	1,472,703	55,895
Secured debt	0	0
Lease liabilities	(45,287)
Accrued expenses and other liabilities	(22,506)	(632)
Total liabilities acquired	(67,793)	(632)
Noncontrolling interests	0	0
Non-cash acquisition related activity	0	0
Cash disbursed for acquisitions	1,404,910	55,263
Construction in progress additions	26,587	11,319
Less: Capitalized interest	(1,788)	(1,221)
Foreign currency translation	0	0
Accruals	45	(4,155)
Cash disbursed for construction in progress	24,844	5,943
Capital improvements to existing properties	18,886	26,526
Total cash invested in real property, net of cash acquired	$ 1,448,640	$ 87,732

XML

Real Property Acquisitions and Development - Construction Activity (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Segment Reporting Information [Line Items]
Total construction in progress conversions	$ 28,117	$ 107,761
Seniors Housing Operating
Segment Reporting Information [Line Items]
Total development projects	28,117	37,215
Triple-net
Segment Reporting Information [Line Items]
Total development projects	0	59,188
Outpatient Medical
Segment Reporting Information [Line Items]
Total development projects	$ 0	$ 11,358

XML

Real Estate Intangibles - Summary of Real Estate Intangibles Excluding Those Classified as Held For Sale (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Assets:
Gross historical cost	$ 1,589,138	$ 1,581,159
Accumulated amortization	(1,163,936)	(1,197,336)
Net book value	$ 425,202	$ 383,823
Weighted-average amortization period in years	8 years 7 months 6 days	16 years
Liabilities:
Gross historical cost	$ 94,082	$ 90,216
Accumulated amortization	(45,147)	(44,266)
Net book value	$ 48,935	$ 45,950
Weighted-average amortization period in years	8 years 2 months 12 days	14 years 8 months 12 days
In place lease intangibles
Assets:
Gross historical cost	$ 1,473,060	$ 1,410,725
Above market tenant leases
Assets:
Gross historical cost	69,656	63,935
Liabilities:
Gross historical cost		8,540
Below market ground leases
Assets:
Gross historical cost		64,513
Lease commissions
Assets:
Gross historical cost	46,422	41,986
Below market tenant leases
Liabilities:
Gross historical cost	$ 94,082	$ 81,676

XML

Real Estate Intangibles - Summary of Real Estate Intangible Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Rental income related to (above)/below market tenant leases, net	$ 73	$ (333)	$ (82)	$ (684)
Amortization related to in place lease intangibles and lease commissions	$ (28,518)	$ (33,763)	$ (53,423)	$ (66,024)

XML

Real Estate Intangibles - Schedule of Future Estimated Aggregate Amortization of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Assets
2019	$ 84,909
2020	101,374
2021	51,215
2022	34,495
2023	28,361
Thereafter	124,848
Net book value	425,202	$ 383,823
Liabilities
2019	4,777
2020	8,835
2021	7,865
2022	7,130
2023	4,989
Thereafter	15,339
Net book value	$ 48,935	$ 45,950

XML

Dispositions and Assets Held for Sale - Narrative (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2019 USD ($) property	Dec. 31, 2018 USD ($)	[1]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real property held for sale	$ 1,704,206	$ 590,271
Held for sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Secured debt	37,429
Net other assets and liabilities	58,816
Net impairment charges	$ 9,939
Seniors Housing Operating
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties classified as held for sale | property	55
Triple-net
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties classified as held for sale | property	30
Outpatient Medical
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of properties classified as held for sale | property	4

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Dispositions and Assets Held for Sale - Summary of Real Property Disposition Activity (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Real estate dispositions:
Total dispositions			$ 451,591	$ 593,247
Gain (loss) on real estate dispositions, net	$ (1,682)	$ 10,755	165,727	348,939
Net other assets/liabilities disposed			(498)	5,032
Proceeds from real estate dispositions			616,820	947,218
Seniors Housing Operating
Real estate dispositions:
Total dispositions			8,726	2,200
Triple-net
Real estate dispositions:
Total dispositions			442,865	367,978
Outpatient Medical
Real estate dispositions:
Total dispositions			$ 0	$ 223,069

XML

Dispositions and Assets Held for Sale - Dispositions and Assets Held for Sale (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues:
Total revenues	$ 112,694	$ 121,079	$ 228,441	$ 249,639
Expenses:
Interest expense	479	579	983	1,200
Property operating expenses	70,244	74,213	146,260	150,120
Provision for depreciation	12,520	18,431	24,897	38,275
Total expenses	83,243	93,223	172,140	189,595
Income (loss) from real estate dispositions, net	$ 29,451	$ 27,856	$ 56,301	$ 60,044

XML

Leases - Narrative (Details) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019 USD ($) building	Jun. 30, 2019 USD ($) building
Lessee, Lease, Description [Line Items]
Pricing period		30 years
Number of buildings subleased | building	7	7
Rental and other revenues related to operating lease payments	$ 385,586	$ 766,670
Rental and other revenues related to operating lease payments, variable leases		$ 94,017
Minimum
Lessee, Lease, Description [Line Items]
Lease term extension period		1 year
Maximum
Lessee, Lease, Description [Line Items]
Lease term extension period		25 years

XML

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Finance lease cost:
Amortization of leased assets	$ 2,153	$ 4,245
Interest on lease liabilities	1,166	2,169
Sublease income	(1,043)	(2,087)
Total	9,951	19,776
Property operating expenses
Operating lease cost:
Lease expense	7,267	14,679
General and administrative expenses
Operating lease cost:
Lease expense	$ 408	$ 770

XML

Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Jun. 30, 2019 USD ($)
Operating Leases
2019	$ 9,809
2020	19,625
2021	19,558
2022	18,627
2023	18,707
Thereafter	1,595,101
Total lease payments	1,681,427
Less: Imputed interest	(1,321,129)
Total present value of lease liabilities	360,298
Finance Leases
2019	4,488
2020	8,821
2021	8,485
2022	7,852
2023	68,967
Thereafter	86,081
Total lease payments	184,694
Less: Imputed interest	(75,963)
Total present value of lease liabilities	$ 108,731

XML

Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018	[1]
Right of use assets:
Total right of use assets, net	$ 550,342
Lease liabilities:
Operating leases	360,298
Financing leases	108,731
Total	$ 469,029	$ 70,668
Weighted average remaining lease term (years):
Operating leases	50 years
Finance leases	15 years 9 months 18 days
Weighted average discount rate:
Operating leases	5.21%
Finance leases	5.17%
Real Estate
Right of use assets:
Operating leases	$ 386,061
Finance leases	164,281
Corporate
Right of use assets:
Operating leases	5,055
Real Estate and Corporate
Right of use assets:
Total right of use assets, net	$ 555,397

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Leases - Supplemental Cash Flow Information Related to Leases (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2019 USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 4,627
Operating cash flows from finance leases	3,916
Financing cash flows from finance leases	$ (1,638)

XML

Leases - Undiscounted Cash Flows for Future Minimum Lease Payments Receivable (Details) $ in Thousands	Jun. 30, 2019 USD ($)
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]
2019	$ 925,026
2020	1,380,111
2021	1,346,698
2022	1,237,904
2023	1,255,408
Thereafter	9,745,880
Totals	$ 15,891,027

XML

Real Estate Loans Receivable - Summary Of Real Estate Loans Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less allowance for losses on loans receivable	$ (68,372)	$ (68,372)
Totals	368,994	330,339
Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate loans receivable	332,770	317,443
Other real estate loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate loans receivable	$ 104,596	$ 81,268

XML

Real Estate Loans Receivable - Summary of Real Estate Loan Activity (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Advances on real estate loans receivable:
Investments in new loans	$ 30,000	$ 27,109
Draws on existing loans	32,935	21,182
Net cash advances on real estate loans	62,935	48,291
Receipts on real estate loans receivable:
Loan payoffs	4,384	58,557
Principal payments on loans	2,456	32,870
Net cash receipts on real estate loans	6,840	91,427
Net cash advances (receipts) on real estate loans	56,095	(43,136)
Seniors Housing Operating
Advances on real estate loans receivable:
Investments in new loans		11,806
Draws on existing loans		0
Net cash advances on real estate loans		11,806
Receipts on real estate loans receivable:
Loan payoffs		0
Principal payments on loans		0
Net cash receipts on real estate loans		0
Net cash advances (receipts) on real estate loans		11,806
Triple-net
Advances on real estate loans receivable:
Investments in new loans	25,000	8,281
Draws on existing loans	20,051	21,182
Net cash advances on real estate loans	45,051	29,463
Receipts on real estate loans receivable:
Loan payoffs	4,384	58,557
Principal payments on loans	2,456	32,870
Net cash receipts on real estate loans	6,840	91,427
Net cash advances (receipts) on real estate loans	38,211	(61,964)
Outpatient Medical
Advances on real estate loans receivable:
Investments in new loans	5,000	7,022
Draws on existing loans	12,884	0
Net cash advances on real estate loans	17,884	7,022
Receipts on real estate loans receivable:
Loan payoffs	0	0
Principal payments on loans	0	0
Net cash receipts on real estate loans	0	0
Net cash advances (receipts) on real estate loans	$ 17,884	$ 7,022

XML

Real Estate Loans Receivable - Narrative (Details) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2019 USD ($)	Jun. 30, 2019 USD ($) loan	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) loan	Jun. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)
Financing Receivable, Modifications [Line Items]
Provision for loan losses	$ 18,690	$ 0	$ 0	$ 18,690	$ 0
Allowance for loan losses	$ 68,372	$ 68,372	$ 68,372	$ 68,372	$ 68,372
Number of real estate loans on non-accrual status | loan		1		1
Real estate loans with outstanding balances		$ 2,534		$ 2,534
Triple-net | Genesis Healthcare Loans
Financing Receivable, Modifications [Line Items]
Loan loss charge						$ 62,966	$ 6,935

XML

Real Estate Loans Receivable - Summary of Impaired Loans (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Mar. 31, 2019
Receivables [Abstract]
Balance of impaired loans at end of period	$ 188,068	$ 214,871
Allowance for loan losses	68,372	68,372	$ 68,372
Balance of impaired loans not reserved	119,696	146,499
Average impaired loans for the period	197,426	252,172
Interest recognized on impaired loans	$ 7,964	$ 8,847

XML

Investments in Unconsolidated Entities - Summary of Investments in Unconsolidated Entities (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	$ 519,387	$ 482,914
Seniors Housing Operating
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	$ 379,886	$ 344,982
Seniors Housing Operating | Minimum
Schedule of Equity Method Investments [Line Items]
Percentage Ownership	10.00%	10.00%
Seniors Housing Operating | Maximum
Schedule of Equity Method Investments [Line Items]
Percentage Ownership	50.00%	50.00%
Triple-net
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	$ 9,459	$ 34,284
Triple-net | Minimum
Schedule of Equity Method Investments [Line Items]
Percentage Ownership	10.00%	10.00%
Triple-net | Maximum
Schedule of Equity Method Investments [Line Items]
Percentage Ownership	49.00%	49.00%
Outpatient Medical
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	$ 130,042	$ 103,648
Outpatient Medical | Minimum
Schedule of Equity Method Investments [Line Items]
Percentage Ownership	43.00%	43.00%
Outpatient Medical | Maximum
Schedule of Equity Method Investments [Line Items]
Percentage Ownership	50.00%	50.00%

XML

Investments in Unconsolidated Entities - Narrative (Details) $ in Thousands	Jun. 30, 2019 USD ($)
Equity Method Investments and Joint Ventures [Abstract]
Aggregate unamortized basis difference of joint venture investments	$ 101,571

XML

Credit Concentration (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($) property	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) property	Jun. 30, 2018 USD ($)	Dec. 31, 2018
Concentration Risk [Line Items]
Total NOI	$ 618,979	$ 557,161	$ 1,220,417	$ 1,097,661
Percentage total investments with top five customers					38.00%
Net Operating Income
Concentration Risk [Line Items]
Number of Properties | property	1,598		1,598
Total NOI			$ 1,220,417
Percent of NOI			100.00%
Net Operating Income | Sunrise Senior Living
Concentration Risk [Line Items]
Number of Properties | property	165		165
Total NOI			$ 174,422
Percent of NOI			14.00%
Net Operating Income | ProMedica
Concentration Risk [Line Items]
Number of Properties | property	218		218
Total NOI			$ 107,541
Percent of NOI			9.00%
Net Operating Income | Revera
Concentration Risk [Line Items]
Number of Properties | property	98		98
Total NOI			$ 72,928
Percent of NOI			6.00%
Net Operating Income | Genesis HealthCare
Concentration Risk [Line Items]
Number of Properties | property	60		60
Total NOI			$ 60,984
Percent of NOI			5.00%
Net Operating Income | Benchmark Senior Living
Concentration Risk [Line Items]
Number of Properties | property	48		48
Total NOI			$ 55,530
Percent of NOI			5.00%
Net Operating Income | Remaining portfolio
Concentration Risk [Line Items]
Number of Properties | property	1,009		1,009
Total NOI			$ 749,012
Percent of NOI			61.00%

XML

Borrowings Under Credit Facilities and Commercial Paper Program - Narrative (Details)	1 Months Ended	6 Months Ended
	Jan. 31, 2019 USD ($)	Jun. 30, 2019 USD ($) term bank	Dec. 31, 2018 USD ($)	[1]
Line of Credit Facility [Line Items]
Number of banks in consortium | bank		31
Borrowings outstanding		$ 1,869,188,000	$ 1,147,000,000
Available to borrow in alternate currencies		$ 1,000,000,000
Applicable margin		0.825%
Facility fee		0.15%
Totals		$ 13,401,538,000
Accordion Feature
Line of Credit Facility [Line Items]
Unsecured line of credit arrangement		1,000,000,000
Unsecured Revolving Credit Facility
Line of Credit Facility [Line Items]
Unsecured line of credit arrangement		3,000,000,000
Borrowings outstanding		$ 935,000,000
Number of successive terms | term		2
Extended expiration period		6 months
Term Credit Facility
Line of Credit Facility [Line Items]
Unsecured line of credit arrangement		$ 500,000,000
Term Credit Facility, CAD Denominated
Line of Credit Facility [Line Items]
Unsecured line of credit arrangement		250,000,000
Term Credit Facility, CAD Denominated | Accordion Feature
Line of Credit Facility [Line Items]
Unsecured line of credit arrangement		250,000,000
Unsecured Credit Facility In Alternate Currencies
Line of Credit Facility [Line Items]
Borrowings outstanding		$ 0
Applicable margin		3.22%
Commercial Paper Note Program
Line of Credit Facility [Line Items]
Unsecured line of credit arrangement	$ 1,000,000,000
Totals		$ 934,188,000
Principal outstanding		935,000,000
Unamortized discount		$ 812,000
Weighted average interest rate		2.70%
Commercial Paper Note Program | Maximum
Line of Credit Facility [Line Items]
Debt instrument, term	397 days
Commercial Paper Note Program | Weighted Average
Line of Credit Facility [Line Items]
Debt instrument, term		31 days

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Borrowings Under Credit Facilities and Commercial Paper Program - Aggregate Borrowings Under Unsecured Revolving Credit Facility and Commercial Paper (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Debt Disclosure [Abstract]
Balance outstanding at quarter end	$ 1,870,000	$ 540,000	$ 1,870,000	$ 540,000
Maximum amount outstanding at any month end	2,880,000	685,000	2,880,000	865,000
Average amount outstanding (total of daily principal balances divided by days in period)	$ 1,807,631	$ 562,747	$ 1,301,883	$ 463,978
Weighted average interest rate (actual interest expense divided by average borrowings outstanding)	3.08%	3.04%	3.11%	2.91%

XML

Senior Unsecured Notes and Secured Debt - Annual Principal Payments Due on Debt Obligations (Details)	6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2019 GBP (£)	Jun. 30, 2019 CAD ($)	Dec. 31, 2018 USD ($)	Jun. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)
Annual principal payments due
2019	$ 312,291,000
2020	1,381,183,000
2021	833,425,000
2022	952,410,000
2023	2,121,469,000
Thereafter	7,800,760,000
Totals	13,401,538,000
Senior Unsecured Notes
Annual principal payments due
2019	0
2020	1,236,665,000
2021	450,000,000
2022	600,000,000
2023	1,790,971,000
Thereafter	6,633,920,000
Totals	$ 10,711,556,000			$ 9,699,984,000	$ 8,461,754,000	$ 8,417,447,000
Senior Unsecured Notes | Minimum
Annual principal payments due
Interest rate	2.86%	2.86%	2.86%
Senior Unsecured Notes | Maximum
Annual principal payments due
Interest rate	6.50%	6.50%	6.50%
Senior Unsecured Notes | Canadian-denominated 3.35% senior unsecured notes due 2020
Annual principal payments due
Interest rate	3.35%	3.35%	3.35%
Face amount	$ 229,165,000		$ 300,000,000
Senior Unsecured Notes | Canadian-denominated unsecured term credit facility
Annual principal payments due
Face amount	$ 190,971,000		$ 250,000,000
Senior Unsecured Notes | Canadian-denominated unsecured term credit facility | Canadian Dealer Offered Rate
Annual principal payments due
Debt instrument, basis spread on variable rate	0.90%
Interest rate at period end	2.86%	2.86%	2.86%
Senior Unsecured Notes | Unsecured term credit facility
Annual principal payments due
Face amount	$ 500,000,000
Senior Unsecured Notes | Unsecured term credit facility | LIBOR
Annual principal payments due
Debt instrument, basis spread on variable rate	0.90%
Interest rate at period end	3.29%	3.29%	3.29%
Senior Unsecured Notes | Senior unsecured notes due 2028
Annual principal payments due
Interest rate	4.80%	4.80%	4.80%
Face amount	$ 698,720,000	£ 550,000,000
Senior Unsecured Notes | Senior unsecured notes due 2034
Annual principal payments due
Interest rate	4.50%	4.50%	4.50%
Face amount	$ 635,200,000	£ 500,000,000
Secured Debt
Annual principal payments due
2019	312,291,000
2020	144,518,000
2021	383,425,000
2022	352,410,000
2023	330,498,000
Thereafter	1,166,840,000
Totals	2,689,982,000			$ 2,485,711,000	$ 2,462,078,000	$ 2,618,408,000
Carrying values of properties securing the debt	$ 5,991,142,000
Secured Debt | Minimum
Annual principal payments due
Interest rate	1.69%	1.69%	1.69%
Secured Debt | Maximum
Annual principal payments due
Interest rate	12.00%	12.00%	12.00%
Unsecured Term Loan Facility
Annual principal payments due
Unsecured line of credit arrangement	$ 1,000,000,000

XML

Senior Unsecured Notes and Secured Debt - Summary of Principal Activity (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)
Amount
Debt issued, unsecured	$ 2,036,964	$ 545,074
Debt issued, secured	295,969	44,606
Ending balance	13,401,538
Senior Unsecured Notes
Amount
Beginning balance	9,699,984	8,417,447
Debt issued, unsecured	2,050,000	550,000
Debt extinguished	(1,050,000)	(450,000)
Foreign currency	11,572	(55,693)
Ending balance	$ 10,711,556	$ 8,461,754
Weighted Avg. Interest Rate
Beginning balance	4.48%	4.31%
Debt issued	0.0358	0.0425
Debt extinguished	0.0498	0.0225
Foreign currency	0.0352	0.0402
Ending balance	4.24%	4.46%
Secured debt
Amount
Beginning balance	$ 2,485,711	$ 2,618,408
Debt issued, secured	295,969	44,606
Debt assumed	42,000	85,192
Debt extinguished	(151,473)	(196,573)
Principal payments	(27,227)	(28,385)
Foreign currency	45,002	(61,170)
Ending balance	$ 2,689,982	$ 2,462,078
Weighted Avg. Interest Rate
Beginning balance	3.90%	3.76%
Debt issued	0.0352	0.0338
Debt assumed	0.0462	0.0440
Debt extinguished	0.0442	0.0566
Principal payments	0.0374	0.0391
Foreign currency	0.0337	0.0333
Ending balance	3.84%	3.76%

XML

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Proceeds from hedge	$ 6,716
Cash payments from hedge		$ 27,774

XML

Derivative Instruments - Notional Amount of Derivatives and Other Financial Instruments (Details) £ in Thousands, $ in Thousands, $ in Thousands	Jun. 30, 2019 USD ($)	Jun. 30, 2019 GBP (£)	Jun. 30, 2019 CAD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2018 GBP (£)	Dec. 31, 2018 CAD ($)
Denominated in Canadian Dollars | Designated as Hedging Instrument | Net Investment Hedging
Derivatives, Fair Value [Line Items]
Derivative asset			$ 500,000			$ 575,000
Derivative liability			250,000			250,000
Denominated in Canadian Dollars | Derivative Instruments Not Designated | Purchase Contracts
Derivatives, Fair Value [Line Items]
Derivative liability			217,500			325,000
Denominated in Canadian Dollars | Derivative Instruments Not Designated | Sales Contracts
Derivatives, Fair Value [Line Items]
Derivative asset			$ 280,000			$ 405,000
Denominated in U.S Dollars | Designated as Hedging Instrument | Cash Flow Hedging
Derivatives, Fair Value [Line Items]
Derivative liability	$ 1,188,250			$ 0
Denominated in U.S Dollars | Derivative Instruments Not Designated
Derivatives, Fair Value [Line Items]
Derivative asset	$ 405,819			$ 405,819
Denominated in Pounds Sterling | Designated as Hedging Instrument | Net Investment Hedging
Derivatives, Fair Value [Line Items]
Derivative asset | £		£ 1,340,708			£ 890,708
Derivative liability | £		1,050,000			1,050,000
Denominated in Pounds Sterling | Derivative Instruments Not Designated | Purchase Contracts
Derivatives, Fair Value [Line Items]
Derivative liability | £		125,000			350,000
Denominated in Pounds Sterling | Derivative Instruments Not Designated | Sales Contracts
Derivatives, Fair Value [Line Items]
Derivative asset | £		£ 125,000			£ 350,000

XML

Derivative Instruments - Impact of Derivative Instruments on the Consolidated Statements of Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Foreign Exchange Contract
Derivative [Line Items]
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	$ 100,407	$ 150,703	$ 12,725	$ 88,005
Designated as Hedging Instrument
Derivative [Line Items]
Gain (loss) on derivative instruments	7,134	4,091	12,467	3,822
Derivative Instruments Not Designated
Derivative [Line Items]
Gain (loss) on derivative instruments	$ (1,128)	$ 734	$ (2,666)	$ 2,453

XML

Commitments and Contingencies (Details) $ in Thousands	Jun. 30, 2019 USD ($) obligation	Dec. 31, 2018 USD ($)	[1]
Commitments and Contingencies Disclosure [Abstract]
Number of outstanding credit obligations | obligation	14
Letter of credit obligation	$ 48,111
Outstanding construction financings for leased properties	363,160	$ 194,365
Additional financing to complete construction	483,210
Total contingent purchase obligations	$ 8,476

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Stockholders' Equity - Summary of Stockholders' Equity Capital Accounts (Details) - $ / shares	Jun. 30, 2019	Dec. 31, 2018	Dec. 31, 2017
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	0	14,375,000
Outstanding shares	0	14,369,965	14,370,060
Common Stock, $1.00 par value:
Par value (in USD per share)	$ 1.00	$ 1.00
Authorized shares	700,000,000	700,000,000
Issued shares	406,497,122	384,849,236
Outstanding shares	405,254,113	383,674,603

XML

Stockholders' Equity - Preferred Stock (Details) - shares	6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Shares
Beginning balance (in shares)	14,369,965	14,370,060	14,370,060
Ending balance (in shares)	0		14,369,965	14,370,060
Weighted Avg. Dividend Rate
Balance	0.00%	6.50%	6.50%	6.50%
Shares converted	6.50%	6.50%
Number of shares converted into common stock (in shares)	0.8857
Common Stock
Shares
Shares converted (in shares)	(14,369,965)	(95)

XML

Stockholders' Equity - Common Stock Narrative (Details) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2019	Jun. 30, 2019	Feb. 28, 2019
Equity, Class of Treasury Stock [Line Items]
Sale of shares (in shares)		4,384,045
Equity Shelf Program
Equity, Class of Treasury Stock [Line Items]
Aggregate amount of common stock offered to sell			$ 1,500,000,000
Remaining capacity		$ 1,360,820,000
Equity Shelf Program | Scenario, Forecast
Equity, Class of Treasury Stock [Line Items]
Sale of shares (in shares)	2,194,575

XML

Stockholders' Equity - Common Stock (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2019 USD ($) $ / shares shares	Jun. 30, 2018 USD ($) $ / shares shares
Shares Issued
Dividend reinvestment plan issuances (in shares) | shares	4,304,712	182,910
Option exercises (in shares) | shares	10,736	1,026
Equity Shelf Program issuances (in shares) | shares	4,384,045
Stock incentive plans, net of forfeitures (in shares) | shares	167,565	114,037
Totals (in shares) | shares	21,579,510	298,056
Average Price
Dividend reinvestment plan issuances (in USD per share) | $ / shares	75.20	55.40
Option exercises (in USD per share) | $ / shares	51.32	53.61
Equity shelf plan issuances (in USD per share) | $ / shares	74.97
Gross Proceeds
Dividend reinvestment plan issuances	$ 323,724	$ 10,133
Option exercises	551	55
Equity shelf plan issuances	328,665
Totals	652,940	10,188
Net Proceeds
Dividend reinvestment plan issuances	320,243	10,133
Option exercises	551	55
Equity shelf plan issuances	326,362
Totals	$ 647,156	$ 10,188
Convertible Preferred Stock
Shares Issued
Preferred stock conversions (in shares) | shares	12,712,452	83

XML

Stockholders' Equity - Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Per Share
Common Stock (in USD per share)	$ 0.87	$ 0.87	$ 1.7400	$ 1.7400
Series I Preferred Stock (in USD per share)			$ 0	$ 1.6250
Amount
Common Stock			$ 698,437	$ 647,098
Series I Preferred Stock			0	23,352
Totals			$ 698,437	$ 670,450

XML

Stockholders' Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018		Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017
Summary of accumulated other comprehensive income/(loss) [Line Items]
Total accumulated other comprehensive loss	$ 15,969,572	$ 16,047,831	$ 15,586,599	[1]	$ 14,800,487	$ 15,059,326	$ 14,925,452
Foreign currency translation
Summary of accumulated other comprehensive income/(loss) [Line Items]
Total accumulated other comprehensive loss	(851,584)		(868,006)
Derivative instruments
Summary of accumulated other comprehensive income/(loss) [Line Items]
Total accumulated other comprehensive loss	751,502		738,777
Actuarial losses
Summary of accumulated other comprehensive income/(loss) [Line Items]
Total accumulated other comprehensive loss	(540)		(540)
Total accumulated other comprehensive loss
Summary of accumulated other comprehensive income/(loss) [Line Items]
Total accumulated other comprehensive loss	$ (100,622)	$ (144,618)	$ (129,769)		$ (132,631)	$ (91,253)	$ (111,465)

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Stock Incentive Plans (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock authorized (in shares)	10,000,000		10,000,000
Option expiration period			10 years
Stock-based compensation expense	$ 7,662	$ 5,167	$ 15,192	$ 16,725
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			3 years
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			5 years

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Earnings Per Share [Abstract]
Numerator for basic and diluted earnings per share - net income (loss) attributable to common stockholders	$ 137,762	$ 154,432	$ 418,232	$ 592,103
Denominator for basic earnings per share - weighted average shares (in shares)	404,607,000	371,640,000	398,073,000	371,552,000
Effect of dilutive securities:
Employee stock options (in shares)	0	14,000	1,000	15,000
Non-vested restricted shares (in shares)	955,000	325,000	911,000	523,000
Redeemable shares (in shares)	1,096,000	1,096,000	1,096,000	1,096,000
Employee stock purchase program (in shares)	15,000	0	15,000	0
Dilutive potential common shares (in shares)	2,066,000	1,435,000	2,023,000	1,634,000
Denominator for diluted earnings per share - adjusted weighted average shares (in shares)	406,673,000	373,075,000	400,096,000	373,186,000
Basic earnings per share (in USD per share)	$ 0.34	$ 0.42	$ 1.05	$ 1.59
Diluted earnings per share (in USD per share)	$ 0.34	$ 0.41	$ 1.05	$ 1.59
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares not included in the computation of diluted earnings per share because such options were anti-dilutive (in shares)			2,194,575

XML

Disclosure about Fair Value of Financial Instruments - Carrying Amounts and Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Financial assets:
Equity securities	$ 11,860
Restricted cash	91,052	$ 100,753	[1]
Financial liabilities:
Unsecured revolving credit facility and commercial paper note program	1,869,188
Carrying Amount
Financial assets:
Equity securities	11,860	11,286
Cash and cash equivalents	268,666	215,376
Restricted cash	91,052	100,753
Foreign currency forward contracts, interest rate swaps and cross currency swaps	91,290	94,729
Financial liabilities:
Unsecured revolving credit facility and commercial paper note program		1,147,000
Senior unsecured notes	10,606,106	9,603,299
Secured debt	2,675,507	2,476,177
Foreign currency forward contracts, interest rate swaps and cross currency swaps	32,249	71,109
Redeemable OP unitholder interests	121,476	103,071
Carrying Amount | Mortgage loans receivable
Financial assets:
Loans receivable	264,398	249,071
Carrying Amount | Other real estate loans receivable
Financial assets:
Loans receivable	104,596	81,268
Fair Value
Financial assets:
Equity securities	11,860	11,286
Cash and cash equivalents	268,666	215,376
Restricted cash	91,052	100,753
Foreign currency forward contracts, interest rate swaps and cross currency swaps	91,290	94,729
Financial liabilities:
Unsecured revolving credit facility and commercial paper note program	1,869,188	1,147,000
Senior unsecured notes	11,026,259	10,043,797
Secured debt	2,737,838	2,499,130
Foreign currency forward contracts, interest rate swaps and cross currency swaps	32,249	71,109
Redeemable OP unitholder interests	121,476	103,071
Fair Value | Mortgage loans receivable
Financial assets:
Loans receivable	274,116	257,337
Fair Value | Other real estate loans receivable
Financial assets:
Loans receivable	$ 105,706	$ 82,742

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Disclosure about Fair Value of Financial Instruments - Summary of Items Measured at Fair Value on a Recurring Basis (Details) $ in Thousands	Jun. 30, 2019 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 11,860
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability)	59,041
Redeemable OP unitholder interests	121,476
Totals	192,377
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	11,860
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability)	0
Redeemable OP unitholder interests	0
Totals	11,860
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	0
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability)	59,041
Redeemable OP unitholder interests	121,476
Totals	180,517
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	0
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability)	0
Redeemable OP unitholder interests	0
Totals	$ 0

XML

Segment Reporting - Summary Information for Reportable Segments (Details) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2019 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) segment	Jun. 30, 2018 USD ($)	Dec. 31, 2018 USD ($)	[1]
Segment Reporting [Abstract]
Number of operating segments | segment				3
Segment Reporting Information [Line Items]
Rental income		$ 385,586		$ 766,670
Rental income			$ 333,601		$ 676,970
Total revenues		1,320,106	1,125,912	2,592,351	2,222,877
Property operating expenses		701,127	568,751	1,371,934	1,125,216
Consolidated net operating income		618,979	557,161	1,220,417	1,097,661
Depreciation and amortization		248,052	236,275	491,984	464,476
Interest expense		141,336	121,416	286,568	244,191
General and administrative expenses		33,741	32,831	69,023	66,536
Loss (gain) on derivatives and financial instruments, net		1,913	(7,460)	(574)	(14,633)
Loss (gain) on extinguishment of debt, net		0	299	15,719	12,006
Provision for loan losses	$ 18,690	0	0	18,690	0
Impairment of assets		9,939	4,632	9,939	32,817
Other expenses		21,628	10,058	30,384	13,770
Income (loss) from continuing operations before income taxes and other items		162,370	159,110	298,684	278,498
Income tax (expense) benefit		(1,599)	(3,841)	(3,821)	(5,429)
(Loss) income from unconsolidated entities		(9,049)	1,249	(18,248)	(1,180)
Gain (loss) on real estate dispositions, net		(1,682)	10,755	165,727	348,939
Income (loss) from continuing operations		150,040	167,273	442,342	620,828
Net income (loss)		150,040	167,273	442,342	620,828
Total assets		33,148,697		33,148,697		$ 30,342,072
Resident fees and services
Segment Reporting Information [Line Items]
Revenue from contract with customer		914,085	763,345	1,782,370	1,499,279
Interest income
Segment Reporting Information [Line Items]
Revenue from contract with customer		17,356	13,462	32,475	28,110
Other income
Segment Reporting Information [Line Items]
Revenue from contract with customer		3,079	15,504	10,836	18,518
Operating Segments | Seniors Housing Operating
Segment Reporting Information [Line Items]
Rental income		0		0
Rental income			0		0
Total revenues		915,529	765,167	1,787,915	1,502,334
Property operating expenses		637,317	525,662	1,245,003	1,037,603
Consolidated net operating income		278,212	239,505	542,912	464,731
Depreciation and amortization		136,551	134,779	268,126	260,548
Interest expense		17,572	16,971	35,823	33,906
General and administrative expenses		0	0	0	0
Loss (gain) on derivatives and financial instruments, net		0	0	0	0
Loss (gain) on extinguishment of debt, net			299	0	110
Provision for loan losses				0
Impairment of assets		0	2,212	0	4,513
Other expenses		11,857	6,167	14,803	5,979
Income (loss) from continuing operations before income taxes and other items		112,232	79,077	224,160	159,675
Income tax (expense) benefit		375	(2,617)	(244)	(2,455)
(Loss) income from unconsolidated entities		(17,453)	(5,204)	(34,033)	(14,684)
Gain (loss) on real estate dispositions, net		(550)	(1)	(710)	4
Income (loss) from continuing operations		94,604	71,255	189,173	142,540
Net income (loss)		94,604	71,255	189,173	142,540
Total assets		16,440,104		16,440,104
Operating Segments | Seniors Housing Operating | Resident fees and services
Segment Reporting Information [Line Items]
Revenue from contract with customer		914,085	763,345	1,782,370	1,499,279
Operating Segments | Seniors Housing Operating | Interest income
Segment Reporting Information [Line Items]
Revenue from contract with customer		0	172	0	257
Operating Segments | Seniors Housing Operating | Other income
Segment Reporting Information [Line Items]
Revenue from contract with customer		1,444	1,650	5,545	2,798
Operating Segments | Triple-net
Segment Reporting Information [Line Items]
Rental income		222,362		454,394
Rental income			197,961		404,792
Total revenues		240,758	224,420	488,999	447,179
Property operating expenses		12,823	136	27,778	157
Consolidated net operating income		227,935	224,284	461,221	447,022
Depreciation and amortization		56,056	55,309	117,404	111,341
Interest expense		3,225	3,800	6,665	7,242
General and administrative expenses		0	0	0	0
Loss (gain) on derivatives and financial instruments, net		1,913	(7,460)	(574)	(14,633)
Loss (gain) on extinguishment of debt, net			0	0	(32)
Provision for loan losses				18,690
Impairment of assets		(940)	2,420	(940)	28,304
Other expenses		5,560	957	8,589	2,077
Income (loss) from continuing operations before income taxes and other items		162,121	169,258	311,387	312,723
Income tax (expense) benefit		(1,361)	(688)	(2,312)	(1,824)
(Loss) income from unconsolidated entities		6,578	5,062	12,236	10,883
Gain (loss) on real estate dispositions, net		(1,130)	10,759	166,444	134,156
Income (loss) from continuing operations		166,208	184,391	487,755	455,938
Net income (loss)		166,208	184,391	487,755	455,938
Total assets		9,494,388		9,494,388
Operating Segments | Triple-net | Resident fees and services
Segment Reporting Information [Line Items]
Revenue from contract with customer		0	0	0	0
Operating Segments | Triple-net | Interest income
Segment Reporting Information [Line Items]
Revenue from contract with customer		17,118	13,247	32,064	27,798
Operating Segments | Triple-net | Other income
Segment Reporting Information [Line Items]
Revenue from contract with customer		1,278	13,212	2,541	14,589
Operating Segments | Outpatient Medical
Segment Reporting Information [Line Items]
Rental income		163,224		312,276
Rental income			135,640		272,178
Total revenues		163,365	135,827	312,826	272,498
Property operating expenses		50,987	42,953	99,153	87,456
Consolidated net operating income		112,378	92,874	213,673	185,042
Depreciation and amortization		55,445	46,187	106,454	92,587
Interest expense		3,386	1,656	6,734	3,332
General and administrative expenses		0	0	0	0
Loss (gain) on derivatives and financial instruments, net		0	0	0	0
Loss (gain) on extinguishment of debt, net			0	0	11,928
Provision for loan losses				0
Impairment of assets		10,879	0	10,879	0
Other expenses		(4)	2,095	750	2,693
Income (loss) from continuing operations before income taxes and other items		42,672	42,936	88,856	74,502
Income tax (expense) benefit		(586)	(378)	(951)	(806)
(Loss) income from unconsolidated entities		1,826	1,391	3,549	2,621
Gain (loss) on real estate dispositions, net		(2)	(3)	(7)	214,779
Income (loss) from continuing operations		43,910	43,946	91,447	291,096
Net income (loss)		43,910	43,946	91,447	291,096
Total assets		7,004,561		7,004,561
Operating Segments | Outpatient Medical | Resident fees and services
Segment Reporting Information [Line Items]
Revenue from contract with customer		0	0	0	0
Operating Segments | Outpatient Medical | Interest income
Segment Reporting Information [Line Items]
Revenue from contract with customer		238	43	411	55
Operating Segments | Outpatient Medical | Other income
Segment Reporting Information [Line Items]
Revenue from contract with customer		(97)	144	139	265
Non-segment / Corporate
Segment Reporting Information [Line Items]
Rental income		0		0
Rental income			0		0
Total revenues		454	498	2,611	866
Property operating expenses		0	0	0	0
Consolidated net operating income		454	498	2,611	866
Depreciation and amortization		0	0	0	0
Interest expense		117,153	98,989	237,346	199,711
General and administrative expenses		33,741	32,831	69,023	66,536
Loss (gain) on derivatives and financial instruments, net		0	0	0	0
Loss (gain) on extinguishment of debt, net			0	15,719	0
Provision for loan losses				0
Impairment of assets		0	0	0	0
Other expenses		4,215	839	6,242	3,021
Income (loss) from continuing operations before income taxes and other items		(154,655)	(132,161)	(325,719)	(268,402)
Income tax (expense) benefit		(27)	(158)	(314)	(344)
(Loss) income from unconsolidated entities		0	0	0	0
Gain (loss) on real estate dispositions, net		0	0	0	0
Income (loss) from continuing operations		(154,682)	(132,319)	(326,033)	(268,746)
Net income (loss)		(154,682)	(132,319)	(326,033)	(268,746)
Total assets		209,644		209,644
Non-segment / Corporate | Resident fees and services
Segment Reporting Information [Line Items]
Revenue from contract with customer		0	0	0	0
Non-segment / Corporate | Interest income
Segment Reporting Information [Line Items]
Revenue from contract with customer		0	0	0	0
Non-segment / Corporate | Other income
Segment Reporting Information [Line Items]
Revenue from contract with customer		$ 454	$ 498	$ 2,611	$ 866

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Segment Reporting - Summary of Geographic Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Dec. 31, 2018 USD ($)
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 1,320,106	$ 1,125,912	$ 2,592,351	$ 2,222,877
Percent of revenues	1.000	1.000	1.000	1.000
Total assets	$ 33,148,697		$ 33,148,697		$ 30,342,072	[1]
Percent of assets	1.000		1.000		1.000
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 1,092,376	$ 895,734	$ 2,136,042	$ 1,759,523
Percent of revenues	0.828	0.795	0.824	0.791
Total assets	$ 27,496,270		$ 27,496,270		$ 24,884,292
Percent of assets	0.829		0.829		0.820
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 112,647	$ 112,031	$ 225,065	$ 228,556
Percent of revenues	0.085	0.100	0.087	0.103
Total assets	$ 3,173,654		$ 3,173,654		$ 3,078,994
Percent of assets	0.096		0.096		0.101
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 115,083	$ 118,147	$ 231,244	$ 234,798
Percent of revenues	0.087	0.105	0.089	0.106
Total assets	$ 2,478,773		$ 2,478,773		$ 2,378,786
Percent of assets	0.075		0.075		0.079

[1] The consolidated balance sheet at December 31, 2018 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

XML

Variable Interest Entities (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Variable Interest Entity [Line Items]
Total assets	$ 1,004,319	$ 1,007,091
Total equity	518,235	523,429
Total liabilities and equity	1,004,319	1,007,091
Net real estate investments
Variable Interest Entity [Line Items]
Total assets	966,417	973,813
Cash and cash equivalents
Variable Interest Entity [Line Items]
Total assets	22,491	18,678
Receivables and other assets
Variable Interest Entity [Line Items]
Total assets	15,411	14,600
Secured debt
Variable Interest Entity [Line Items]
Liabilities	462,836	465,433
Lease liabilities
Variable Interest Entity [Line Items]
Liabilities	1,326
Accrued expenses and other liabilities
Variable Interest Entity [Line Items]
Liabilities	$ 21,922	$ 18,229

XML

Subsequent Events (Details) - Subsequent Event $ in Millions	Jul. 16, 2019 USD ($) property
Bridge Loan
Subsequent Event [Line Items]
Extinguishment of debt	$ 1,000
Secured Debt
Subsequent Event [Line Items]
Extinguishment of debt	24
Benchmark Senior Living Portfolio | Disposal Group, Disposed of by Sale, Not Discontinued Operations
Subsequent Event [Line Items]
Gross sale price	$ 1,800
Number of seniors housing operating properties | property	48